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Contact lenses suffer from the same problems of deposition that other biomaterials 
exhibit, being rapidly coated with a variety of proteins, lipids and mucins. The first event 
observed at the interface between a contact lens and tear fluid is protein adsorption. Protein 
deposits on contact lenses are associated with diminished visual acuity, dryness and 
discomfort and lid-related inflammatory changes.  
 
The aim of this thesis was to determine the quantity and the conformational state of 
lysozyme deposited on contact lens materials over various time periods and also to determine 
the clinical relevance of protein deposits on contact lenses. The specific aims of each chapter 
of this thesis were as follows: 
 
• Chapter 4: To determine the total lysozyme deposition on conventional and silicone 
hydrogel contact lens materials as a function of time by artificially doping lenses with 
125I-labeled lysozyme.  
• Chapter 5: To determine the conformational state of lysozyme deposited on conventional 
and silicone hydrogel contact lens materials as a function of time using an in vitro model. 
• Chapter 6: To quantify the total protein, total lysozyme and the conformational state of 
lysozyme deposited on a novel, lathe-cut silicone hydrogel contact lens material after 
three-months of wear. 
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• Chapter 7: To determine the relationship between protein deposition and clinical signs & 
symptoms after one-day wear of etafilcon lenses in a group of symptomatic and 
asymptomatic lens wearers. 
• Chapter 8: To determine the influence of individual tear proteins (lysozyme, lactoferrin 
and albumin) on the adhesion of Gram positive and Gram negative bacteria to 
conventional and silicone hydrogel contact lens materials. 
 
Methods 
• Chapter 4: Conventional hydrogel FDA group I (polymacon), group II (alphafilcon A and 
omafilcon A), group IV (etafilcon A and vifilcon A), polymethyl methacrylate and 
silicone hydrogel lens materials (lotrafilcon A, lotrafilcon B, balafilcon A, galyfilcon A 
and senofilcon A) were incubated in a lysozyme solution containing 125I-labeled 
lysozyme for time periods ranging from 1 hour to 28 days. After each time period, 
lysozyme deposited on contact lens materials was determined using a Gamma Counter.  
• Chapter 5: Conventional hydrogel FDA groups I, II, IV and silicone hydrogel lens 
materials were incubated in lysozyme solution for time periods ranging from 1 hour to 28 
days. After each time period, the lysozyme deposited on the lenses was extracted and the 
sample extracts were assessed for lysozyme activity and total lysozyme. 
• Chapter 6: 24 subjects completed a prospective, bilateral, daily-wear, nine month clinical 
evaluation in which the subjects were fitted with a novel, custom-made, lathe-cut silicone 
hydrogel lens material (sifilcon A). After 3 months of wear, the lenses were collected and 
total protein, total lysozyme and active lysozyme deposition were assessed. 
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• Chapter 7: 30 adapted soft contact lens wearers (16 symptomatic and 14 asymptomatic) 
were fitted with etafilcon lenses. Objective measures and subjective symptoms were 
assessed at baseline and after hours 2, 4, 6 and 8. After 2, 4, 6 and 8 hour time points, 
lenses were collected and total protein, total lysozyme and active lysozyme deposition 
were assessed. 
• Chapter 8: Three silicone hydrogel (balafilcon A, lotrafilcon B & senofilcon A) and one 
conventional hydrogel (etafilcon A) lens materials were coated with lysozyme, lactoferrin 
and albumin. Uncoated and protein-coated contact lens samples were incubated in a 
bacterial suspension of Staphylococcus aureus 31 and two strains of Pseudomonas 




• Chapter 4: Lysozyme accumulated rapidly on conventional hydrogel FDA group IV 
lenses, reached a maximum on day 7 and then plateaued with no further increase. PMMA 
showed a deposition pattern similar to that seen on lotrafilcon A and lotrafilcon B 
silicone hydrogel lenses. After 28 days, conventional hydrogel FDA group IV lenses 
deposited the most lysozyme. 
• Chapter 5: After 28 days, lysozyme deposited on group IV lenses exhibited the greatest 
activity. Lysozyme deposited on polymacon, lotrafilcon A and lotrafilcon B exhibited the 
lowest activity. Lysozyme deposited on omafilcon, galyfilcon, senofilcon, and balafilcon 
exhibited intermediate activity. 
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• Chapter 6: The total protein recovered from the custom-made lenses was 5.3±2.3 µg/lens 
and the total lysozyme was 2.4±1.2 µg/lens. The denatured lysozyme found on the lenses 
was 1.9±1.0 µg/lens and the percentage of lysozyme denatured was 80±10%. 
• Chapter 7: Correlations between subjective symptoms and protein deposition showed 
poor correlations for total protein/ lysozyme and any subjective factor, and only weak 
correlations between dryness and active lysozyme. However, stronger correlations were 
found between active lysozyme and subjective comfort.  
• Chapter 8: Different tear proteins had varying effects on the adhesion of bacteria to 
contact lens materials. Lysozyme deposits on contact lenses increased the adhesion of 
Gram positive Staphyloccocus aureus 31 strain, while albumin deposits increased the 
adhesion of both the Gram positive Staphyloccocus aureus and Gram negative 
Pseudomonas aeruginosa 6206 & 6294 strains. Lactoferrin deposits increased the total 
counts of both the Gram positive and Gram negative strains, while they reduce the viable 
counts of the Gram negative strains. 
 
Conclusions 
• Chapter 4: Lysozyme deposition is driven by both the bulk chemistry and also the surface 
properties of conventional and silicone hydrogel contact lens materials. The surface 
modification processes or surface-active monomers on silicone hydrogel lens materials 
also play a significant role in lysozyme deposition. 
• Chapter 5: The reduction in the activity of lysozyme deposited on contact lens materials 
is time dependent and the rate of reduction varies between lens materials. This variation 
  vii
in activity recovered from lenses could be due to the differences in surface/ bulk material 
properties or the location of lysozyme on these lenses. 
• Chapter 6: Even after three-months of wear, the quantity of protein and the 
conformational state of lysozyme deposited on these novel lens materials was very 
similar to that found on similar surface-coated silicone hydrogel lenses after two to four 
weeks of wear. These results indicate that extended use of the sifilcon A material is not 
deleterious in terms of the quantity and quality of protein deposited on the lens. 
• Chapter 7: In addition to investigating the total protein deposited on contact lenses, it is 
of significant clinical relevance to determine the conformational state of the deposited 
protein. 
• Chapter 8: Uncoated silicone hydrogel lens materials bind more Gram positive and Gram 
negative bacteria than uncoated conventional hydrogel lens materials. Lysozyme 
deposited on contact lens materials does not possess antibacterial activity against all 
bacterial strains tested, while lactoferrin possess an antibacterial effect against certain 
Gram negative strains tested in this study. 
 
This thesis has provided hitherto unavailable information on contact lens deposition 
and its influence on subjective symptoms and bacterial binding. These results suggest that 
protein deposition has a significant potential to cause problems. Therefore, it is important 
that practitioners advise their patients regarding the importance of lens disinfection and 
cleaning and appropriate lens replacement schedules. These results will also be useful for the 
contact lens industry and the general field of biomaterials research. 
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1 Introduction 
The use of artificial materials (or “biomaterials”) within the body as replacement 
prostheses has seen a rapid rise over the last few years. 1 As a consequence, the study of 
interactions between implantation materials and body tissues has become increasingly 
important. Once inserted, the biomaterial undergoes various interactions with the host 
biological environment and the “biocompatibility” of the given material depends upon 
many factors, related to both the host and implanted material. To date, soft contact lens is 
one of the biomaterials that has received great clinical exposure.  
 
Over the last 35 years, the number of contact lens wearers has increased from 10 
million to 140 million, with the vast majority (over 90%) of the patients being fitted with 
soft, hydrophilic lenses. 2 Recent reports suggest that the contact lens industry is healthy 
and the worldwide soft contact lens market is estimated at $5.3 billion, while the U.S. 
market is estimated at $1.9 billion. 3 However, it has been observed that 35% of contact 
lens wearers discontinue from lens wear due to various issues including, discomfort and 
dryness, 4 possibly as a direct consequence of lens deposition. 5, 6 
 
Contact lenses suffer from the same problems of deposition that other 
biomaterials exhibit, being rapidly coated with a variety of proteins, lipids and mucins. 6-
13 The first event observed at the interface between a contact lens and tear fluid is protein 
adsorption.14, 15 Of late, the study of interaction of tear proteins with contact lenses has 
become an important field of research, following the widespread use of contact lenses in 
many physiological and pathological conditions. Tears have a rich and complex 
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composition, allowing a wide range of interactions and competitive processes. Protein 
adsorption on contact lenses is the overall result of various types of interactions between 
the different components present, i.e. the chemical composition and the surface charge, 
the structure of the protein molecules, the nature of the medium (tears) and many other 
solutes present in tears.  
 
To improve the biocompatibility of contact lenses with the ocular surface, there 
needs to be a better understanding of the way in which contact lenses interact with the 
corneal surface and the tear film, and of the lens-related factors contributing to infection 
and inflammatory responses. The aim of this thesis is to gain a greater understanding of 
the interaction of tear proteins with conventional and novel silicone hydrogel lens 
materials and also to determine the influence of tear protein deposits on the subjective 
symptoms and bacterial adhesion to contact lens materials.  
 
Chapter 2 of this thesis provides an overview of literature concerning various 
contact lens materials, the tear film, tear film proteins, deposition of tear proteins on 
contact lens materials, various methods used to determine the protein deposited on 
contact lenses and also on the major corneal infections related to contact lens wear. 
Chapter 3 lists the various objectives of this thesis. Chapter 4 determines the quantity of 
total lysozyme deposited on various conventional and silicone hydrogel contact lens 
materials over time. Chapter 5 discusses the conformational state of the lysozyme 
deposited on various conventional and silicone hydrogel contact lens materials as a 
function of time using an in vitro model. Chapter 6 determines the protein deposition on a 
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novel, lathe-cut silicone hydrogel contact lens material after three months of wear. 
Chapter 7 discusses the relationship between protein deposition and clinical signs and 
symptoms after one-day wear of etafilcon contact lenses in a group of symptomatic and 
asymptomatic contact lens wearers. Chapter 8 determines the effect of protein deposits on 
bacterial adhesion to conventional and silicone hydrogel contact lens materials. Chapter 9 
provides a summary of all the results from this thesis and chapter 10 recommends a list of 
projects that can be conducted as a continuation of this research work, which would be 
valuable additions to the literature and would help in the development of safer and more 
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2 Literature Review 
2.1 Contact lenses 
Contact lenses are one of the most widely used biomedical devices in the world. 1 
They have been studied extensively with respect to their level of deposition, primarily 
due to their non-invasive use and easy recovery compared to other biomaterials in contact 
with biological fluids. 2 Contact lens materials can broadly be classified into two types 
based on their modulus and elasticity, (a) water-containing soft (hydrogel) and (b) non-
water containing rigid gas-permeable (RGP) materials.  
 
2.1.1 Conventional hydrogel contact lens materials 
Hydrogels are water-absorbing, hydrophilic polymeric materials. The amount of 
water adsorbed by the hydrogel is described by the term “equilibrium water content” 
(EWC) and this factor strongly influences the polymer’s surface, mechanical and 
transport properties. 3 The first successful material of this type (poly-2-hydroxyethyl 
methacrylate [polyHEMA]) was developed by Wichterle and Lim in the late 1960’s as a 
general purpose surgical material. 3 The hydrophilicity of polyHEMA arises from the 
presence of hydrophilic side groups. 3, 4 As noted above, the amount of water absorbed by 
a hydrogel is expressed as the EWC, which represents a percentage ratio between weight 
of water in the gel and weight of the hydrated gel. EWC is a crucial factor for oxygen 
permeability of polyHEMA-based hydrogels, because oxygen permeation occurs 
primarily through the water filled channels of the swollen gel.  
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Oxygen delivery to the cornea depends upon both the oxygen permeability (Dk) 
of the material and the thickness (t) of the lens. 4 The Dk of conventional hydrogels is 
directly related to the amount of water that a polymer can hold, since the oxygen 
dissolves into the water-phase of the material and diffuses through the lens from the 
anterior to the posterior lens surface. 4 The Dk increases logarithmically with increasing 
water content of the material. 5 Unfortunately, this reliance on water to maximize Dk has 
been a severely limiting factor for the development of hydrogels, since water has a Dk 
value of only 80 barrer. 6  
 
Morgan and Efron estimated that polyHEMA has a Dk of only 9-10 barrers. 7 In 
order to increase the Dk of a conventional hydrogel contact lens material beyond that of 
polyHEMA, it is necessary to incorporate monomers that will bind more water into the 
polymer. Two principal strategies are available to increase the water content of hydrogels 
above that of polyHEMA. Small quantities of charged groups such as methacrylic acid or 
larger amounts of hydrophilic, neutral groups such as polyvinyl alcohol or N-vinyl 
pyrrolidone are added to polyHEMA or methyl methacrylate to raise their equilibrium 
water contents to 60% or greater. 4, 8 However the incorporation of these more 
hydrophilic monomers also results in contact lenses with decreased strength and 
elasticity. 8 On the other hand, copolymerization with hydrophobic monomers like methyl 
methacrylate (MMA) and tetraethyleneglycol dimethacrylae (TEGDMA) decreases water 
content, while increasing lens stiffness and reducing elasticity. 8 
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Commercially available hydrogel contact lens materials are divided into various 
groups depending upon their charge and water content. The United States Food and Drug 
Administration (FDA) currently classifies contact lens materials into four groups, 
depending upon their charge and water content (Table 2.1). 
 
Table 2-1: FDA classification of hydrogel contact lens materials 
FDA Classification Group I Group II Group III Group IV 
Water Content Low High Low High 
Charge Non-Ionic Non-Ionic Ionic Ionic 
Low = < 50% water; High = > 50% water; Ionic = Charged; Non-Ionic = No charge  
From a clinical perspective, it must be remembered that oxygen delivery to the 
cornea depends upon both the Dk of the material and the lens thickness (t), with thinner 
lenses providing the cornea with more oxygen, since there is less of a barrier for the 
oxygen to diffuse through. The most widely cited figures for the minimum acceptable 
Dk/t are 24 x 10-9 units for daily wear and 87 x 10-9 units for overnight or extended wear.  
9 Recently, a level of 125 x 10-9 units has been reported as a requirement to prevent 
stromal anoxia during closed-eye conditions. 10, 11 
 
Hydrogel contact lenses are used for different wearing modalities. They are as 
follows: 
1. Daily wear (DW) lenses are cleaned and removed each night and are discarded 
after a period of time. This period varies from one day to one year, but usually 
after 30 days or less. 
 9
2. Extended wear (EW) contact lenses are worn for 7 days and 6 nights, with the 
lens disposal occurring after this time-frame. The advantages of extended wear 
are that this wearing modality offers the convenience of less handling and 
maintenance and therefore fewer lens solutions and potentially lower costs. 
Patients can awake in the morning seeing clearly. The disadvantages of extended 
wear with conventional soft materials are the associated hypoxic complications 
that occur. 
3. Continuous wear (CW) refers to wearing contact lenses while sleeping overnight 
for periods of up to thirty days and nights consecutively. Under this modality, 
contact lenses remain on the ocular surface for up to 30 days and nights without 
removal, after which they are discarded. 
 
To maintain normal corneal physiology and to prevent corneal infection, the 
corneal tissues require sufficient oxygen to function without compromising cellular 
processes. Clearly, this is more difficult under closed-eye conditions, when the lid 
severely limits oxygen transport to the cornea. In order to provide a healthy ocular 
surface under extended wear and continuous wear conditions, it is important that the lens 
material transmits a substantial amount of oxygen to the ocular surface. It is clear that the 
conventional hydrogel lens materials provide inadequate oxygen transmissibilities for 
safe, edema-free overnight wear. This awareness of the short-comings of conventional 
hydrogel materials resulted in the development of novel silicone hydrogel materials that 
would transmit increased amounts of oxygen to the corneal surface. 
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2.1.2 Silicone hydrogel contact lens materials 
2.1.2.1 Development of silicone hydrogel contact lenses 
Preliminary attempts (in the 1970’s and early 1980’s) to use silicone within 
hydrogel lenses in the silicone elastomers failed due to the exposure of hydrophobic 
silicone on the surface of the lens material. 12 This resulted in increased lens binding to 
the cornea, enhanced lipid deposition and decreased in-eye wettability of the lens. 13 In 
order to cope with this problem, lens materials had to undergo a surface modification 
process, which would increase the hydrophilicity of the lens surface and make the surface 
more wettable and hence more biocompatible. 14 Additionally, the surface treatment 
should maintain a stable tear film layer, be non-irritating, provide low bacterial adherence 
and minimize deposition of substances from tears. 15 
The most common silicone is polydimethylsiloxane (PDMS), which features a 
repeating (CH3)2SiO unit (Figure 2.1). 12 Due to the presence of the Si-O backbone, 
PDMS possesses relatively higher oxygen permeability when compared to polyHEMA-
based polymers. 16 However, its highly hydrophobic characteristic induces increased lipid 
affinity, poor wettability and corneal adhesion. 12, 16 To overcome these issues, PDMS 
had to be modified significantly before being considered as a contact lens material. The 
main modification strategy involved combining the high oxygen permeability property of 
PDMS with the hydrophilic nature and wettability of polyHEMA. 12 The major challenge 
in designing these copolymers is combining the hydrophobic silicone macromers with the 
hydrophilic monomers. 12 The early copolymerizations resulted in opaque and phase-
separated materials. However successful materials have been generated, involving 
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strategies including the use of hydrophilic block siloxane copolymers, siloxane graft 
copolymers and modification of trimethylsiloxy silane (TRIS), which led to the 
development of commercial contact lenses based on silicone technology. 16  
 
Figure 2-1: The structure of PDMS  
Two key approaches significantly contributed to the development of silicone 
hydrogel contact lens materials. 12, 16 The first approach involved the incorporation of 
fluorine into silicone hydrogels, resulting in fluorosilicone hydrogels. The reactive site is 
shown in Figure 2.2. These types of fluorosiloxane-containing monomers enhance the 
relative compatibility with hydrophilic monomers, obtaining the desired transparent 
copolymers. 17 Furthermore, fluorosilicone hydrogels improved deposit resistance due to 
the presence of the fluorinated group. 16, 17    
 
Figure 2-2: Modification site of TRIS by the introduction of hydrophilic groups.  
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The other approach involved the development of siloxane macromers. A typical 
siloxane macromer is copolymerized by combining siloxane monomers (such as TRIS), 
hydrophilic monomers (such as NVP or DMA) and fluorinated monomers. 16 These types 
of hydrophilic macromers are the major polymeric components used in silicone hydrogel 
formulations. 16 Figure 2.3 shows the structure of a siloxane macromer used in silicone 
hydrogel lenses.  
 
Figure 2-3: Structure of siloxy-based polyfluoroether macromer.  
 
Consequently, silicone hydrogel lenses were developed and were first introduced 
into the market in 1999. 12 The addition of silicone to the lens increases the material’s 
oxygen transmission, while the hydrogel component allows for fluid transport and lens 
movement. The combination of these two components allows for safe, extended wear of 
lenses when compared to conventional lens materials. 4, 13 These lens materials transmit 
5-6 times more oxygen than the conventional polyHEMA-based lenses and hence could 
provide safe overnight wear. 4  
 
2.1.2.2 Properties of silicone hydrogel contact lenses 
Currently six silicone hydrogel lenses are available in the North American market. 
Table 2.2 summarizes the differences between the six silicone hydrogel lenses that are 
currently available.  
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Table 2-2: Characteristics of currently available silicone hydrogel lenses 





USAN Lotrafilcon A Lotrafilcon B Balafilcon A Galyfilcon A Senofilcon A ComfilconA 
Manufacturer CIBA Vision CIBA Vision Bausch & Lomb Johnson & Johnson 
Johnson & 
Johnson CooperVision 
Water content (%) 24 33 36 47 38 48 
Oxygen Permeability 
(Dk) † 140 110 91 60 103 128 
Centre thickness (mm)  
-3.00D 0.08 0.08 0.09 0.07 0.07 0.08 
Oxygen 
Transmissibility  
(Dk/t) ††  at 35˚C 
175 138 101 86 147 160 
FDA group I I III I I I 
Modulus (MPa) 1.5 1.0 1.1 0.4 0.7 0.75 
Surface Treatment 
25nm plasma coating 
with high refractive 
index 
25nm plasma coating 









wetting agent.  
No surface 
treatment 

















DMA (N,N-dimethylacrylamide); EGDMA (ethyleneglycol dimethacrylate); HEMA (poly-2-hydroxyethyl methacrylate); mPDMS 
(monofunctional polydimethylsiloxane) NVP (N-vinyl pyrrolidone); TEGDMA (tetraethyleneglycol dimethacrylate); TPVC (tris-
(trimethylsiloxysilyl) propylvinyl carbamate); TRIS (trimethylsiloxy silane); NVA (N-vinyl aminobutyric acid); PBVC (poly[dimethysiloxy] di 
[silylbutanol] bis[vinyl carbamate]); PVP (polyvinyl pyrrolidone). 
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† The oxygen permeability of a material is referred to as the Dk. The units of 10 -11 cm2/s 
ml O2/ml X mm Hg are often omitted for convenience. Dk value is a physical property of 
a contact lens material and describes its intrinsic ability to transport oxygen. “D” is the 
diffusion coefficient – a measure of how fast dissolved molecules of oxygen move within 
the material and “k” is a constant representing the solubility coefficient or the number of 
oxygen molecules dissolved in the material. 
  
†† Oxygen transmissibility is referred to as Dk/t, with units of 10 -9 cm/s ml O2/ml X mm 




CIBA Vision’s Night & Day™ material, lotrafilcon A, employs a co-continuous 
biphasic or two channel molecular structure, in which two phases persist from the front to 
the back surface of the lens. 18-21 The siloxy phase facilitates the solubility and 
transmission of oxygen and the hydrogel phase transmits water and oxygen, allowing 
good lens movement. The two phases work concurrently, to allow the co-continuous 
transmission of oxygen and aqueous salts. Lotrafilcon A is comprised of a fluoroether 
macromer co-polymerised with the monomer TRIS and N,N-dimethyl acrylamide 
(DMA), in the presence of a diluent. 12, 22 The resultant silicone hydrogel material has a 
water content of 24% and a Dk of 140 barrers. 23 CIBA Vision’s O2Optix™ material, 
lotrafilcon B, is based upon the technology used in Night & Day™ and is surface treated 
in the same manner. It has a water content of 33% and a Dk of 110 barrers and is less stiff 
than the lotrafilcon A material. The surfaces of the lotrafilcon A and B lenses are 
permanently modified in a gas plasma reactive chamber to create an ultrathin (25 nm), 
high refractive index, continuous hydrophilic surface. 12, 18-21 
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Balafilcon lenses are surface treated in a gas plasma reactive chamber, which 
transforms the silicone components on the surface of the lenses into hydrophilic silicate 
compounds. 12, 22 This results in glassy, discontinuous silicate islands and the 
hydrophilicity of these areas bridges over the underlying hydrophobic balafilcon material. 
Balafilcon A is a homogeneous combination of the silicone-containing monomer 
polydimethylsiloxane (a vinyl carbamate derivative of TRIS) co-polymerized with the 
hydrophilic hydrogel monomer N-vinyl pyrrolidone (NVP). 16, 22, 24, 25 This silicone 
hydrogel material has a water content of 36% and a Dk of 101 barrers.  
 
Vistakon’s Acuvue® Advance™ material, galyfilcon A, incorporates a long 
chain, high molecular weight molecule called Hydraclear™, which maintains flexibility 
and moisture. 26-28 This wetting agent is present throughout the lens material and hence 
no surface treatment is required for these lenses. 26 This lens material has a water content 
of 47%. It was the first of the so-called “second generation” silicone hydrogels 29 and has 
a UV blocker, with a reported Class 1 UV protection, blocking >90% of UVA and >99% 
of UVB rays. 26-28, 30 Vistakon’s Acuvue® OASYS™ (senofilcon A) has a light blue tint, 
Class 1 UV blocking capabilities and a 1-2-3 inversion marker. 31 
 
CooperVision’s Biofinity® lens is manufactured from comfilcon A and has a 
significantly higher oxygen permeability 32 than would be predicted from its water 
content, implying that the chemistry upon which it is based is different to that employed 
in the current silicone hydrogels, which are all based on the highly oxygen permeable 
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monomer TRIS. This silicone hydrogel material has a water content of 48% and a Dk of 
128 barrers. 
 
Once the contact lens is inserted onto the eye, it interacts to a great extent with the 
tear film. The next section provides an overview of the tear film, its structure, functions 
and various components that are present in the tear film.  
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2.2 The tear film 
The tear film is by far the most dynamic unit in the lacrimal functional unit. The 
tear film consists of a variety of components, including electrolytes, salts, proteins, lipids, 
mucins and peptides. The normal pH value of the tear film is between 7.14 and 7.82, with 
a mean value of 7.4-7.5, which is similar to plasma pH. 33 The tear film has several 
specific functions and they are listed below: 
1. It provides lubrication to the ocular surface and nurtures the anterior tissues of the 
eye. 
2. It provides a regular optical surface for the eye’s optical system, by filling the 
irregularities of the corneal epithelium.  
3. The corneal epithelium and stroma receive oxygen that is dissolved in the tear 
film.  
4. The tear film is an integral part of the ocular surface defense mechanism.   
5. It removes cellular debris and metabolic waste from the cornea and conjunctiva 
with blink.  
 
In 1946, Wolff proposed that the tear film was a three-layered structure, 
consisting of an anterior lipid layer, middle aqueous layer and deeper mucin layer (Figure 
2.4). 34 Another model with six layers has been proposed by Tiffany, 35 which included 
the original three layers proposed by Wolff, along with air-lipid, lipid-aqueous and 
aqueous-mucus interfaces. Dilly suggested that there are dissolved mucins in the aqueous 
layer, which decrease in concentration towards the lipid layer. 36 Currently the most 
 18
accepted concept is that the tear film is a bilayered structure, consisting of an 
aqueous/mucinous phase, with an overlying superficial lipid phase. 37  
 
Figure 2-4: Layers of the tear film  
Composition of the tear film, showing the three layers: an outer lipid layer, an 
intermediary aqueous layer and inner layer of mucins (Reproduced from http://www.lea-
test.fi/en/eyes/images/pict7b.jpg) 
 
2.3 Layers of the tear film 
2.3.1 The lipid layer 
Lipid forms the superficial/outermost layer of the tear film and is derived 
primarily from the meibomian glands in the eyelids. 38 It is believed that the lipid layer 
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has two distinct regions - a relatively thick outer layer, containing non-polar lipids such 
as wax esters, sterol esters, hydrocarbons, and triglycerides; and a thin polar inner layer, 
predominantly consisting of phospholipids. 39 The polar phase of the lipid layer owes its 
surfactant properties which facilitate mixing with both aqueous and non-polar lipids. It 
acts base for the more superficially located non-polar lipids. 40 The major classes of lipids 
are the wax monoesters and sterol esters, which comprise approximately three-quarters of 
the meibomian gland fluid. 40, 41 Studies using specular microscopy have reported lipid 
thickness values of 100 nm. 42 Using specular reflectometry, it was found that the lipid 
layer thickness was 13-70 nm. 43 The refractive index of meibomian lipid was found to be 
1.4766 at 589 nm and 35°C. 44  
 
2.3.1.1 Functions of the lipid layer 
1. To provide an effective barrier and prevent evaporation. 45 
2. To provide a surfactant layer that acts as an effective bridge between the non-
polar lipid layer and the aqueous mucinous layer. 46 
3. To act as a lubricant to facilitate the movement of the eyelids during blinking. 47 
4. To maintain compression and expansion of the lipid film during blinks, to prevent 
tear overflow. 47 
5. To form a barrier for preventing contamination of the tear film. 44 




2.3.2 The aqueous layer 
The aqueous layer of the tear film forms the bulk of the tear film thickness. The 
aqueous layer is approximately 6.5-7.5 μm thick. 49 This intermediary watery phase is 
mainly produced by the main lacrimal gland, and also by the accessory glands of Krause 
and the accessory glands of Wolfring. This layer is composed of electrolytes, protein 
enzymes and metabolites. The bulk of the aqueous component of the tears is not only 
composed of water, but contains numerous electrolytes, proteins, peptide growth factors, 
vitamins, anti-microbials, cytokines, immunoglobulins, and hormones. The composition 
of the tear film varies in response to environmental and bodily conditions. Electrolytes 
present in the tear film include sodium, potassium, magnesium, calcium, chloride, 
bicarbonate, and phosphate ions. These are largely responsible for modifying the 
osmolality of tears, 50 act as a buffer to maintain pH at a relatively constant level 51 and 
maintain epithelial integrity. 52  
 
To date, over 90 human tear proteins have been identified (Table 2.4), 53-55 of 
which the primary proteins are lysozyme, lactoferrin, and lipocalin. 56 Other important 
proteins of note include serum albumin, IgG, ceruloplasmin, transferrin, and monomeric 
IgA. 56 The tear proteins are explained in greater detail in an upcoming section (Section 
2.4). Numerous peptide growth factors including EGF, HGF, TGF β are also found in the 
aqueous layer. 54, 55  
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2.3.2.1 Functions of the aqueous layer 
1. This layer is responsible for creating a conducive environment for the epithelial 
cells of the ocular surface, carrying essential nutrients and oxygen to the cornea, 
allowing cell movement over the ocular surface. 57 
2. The major tear proteins found in this layer (lysozyme, lipocalin, lactoferrin and 
IgA) are responsible for antimicrobial activity. 57-59 
3. Washing away debris, toxic substance and foreign bodies with blink. 59 
4. Many of the growth factors that are present in the aqueous phase play a significant 
role in corneal physiology. 59 
5. Quantitatively, this is the most important layer.  
 
Table 2.3 lists some of the various components of the aqueous and lipid phase, 
their concentrations and other physical characteristics. 
 




Basal (or Open) Eye 
Tear Fluid 
Closed Eye (sleep) 
Tear Fluid 
Reflex Lacrimation/ 
during SCL wear 
Water 60 98 – 98.5% - - 
Oxygen 61 155mm Hg 55mm Hg - 
Fluid volume 62 6.2 – 9.0 μl  - - 
pH 63 Range 6.5 - 7.8 - SCL: range 6.6 – 7.3 
Osmolarity 64, 65 302 – 325  mOsm/l < 300mOsm/l Reflex: 285 mOsm/l SCL: 307 mOsm/l 
Flow rate62, 66 0.5 - 1.2 μl/min Almost stagnant Reflex: > 1.2 μl/min 
Turnover rate 67 14-15 %/min - - 
Refractive index 68 1.335 – 1.53 - - 
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14.7 ± 6.0 gm.cm-2.sec-1 - - 
Viscosity 60, 71 5 - 8 mPa.s 9 mPoises - - 
Tonicity 60 Equal to 1.0% NaCl Equal to 0.9% NaCl - 
Ions Content 72 
Sodium 145 mEq/l 
Potassium 20 mEq/l 
Chloride 128 mEq/l 
Bicarbonate 26 mEq/l 
Calcium 2.11 mg/dl 













5 mg% - 
Antioxidants 74 
Ascorbic acid 665 μM 
Tyrosine 45 μM 
Glutathione 107 μM 
Cysteine 48 μM 
Uric acid 328 μM 
Ascorbic acid 116 μM 
Tyrosine 16 μM 
Glutathione 131 μM 
Cysteine 20 μM 





Range 4.0 – 9.4 mg/ml 18 - 43 mg/ml  
Reflex: 6.0 mg/ml 
SCL: Range 8-14 mg/ml 
Secretory IgA 
Concentration 75-77 0.54 - 0.85 mg/ml 8.4 - 5.5 mg/ml 
Reflex: 0.23 mg/ ml 




0.8 – 6.3 mg/ml 1.8 mg/ml Similar to basal tears 
Reflex: 1.8 mg/ml 








1.2 - 4.6 mg/ml 1.8 mg/ml Similar to basal tears 
Reflex: 1.6 mg/ml 
Similar to basal tears 
SCL: 1.4 – 1.7 mg/ml 
Enzyme Content 
83, 84 
Peroxidase 5.2 – 7.7 U/ml 
Secretory phospholipase A2 
1.45 μg/ml 
Gelatinase 0.3 ng/ml 
β-lysin 0.3 ng/ml 
- - 
Lipid layer 
Content 85 0.13 – 1.8 mg/ml - - 
Lipid components 
(percentage by 
weight) 85, 86 
Sterol esters  27 - 29.5%w 
Waxy esters 32 – 35%w 
Triacylglycerols 4.0%w 
Free sterols 1.8 – 2.0%w 
Free fatty acids 0.5 - 2.1%w 
Polar lipids 15.0 - 16.0%w 





2.3.3 The mucin layer 
Mucins are primarily produced in the goblet cells of the conjunctiva and the 
crypts of Henle in the conjunctival fornices. 87 A secondary source of mucin is from the 
squamous epithelial cells of the ocular surface (cornea and conjunctiva), 36, 88, 89 with a 
small contribution from the lacrimal gland. Goblet cell mucin forms a gel in the deepest 
layer of the tear film, while soluble mucin is found in the aqueous layer. 90  
 
Mucins are high molecular weight glycoproteins, that have at least 50 to 80% of 
their mass as carbohydrate, O-linked to serine and threonine residues present within 
tandem repeats of amino acids in their protein backbone. 91-93 Mucins are hydrophilic in 
nature and their molecular mass range from 3 × 105 to over 4 × 107 kDa. 91-93 To date, at 
least 20 distinct human mucins have been cloned (MUC1– MUC20, including 3A, 3B, 
5AC, and 5B). 94, 95 Mucins are classified as either transmembrane or secretory mucins. 91 
Secreted mucins can further be sub-classified as gel-forming or soluble, based on their 
ability to form polymers. Of these, MUCs 1, 3A, 3B, 4, 12, 13, 15, 16, 17 and 20 have 
been characterized as membrane associated. MUC 2, 5AC, 5B, 6, 7 and MUC9 are 
classified as secretory mucins. 96 In this category, MUC 2, 5AC, 5B, 6 are categorized as 
gel-forming mucins and MUC7 & MUC9 are classified as soluble mucins. 96 Several 
reports have shown alterations of mucin products in the ocular surface in dry eye. 97-99 
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2.3.3.1 Functions of the mucin layer 
1. One of the primary functions of mucin is lubrication, facilitating the eyelid 
margins and palpebral conjunctiva to slide smoothly over one another during 
blinking and ocular rotational movements. 100 
2. Mucus plays an important role in overcoming this hydrophobicity of the corneal 
surface, when non-wetting occurs in some areas of the cornea. 100 
3. Mucus threads protect the cornea and conjunctiva from abrasion by covering 
foreign bodies with a slippery coating. 101 
4. Mucus also helps in wetting the ocular surface and in glycocalyx formation. 36 







2.4 Tear Proteins 
Using a proteomic technique, 97 proteins have been identified in the tear film. 55 
The various tear proteins that were identified in the study 55 are mentioned in Table 2.4. 
Table 2-4: List of tear proteins identified using tear proteomic approach 55 
  Protein Function - location 
1 Lactoferrin Transfer/carrier – secretory granule 
2 Poly Ig receptor Immune response – plasma membrane 
3 Serum albumin Transfer/carrier - extracellular 
4 Basic proline-rich protein Unclassified - extracellular 
5 Ig Alpha 1 bur Immune response – plasma membrane 
6 IGHA1 Protein Immune response - plasma membrane 
7 Zn-alpha2-glycoprotein Lipid and fatty acid metabolism, glycolysis - 
extracellular 
8 Lipocalin 1 Transfer/carrier - extracellular 
9 Proline Rich 4 Unclassified - extracellular 
10 Ig alpha 1 Immune response – plasma membrane 
11 Haptoglobin Serine protease - extracellular 
12 Lacritin Unclassified - extracellular 
13 Cystatin S Protease inhibitor - cytoplasm 
14 IgG Kappa Immune response - plasma membrane 
15 Keratin 9 Cell structure - cytoplasm 
16 Immunoglobin J Immune response – endoplasmic reticulum 
17 Prolactin induced protein Unclassified - extracellular 
18 Keratin 14 Cell structure - cytoplasm 
19 Keratin 10 Cell structure - cytoplasm 
20 Lysozyme Carbohydrate metabolism - extracellular 
21 Cystatin SN Protease inhibitor - cytoplasm 
22 Secretoglobin, family 2A, 
member 1 (Lipohilin C) 
Unclassified - extracellular 
23 Secretoglobin, family 1D, 
member 1 (Lipophilin A)  
Transfer/carrier - extracellular 
24 Alpha1-antichymotrypsin Protease inhibitor - extracellular 
25 Ig Variable Immune Response - plasma membrane 
26 HRPE773 Unclassified - unknown 
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27 Protein Len, Bence Jones Immune response - plasma membrane 
28 Ig Mu Immune response - extracellular 
29 Ig alpha chain C Immune response - plasma membrane 
30 DMBT1 (gp 340) Extracellular transport and import - extracellular 
31 Annexin A1 Fatty acid metabolism, cell motility – plasma 
membrane 
32 Lactate dehydrogenase A Glycolysis - cytoplasm 
33 Annexin A2 Transfer/carrier  - nucleus 
34 Heat shock 70 KDa 1B Chaperone - cytoplasm 
35 Triosephosphate isomerase Glycolysis, metabolism - cytoplasm 
36 Immunoglobin lambda Immune response - plasma membrane 
37 Aldehyde dehydrogenase 1 Dehydrogenase - unknown 
38 Heat shock 27 KDa protein 1 Chaperone, Cell structure (muscle contraction 
vision) - cytoplasm 
39 IGHM Protein Immune response 
40 Keratin 1 Cell Structure – plasma membrane 
41 proapolipoprotein Transporter lipid and fatty acid 
42 Peroxiredoxin 1 Antioxidation and free radical removal - 
cytoplasm 
43 Keratin 6B Cell Structure - cytoplasm 
44 Neutrophil gelatinase-
associated Lipocalin 
Small molecule transport - extracellular 
45 Keratin 6A Cell structure - cytoplasm 
46 Transferrin Transfer/carrier - extracellular 
47 Selenium binding protein Immune response - cytoplasm 
48 Pyruvate kinase Glycolysis - unknown 
49 Prostatic binding protein Transfer/carrier - cytoplasm 
50 Hornerin Unclassified – plasma membrane 
51 Peroxiredoxin 2 Antioxidation and free radical removal - 
cytoplasm 
52 Glutathione S-transferase Detoxification - cytoplasm 
53 Immunoglobin lambda light 
chain 
Immune response – plasma membrane 
54 S100 Calcium binding 
protein A11 
Signaling, DNA replication - cytoplasm 
55 Ezrin Cell structure - cytoplasm 
56 Peroxiredoxin 5 Antioxidation and free radical removal - 
cytoplasm 
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57 Cyclophilin A Transport/immune response - cytoplasm 
58 Eukaryotic translation 
elongation factor 
Translational regulation - cytoplasm 
59 S100 Calcium binding 
protein A9 
Cell communication, immune response - 
cytoplasm 
60 Actin, beta Cell structure - cytoplasm 
61 Serine Proteinase inhibitor Proteolysis - extracellular 
62 S100 Calcium binding 
protein A8 
Cell Communication - cytoplasm 
63 S100 Calcium binding 
protein A6 
Signal transduction - cytoplasm 
64 Polyubiquitin Proteolysis - cytoplasm 
65 S100 Calcium binding 
protein P 
Cell Communication - cytoplasm 
66 S100 Calcium binding 
protein A4 
Macrophage mediated immunity - cytoplasm 
67 Cystolic malate 
dehydrogenase 
Dehydrogenase - cytoplasm 
68 PGK1 Glycosysis - cytoplasm 
69 Skeletal muscle alpha-actin Cell structure - cytoplasm 
70 Thioredoxin peroxidase Antioxidation, free radical removal - cytoplasm 
71 Enolase 1 Glycolysis - cytoplasm 
72 Peptidylprolyl isomerase A 
(Cyclophilin A) 
Protein folding, immune response - cytoplasm 
73 Calmodulin Protein phosphorylation, Ca mediated signaling, 
muscle contraction - cytoplasm 
74 Isocitrate dehydrogenase 1 Tricarboxylic acid pathway - cytoplasm 
75 Ig G1 H Nie Immune response – plasma membrane 
76 Aldehyde dehydrogenase 
Isozyme 3 
Other carbon metabolism - cytoplasm 
77 Aldehyde dehydrogenase 
1A1 
Other carbon metabolism - unknown 
78 Alpha-1-antitrypsin Proteolysis - extracellular 
79 Heat shock 70KDa protein 6 Protein folding, stress response - Nucleus 
80 Heat shock 70KDa protein 8 Protein folding, stress response - nucleolus 
81 Hemopexin Transfer/carrier protein - extracellular 
82 Argininosuccinate synthetase Amino acid synthesis - cytosol 
83 Villin 2 Cell structure - cytoplasm 
84 Gelosin isoform a Cell structure - unknown 
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85 Protein Rei, Bence-Jones Immune response – plasma membrane 
86 Transcobalamin 1 Vitamin metabolism, Cation transporter - 
extracellular 
87 NGAL (Lipocalin 2) Small molecule transport - extracellular 
88 Secretory leukocyte 
peptidase inhibitor 
Protease inhibitor - extracellular 
89 Beta-2 microglobin Cell Structure - extracellular 
90 Cystatin C Protease inhibitor - extracelluar 
91 Mesothelin/megakaryocyte 
potentiating factor 
Ligand-mediated signaling, cell adhesion - 
unknown 
92 Keratin 2a Cell structure - cytoplasm 
93 Pre-pro-megakaryocyte 
potentiating factor 
Ligand-mediated signaling, cell adhesion - 
unknown 
94 Clusterin (apolipoprotein J) Apoptosis - extracellular 
95 Complement Component 3 Immune response - extracellular 
96 Secretoglobin, family 2A 
member 2 (Mammaglobin 2) 
Unclassified - extracellular 
97 Ig J Immune response – plasma membrane 
   
 
The following section provides a brief overview of some of the major tear 




Lysozyme (also called Muramidase) is a bacteriolytic enzyme that was discovered 
by Fleming in 1922. 102 It is found in mammalian urine, saliva, tears, milk, cervical 
mucus, leukocytes and kidneys. 103 Tear lysozyme is derived from the acinar and ductal 
epithelial cells of both main and accessory lacrimal glands. 104, 105  
 
2.4.1.1 Lysozyme structure 
Lysozyme is a compact globular protein molecule with a molar mass of 14,500 
Da. 105 It has a slightly ellipsoidal shape, and its dimensions are 45 X 30 X 30 Å. 106 It is 
a compact protein of 129 amino acids which folds into a compact globular structure. 106 
The 129 amino acid sub-units are cross-linked by four disulphide bridges. 107 There is a 
close cluster of basic groups (Arginine 45 and 68 in one region, Arginine 61 and 73 in a 
second and Arginine 5, 125 and 128 in a third) which form the highly positively charged 
surface regions of lysozyme, which give it a very high isoelectric point of 11.1. 
Lysozyme is a relatively stable protein when compared to most other proteins. 108 The 
properties of lysozyme do not change at pHs between 1 and 8. 109 A study by Ikeda and 
colleagues showed that lysozyme denatures only when the pH is above 12. 110 The 
thermal stability of lysozyme in various solutions was studied by Hamaguchi and Sakai  
and they demonstrated that its structure is not affected by heat up to 55˚ C. 111 Moreover, 
by increasing the temperature only the internal fold of lysozyme is disrupted and no 
changes occur in the helical part at high concentrations of organic solvents.  
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The polypeptide chain forms five helical segments, a 3 stranded anti-parallel Beta 
sheet that comprises one wall of the binding cleft.  A deep cleft contains the active site 
(described later in Section 2.4.1.4) which divides the molecule into two domains. These 
domains are linked by alpha-helix residues. One domain consists of residues that have 
Beta Sheet structure; the other domain has in its residues that are helical in nature. 106   
 
2.4.1.2 Structural aspects of lysozyme – from the viewpoint of an antibody 
Lysozyme, in its native globular state contains two fragments which have 
immunologic activity and encompass two independent antigenic determinants. 112 One of 
these immunologically active fragments consists of two peptides, derived from the NH2-
terminus and the COOH-terminus of lysozyme linked together by a disulphide bond. The 
second immunologically active component isolated was a large fragment derived from 
the region located between residues Leucine 57 and Arginine 107 of the lysozyme 
sequence. 112 This peptide which contains two disulphide bridges, is also capable of 
binding to anti-lysozyme antibodies. Similar structure was obtained for lysozyme in 
further experiments conducted using epitope mapping. 113   
 
2.4.1.3 Structural comparison of human lysozyme versus hen egg lysozyme 
X-Ray crystallographic studies 107, 114 and far-UV circular dichroism studies 115, 116 
suggest that the two enzymes namely, human lysozyme and hen egg lysozyme have very 
similar secondary structures. Despite the fact that the sequences in human lysozyme and 
hen egg lysozyme are different, 117 sizable numbers of substitutions are non-conservative; 
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however the structures and functions are highly similar. 106 Moreover, if the ionic 
strength was maintained constant within a certain range (pH 5 to 9), the activity of both 
these enzymes were found to be same. 106, 118   
 
2.4.1.4 Structure – Activity Relationship of lysozyme 
Lysozyme is instrumental in destroying certain species of bacteria which are 
gram-positive. 103, 106 These gram-positive bacteria possess an outer coat of a 
peptideglycan (sugar) polymer (or peptidoglycan), which, in gram-negative bacteria, is 
only transiently stained since those bacteria are covered by a second, outer lipid 
membrane. 119 Lysozyme hydrolyzes or breaks up the glycan (sugar polymer) 
components of the peptidoglycan of gram-positive bacteria. 119 Specifically, lysozyme 
breaks β-1,4 glycosidic bond of the oxygen bridge between the repeating glycan units of 
N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG), which is responsible for 
its anti-bacterial properties. 119  
 
A portion of the bacterial peptidoglycan is able to fit in a groove on the outer 
surface of the enzyme that contains the active site. 106 The active site contains two amino 
acid components (Glutamine and Aspartic Acid) whose carboxylate groups participate in 
the hydrolysis. 106 The molecular mechanism of lysozyme catalysis at the active site 
involves multiple steps, in which a proton is donated by an uncharged Glutamine residue 
at the active site by breaking the glycosidic bond. 119 At completion, the original forms of 
the enzymes are regenerated and the hydrolyzed chains of the peptidoglycan leave the 
active site of the enzyme. 
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2.4.2 Lactoferrin 
Lactoferrin is a large basic glycoprotein (pI 7.5-8.5) which is member of the 
transferrin family. 59 Its primary role in the tear film is to chelate iron, which during a 
bacterial invasion, would halt the growth of most bacteria. 59 Lactoferrin is produced in 
the acinar epithelium of the main and accessory lacrimal glands. 120 The major form of 
lactoferrin has a molecular weight of 78 kDa, while the minor form corresponds to an 83 
kDa in gel electrophoresis. Kijlstra and co-workers investigated the various forms of 
lactoferrin and showed that the two isoforms were not due to iron or carbohydrate 
changes within the structure. 121 Instead, it was found that an increase in iron ions in 
human tears produces a protein species around 52 kDa. 121  It is considered that the minor 
form, in being slightly larger than the major lactoferrin species, is actually a precursor of 
lactoferrin.   
 
Fullard and Tucker showed that the concentration of lactoferrin remained 
relatively constant through a series of non-stimulated and stimulated tear samples. 81  
Therefore, lactoferrin reductions are correlated with decreases in tear production from the 
lacrimal gland. 122 Lactoferrin concentrations, being not significantly reduced during the 
reflex action of tearing, are usually around 1.7 to 2.5 mg/ml for basal tears and 1.5 to 1.8 
mg/ml during stimulation. 66, 123 No differences in lactoferrin concentration has been 
found between men and women, and similarly, no significant differences for an age range 
from 17-60 years using reflex tears. 78 
  
In another study, it was found that the concentration of lactoferrin was 
significantly decreased in the tears of patients with non-Sjogren syndrome, Sjogren 
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syndrome and Stevens-Johnson syndrome, when compared with control subjects. 124 
Previous studies have also proposed that lactoferrin and other glycoproteins adsorbed on 
to contact lens materials can promote bacterial adhesion, since their carbohydrate 
moieties may act as receptors for bacterial lectins. 125, 126 Another study demonstrated that 
lactoferrin deposited on the lens surface promotes the adhesion of Pseudomonas 
aeruginosa strain Paer 1; nevertheless, once adherent, this protein reduces the proportion 
of viable bacteria on the lens surface. 127 Lactoferrin is considered to play an important 
role in the specific defense of the ocular surface against a variety of bacteria. 59, 128, 129 
Lactoferrin forms complexes by binding to acidic macromolecules (including 
immunoglobulins and serum albumin). 77 Lactoferrin in the tears interacts with both 
human lysozyme and bacterial lipid A showing that individual proteins play many roles, 
both protecting and interacting with other tear components. 130-132 Lactoferrin can inhibit 
the formation of classical C3 convertase of the complement system preventing 
complement activation in the tear film and thus decreasing inflammation.  133  
 
2.4.3 Albumin 
The presence of albumin in the tear fluid is due to serum leakage from the vessels 
of the conjunctiva and acts as an indicator of the integrity of the blood/tear barrier. 104, 134  
Albumin has molecular weight (apparent) of 60 kDa and a neutral isoelectric point. 
During an eye infection 135, 136 and during the closed eye state/ sleep, 137  there is often an 
increase in vascular permeability and a concomitant increase in albumin concentration. 75 
The concentration of tear albumin ranges from 10-73 μg/ml with no change with contact 
lens wear after 6 months. 79 In related studies looking into the role of albumin in fluids, 
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an increase in gastric mucus viscosity occurred with increasing albumin concentration. 138 
This may be of significant importance as this may have an influence on friction and 
movement of contact lenses over the ocular surface. An albumin to lactoferrin ratio of 2:1 
has been suggested to indicate Sjögren’s syndrome. 139 To-date, there are very few 
reports on albumin deposition on either conventional hydrogel lens materials 140-143 or 
silicone hydrogel contact lens materials. 144 It has previously been shown that contact 
lens-induced papillary conjunctivitis is associated with increased albumin deposits on 
hydrogel contact lenses. 140 Previous studies have also shown that albumin adsorbed onto 
the contact lens surface could modulate the adherence ability of Pseudomonas 
aeruginosa and Staphylococcus epidermidis on hydrogel contact lens materials. 145-147 
 
2.4.4 Immunoglobulins 
Immunoglobulins (Ig) are a large group of proteins whose molecular weights 
range between 100-500 kDa. 56 Immunofluorescent staining in both the main and 
accessory lacrimal glands shows IgA, IgG, IgM, IgD and IgE, with the secretory form of 
IgA (sIgA) being the predominant immunoglobulin. 66 IgA (145 kDa) may form dimers 
spontaneously through association with a cysteine-rich polypeptide known as the J 
(joining) chain.  sIgA (500 kDa) is a combination of two IgA molecules (heavy chain 64 
kDa; light chain 28 kDa) with a secretory piece (85 kDa; T-piece) joined by disulfide 
bonds and the J chain. 148 IgA and the J chain are produced by lymphocytes (plasma 
cells) transported into acinar cells and secreted into tears as s IgA. 149   
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sIgA levels in tears vary from 0.5 – 1.0 mg/ml which is much higher than found in 
serum. 75, 76 In closed eye condition, sIgA is secreted from the lacrimal gland and its 
concentration can be as high as 8.6 mg/ml. 75 There is no significant difference in the 
concentrations of sIgA during daily contact lens wear and non-contact lens wear. 76  
During extended contact lens wear, sIgA decreases in concentration as compared to daily 
lens wear (2.42 mg/ml to 0.72 mg/ml). 150 Previous studies have shown varied results for 
the level of sIgA in the tears of contact lens wearers, with both increases 151 and 
unchanged levels of sIgA being detected. 152 Macki and Seal did not demonstrate a 
change in the amount of sIgA in tears of patients with Keratoconjunctivitis Sicca. 153  
 
Secretory IgA is considered one of the most important immunoglobulins in the 
defence of the ocular surface. It interacts with other proteins and with bacterial 
contaminants. 75, 76 sIgA is thought to modulate the ability of  microorganisms to colonize 
the ocular surface. 154 It has been shown that sIgA has specific antigenic activity against 
Staphylococcus intermedius and Pseudomonas aeruginosa enhancing the effectiveness of 
polymorphonuclear leukocytes phagocytic activity towards the bacteria. 155 
 
2.4.5 Lipocalin 
The lipocalins are a family of lipid binding proteins with a molecular weight 
between 18 and 25 kDa. 156, 157 In tears, associated members of the lipocalin family 
include apolipoprotein D and tear specific prealbumin, now referred to simply as tear 
lipocalin. 157 The non-reduced form of lipocalin can dimerise and these have been 
previously labeled as tear protein G observed in protein gel electrophoresis. 158 Lipocalins 
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in tears are regulated proteins produced by acinar cells. 80 Lipocalins comprise 15 - 33% 
of tear protein ranging in concentration from 1.2 - 1.7 mg/ml. 159 Six isoforms with 
isoelectric points ranging through 4.6-5.4 are known, although recently another four 
isoforms have been identified through HPLC and two dimensional electrophoresis 
techniques. 159   
 
Tear lipocalin binds to and may have a direct functional role with both lactoferrin 
and lysozyme in the tear film. 160, 161 Tear lipocalins bind a broad array of lipids including 
fatty acids, cholesterol, phospholipids and glycolipids. 80 Lipids that contaminate the 
corneal surface after tear film drying could potentially de-stabilize the reforming tear 
film. Removal of such lipids by lipocalin may prevent the repeated drying cycle on the 
ocular surface. 58 Glasgow and co-workers showed that tear lipocalins could interact with 
both the air and aqueous phase of solutions such as the tear film. 58 The lipid binding 
ability of lipocalins suggests that it could potentially be an important secondary 
component used in tear film stabilization.   
 
2.4.6 Phospholipase A2 
Phospholipases consist of a family of cytosolic and secretory lipolytic enzymes.  
In tears, group II (secretory) phospholipase A2 (sPLA2; 14 kDa; pI > 10.5) is found in 
concentrations averaging 1.450 μg/ml. 84 This lipolytic enzyme catalyses the hydrolysis 
of the fatty acid acyl ester bond at the sn-2 position (CO-OCH linked to saturated or 
unsaturated aliphatic groups) of phosphocholine, ethanolamine, glycerol, inositol and 
other alcohol lipids. 162 Group II sPLA2 is released from specialized acinar cells 
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predominately in the centre of the lobules of the lacrimal gland (Aho et al. 1996, Gillette 
and Allansmith 1980). 120, 162 Gram-negative organisms covered with lipopolysaccharides 
external to their peptidoglycan layer are resistant to lysis by lysozyme. Group II PLA2 
might act synergistically with lysozyme (and also complement) to lyse these bacteria. 162, 
163 Group II PLA2 in the presence of calcium can kill staphylococci and other gram-
positive bacteria. 164 It has been suggested that Secretory PLA2 could potentially remodel 
or remove peroxidised or senescent phospholipids from the tear film. 165 
 
2.4.7 Other tear proteins of significance 
The complement system is one of the main effector mechanisms of the immune 
response on the ocular surface.  All components of the complement system were found to 
be activated in tears with a great increase in their concentration during sleep. 123 
Lactoferrin, decay-accelerating factor (DAF) and CD59, are known to control or regulate 
the complement system. These proteins are present in both the tears and on the plasma 
membranes of corneal and conjunctival epithelia. 123, 166 Additionally, all three regulators 
have been shown to bind to hydrogel lenses. 166, 167 This could assist in damping the 
activation of complement on the lens, and also minimize the inflammatory effect of other 
deposited proteins, or inversely the bound regulators could incite inflammation. 
 
The corneal epithelium produces gelatinase B, an enzyme that participates in the 
wound healing process that follows mechanical, thermal or laser injury of the cornea. 168 
Gelatinase B is a matrix metalloproteinase (apparent molecular weight of 92kDa, also 
known as MMP-9) that is found in ng/ml quantities in the tear fluid of healthy subjects. 
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An 84 kDa active form has a much greater activity in patients with ocular rosacea. 83  
MMP-9 activity is correlated with a delayed tear clearance and elevated tear interleukin-
1α concentrations. 83 Interleukin-1 increases the production and activity of enzymes of 
the matrix metalloproteinase family, including collagenases and gelatinases, that degrade 
extracellular matrix and may contribute to the development of the eyelid and ocular 
surface disease in rosacea. 169, 170 Collagenases have the potential to break down the 
corneal epithelial basement membrane and hence to dissolve collagen. These processes 
could lead to corneal epithelial erosion and possible ulcerations. 171 
Table 2-5: Summary of major tear proteins and their significance 
Protein MW (kDa) Produced in Role Concentration 
Lysozyme 66, 
120, 162 14.5 
acinar & intralobular 
epithelial cells of 










59, 78, 121, 123, 
162 
78 
acinar & intralobular 
epithelial cells of 
main & accessory 
lacrimal gland 








79, 81 60 
serum derived - enters 








IgA 76, 81 145 
Plasma cells of the 
lacrimal gland - 








80, 157, 161 18-25 Acinar cells Binds lipids 1.2-1.7 mg/ml 
Phospholipase 
84, 162 14 
some acinar cells, and 
central lobular cells of 
the main lacrimal 
gland 
Lipolytic 
enzyme 1.45 g/ml 
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2.5 Contact lens deposits 
One of the major problems associated with hydrophilic contact lenses is that they 
are susceptible to spoilage from constituents of the tear film, which include a wide 
variety of proteins, 108, 172-176 lipids, 177-181 and mucins. 182 At extreme levels of build-up, 
these deposits are associated with diminished visual acuity, 183, 184 reduced wearing time 
185 and a feeling of dryness and discomfort. 179, 186-188 Deposits can potentially lead to 
more serious clinical conditions such as hypersensitivity reactions and contact lens 
associated papillary conjunctivitis. 189-192 Moreover, these deposits are known to increase 
the risk of bacterial attachment, by providing a solid substrate and shelter. 146, 147, 193  
 
The adsorption of tear derived substances at the contact lens interface is highly 
complex and is dependent upon a number of factors. Notable amongst these are the 
material’s water content, 141, 173, 174, 194-197 hydrophobicity, 141, 143, 173, 198, 199 charge, 175, 194, 
196, 200, 201 pore size, 194, 202 surface roughness, 143 age of the lens material 179 and the size 
or charge of the protein. 203 However, the relative importance of the different components 
of deposited films to these clinical effects remains largely unknown.  
 
As already mentioned, the newly introduced silicone hydrogel contact lenses have 
significantly increased oxygen transmission due to the incorporation of siloxane groups. 
23, 204, 205 The incorporation of silicone results in an increased degree of hydrophobicity, 
which results in increased lipid deposition compared with other non silicone-containing 
materials. 4, 206, 207 However, these lens materials do deposit extremely low levels of 
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protein compared to conventional hydrogel lenses, with typical levels being in the < 20 
μg/lens range. 204, 208, 209  
 
2.5.1 Protein deposits on contact lenses 
Proteins primarily are deposited onto the contact lenses from the tear fluid. 210 
Proteins deposit on the contact lenses as films and these protein films are invisible during 
the early stages of the spoilation process, but with the advancement of time, the protein 
denatures and they assume a thin, translucent, whitish appearance. 211 These protein 
deposits remain primarily on the surface, but in high water content lenses they may 
penetrate into the lens matrix. 212 All proteins in the tear film have the potential to form 
contact lens deposits, although, several factors ultimately influence the type, quantity and 
structure of such deposits. 1  
 
 
Figure 2-5 Protein deposits on contact lens. 
(Picture courtesy of Dr. Lyndon Jones) 
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Protein deposition onto hydrogel lens materials is a highly complex process, 
depending upon the charge and size of the protein, environmental pH, charge and water 
content of the substrate and competition between the various tear film constituents that 
are present. 142, 167, 173 Protein has been the major focus of both identification and 
quantitation studies of contact lens deposits. Estimates of the total amounts vary but fall 
within a reasonably well-defined range. Group I lenses typically attract less than 10 µg of 
protein, Groups II and III lenses approximately 30 µg, and Group IV lenses 1000 µg or 
more. 108, 126, 167, 172-176, 178, 213-217  Silicone hydrogel contact lens materials deposit 
extremely low levels of lysozyme compared to conventional hydrogel lenses, with typical 
levels being in the < 20 μg/lens range. 204, 208, 209 Using mass spectrophotometry, recent 
studies have shown that over 60 proteins can be detected on worn silicone hydrogel 
contact lens materials. 218, 219 The various proteins that were detected on the contact lens 
materials are listed in the following table (Table 2.6).  
 
Table 2-6: List of tear proteins detected on silicone hydrogel contact lenses 
identified using tear proteomic approach 219 
Major tear proteins 
1. Lysozyme  
2. Lipocalin 1 
3. Lactoferrin  
 
Immunoglobulin family 
4. Heavy chain of IgA2  
5. Light chain of IgA1  
6. Immunoglobulin J chain  
7. Large anti-HSV-glycoprotein D single chain antibody  
8. Heavy chain of IgM  
9. Ig kappa light chain  
10. Ig rheumatoid factor H  
11. Immunoglobulin heavy chain variable region  
12. Poly-Ig receptor (secretory component)  
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Proline Rich Proteins 
13. Proline rich 4 isoform 1 or 2 (lacrimal)  
14. Nasopharyngeal carcinoma associated proline rich 4 
15. Basic proline-rich protein (Lacrimal) (pHL E1F1)  
 
Apolipoproteins 
16. Apolipoprotein J/Clusterin  
17. Apolipoprotein  
 
Albumin 
18. Serum albumin  
 
Hemoglobins 
19. Hemoglobin subunit alpha  
20. Hemoglobin subunit beta  
 
Complement proteins 
21. C9 complement protein  
22. Complement component C3  
 
Keratins 
23. Keratin 1 (stratum corneum/keratinocytes – keratin 10/9 pair) 
24. Keratin 2 ( stratum corneum/keratinocytes – keratin 10/9 pair) 
25. Keratin 3 (cornea – keratin 12 pair)  
26. Keratin 4 (stratified epithelium – keratin 13 pair)  
27. Keratin 5 (stratified epithelium – keratin 14/15 pair)  
28. Keratin 6  
29. Keratin 9 (stratum corneum/keratinocytes – keratin ½ pair) 
30. Keratin 10 (stratum corneum/keratinocytes – keratin ½ pair) 
31. Keratin 12 (cornea – keratin 3 pair)  
32. Keratin 13 (stratified epithelium – keratin 4 pair) 
33. Keratin 14 (stratified epithelium – keratin 5 pair)  
34. Keratin 15 (stratified epithelium – keratin 5 pair)  
35. Keratin 18 (simple epithelia – keratin 8 pair)  
36. Keratin, type I (Hair keratin)  
 
Proteoglycans and mucins/mucin-like proteins 
37. Heparan sulphate proteoglycan  
38. DMBT-1, isoform b precursor variant  
 
Other proteins 
39. Prolactin-induced protein  
40. Heat shock protein 27  
41. Predicted protein, similar to Mammaglobin A precursor  
42. Retinoic acid receptor responder 1, isoform 1 or 2  
43. Peptide PB saliva  
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44. Peptide PA saliva  
45. Transferrin  
46. Aldehyde dehydrogenase  
47. Alpha - tubulin  
48. Chain A, Human cathepsin G  
49. Dermcidin preproprotein  
50. Fibrinogen betaB  
51. Fibronectin  
52. Ficolin 2 isoform b  
53. Lacritin  
54. Pre-pro-megakaryocyte potentiating factor 
55. Tubulin 5 - beta  
56. Vitronectin precursor  
57. Mesothelin or CAK1 antigen precursor  
58. Matrix Gla protein  
59. Heterogenous nuclear ribonucleoproteins A2/B1 isoform A2 
60. Heterogenous nuclear ribonucleoproteins A1  
61. Heterogenous nuclear ribonucleoproteins A3  
62. Plasminogen  
63. E-cadherin  
64. Cystatin SA-III  
65. hCG22067  
66. Alpha-S1-casein  
67. Actin  
68. Phospholipid transfer protein isoform a 
 
 
Tear film proteins frequently detected on hydrogel contact lenses include 
lysozyme, lactoferrin and albumin, 142, 211, 215, 218-220 and among these lysozyme has been 
the most widely studied. 108, 173, 194, 203, 221 The following section provides a brief overview 
of lysozyme deposition on contact lenses. 
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2.5.2 Lysozyme and contact lenses 
The major proteins that are deposited on contact lenses include lysozyme, 
lactoferrin and albumin, 142, 211, 215 and among these lysozyme has received the greatest 
attention. 108, 173, 194, 203, 221 Karageozian first reported that the principal component of 
deposits that presented problems with contact lens wear was lysozyme, which may be 
selectively adsorbed and denatured on the lens surface. 222 Many others have since 
confirmed the predominance of lysozyme in lens deposition. 108, 126, 213, 215, 216, 223, 224   
 
Lysozyme is a major component in tears and of contact lens deposits. 55, 219 It 
accounts for approximately 40% of total protein found in tears and is the major protein 
(approximately 36 to 95% depending on lens type) deposited on hydrogel contact lenses. 
195, 225 In addition to its bactericidal properties (described earlier), lysozyme is also 
reported to have anti-inflammatory properties in the tear film, although the mechanism 
through which this action occurs is unknown. 82 Exploration of lysozyme deposition 
(quantity and conformation) on a number of different conventional and silicone hydrogel 
surfaces is of growing interest due to observations that patients using silicone hydrogel 
lenses are prone to develop papillary conjunctivitis, possibly due to the denaturation of 
lysozyme on the lens materials. 190, 192, 226-229 
 
Lysozyme is a positively charged molecule and this, coupled with its small size, 
results in its increased adsorption onto negatively charged substrates such as FDA group 
IV contact lens materials. 108, 195, 199, 203, 230-232 Studies to date, suggest that the novel 
silicone hydrogel lens materials deposit extremely low levels of lysozyme compared to 
 45
conventional hydrogel lenses, with typical levels being in the < 20 μg/lens range. 204, 208, 
209 Once lysozyme firmly adsorbs onto contact lens materials, it tends to undergo 
conformational changes, 108, 208, 209, 232 which might potentially result in a variety of 
immunological responses, including contact lens associated papillary conjunctivitis. 190, 
192, 226-229 Some studies have speculated that the conformational state of the deposited 
protein could have an influence on various subjective symptoms in contact lens wearers; 
1, 233 however, to-date, no study has determined the relationship between subjective 
symptoms and the conformational state of the deposited protein. Therefore, in addition to 
investigating the total quantity of the deposited protein, it is of significant clinical 
relevance to study the conformational state of the deposited protein.  
 
Several studies have investigated the kinetics of protein or lipid deposition on 
contact lens materials in vitro, 143, 172, 182, 197, 203, 221, 234-236 and in vivo 126, 167, 180, 213, 230, 237-
240 on conventional hydrogel contact lens materials. Although, the quantity and/or 
conformational state of lysozyme deposited on silicone hydrogel lens materials have been 
reported, 204, 208, 209 to-date, no study has examined the deposition of lysozyme or the 
conformational state of lysozyme deposited on silicone hydrogel contact lens materials as 
a function of time. Knowing the rate of protein deposit accumulation and the duration 
over which lysozyme denatures is clinically relevant to patient symptoms and in 
determining the most appropriate replacement frequency. In addition, this information 
would be very useful for designing clinical investigations of hydrogel lenses and 
associated lens care products. 
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2.6 Methods used to determine protein aggregation 
In this section, a brief overview of various physical methods that are used to 
determine protein aggregation and some of the advantages and disadvantages of each of 
these techniques are discussed. 
 
2.6.1 Atomic Force Microscopy  
Atomic Force Microscopy (AFM) is a direct, in-situ method for visualizing the 
surface morphology of protein aggregates that are being studied. 241 AFM works by a 
flexible force-sensing cantilever which is scanned over the surface of the sample in a 
pattern to reveal atomic level resolution. 241, 242 Some disadvantages of AFM include 
issues of the uniformity of the sample being measured, the possibility of damage to the 
sample from the force being applied by the AFM measurement. 243 Moreover, this is only 
a surface morphology technique, and AFM does not provide any information about the 
actual composition of the aggregate being measured. 243  
 
2.6.2 Electron Microscopy  
Electron Microscopy (EM) works by a focused beam of electrons being scanned 
across the surface of the sample producing backscattered and secondary electrons as a 
way to image the sample. 241 The EM technique is extremely useful for determining the 
morphology of the sample, especially when used in conjunction with other, 
complimentary physical methods. 241 EM is a very sensitive method which has the 
capability to detect at atomic resolution and to see “a” species rather than “the” dominant 
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species more accurately. 241 Another well-known disadvantage of EM is the possibility of 
the electron beam damaging the sample by either causing nucleation or changing the 
morphology of the fibrils already present in the sample. 244  
 
2.6.3 Circular Dichroism   
Circular Dichroism (CD) is a direct, usually in-situ measurement and involves the 
detection of circularly polarized light in the absence of a magnetic field. 245 CD is also 
capable of giving information about the secondary structure of the protein, 245, 246 so that a 
conformational change, for example, can be followed over time. Another useful 
advantage of this technique is the ability to differentiate between the formation of α-
helices and β-sheets by their signature spectra. 245 One of the requirements for this 
method is that the sample should be optically active. 245 
 
2.6.4 Dyes 
 The use of dyes is a commonly employed technique for the detection of protein 
aggregation due to the sensitivity of the technique. 242 It is usually an ex-situ method as 
the concentrations of proteins used for these experiments must be increased in order to be 
detected by the dyes used. 243 This results in a fluorescence spectrum that shows an 
increase in the amount of fluorescence with the formation of more aggregates. 247 A 
disadvantage of this technique is that, as with some other techniques, different species 
deposited on the biomaterial cannot be differentiated from one another and all contribute 
to the fluorescence in a combined, averaged way. 248 Recently, tear proteins such as 
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lysozyme and albumin were tagged with fluorescent dyes. 144, 249, 250 Using confocal 
microscopy, the location of these fluorescently-tagged proteins have been determined on 
conventional and novel silicone hydrogel contact lens materials. 144, 249, 250 These studies 
have demonstrated that the location of the proteins depends upon the nature of the protein 
and also on the polymer make-up and/ or surface modification processes of the 
conventional and silicone hydrogel lens materials. 144, 249, 250 
 
2.6.5 Fluorescence Spectroscopy with Extrinsic and Intrinsic Fluorophores 
Fluorescence spectroscopy involves measuring the fluorescence intensity of either 
fluorophores to gain information on conformation changes occurring in the protein. 247 
This technique is advantageous in that it is broadly applicable, is sensitive enough and 
provides good signal to noise ratios and the kinetics of deposition can be readily 
measured. 247 There are several sub-categories of fluorescence spectroscopy which can be 
used to elucidate information on folding, membrane-protein interactions and fibril 
formation. 247 Although fluorescence spectroscopy is a powerful technique to follow 
structural changes, other complementary techniques should be used in conjunction with it 
to verify the fluorescence observed. 243 
 
2.6.6 Fourier Transform Infrared Spectroscopy 
Fourier Transform Infrared Spectroscopy (FTIR) is a direct, usually ex-situ 
method that can be used to detect the β-structure of proteins as well as the orientation of 
adjacent β-sheets to determine whether they are in a parallel or anti-parallel 
 49
configuration. 251 Therefore, FTIR can provide quantitative information about the larger 
aggregates being formed and information about the morphology of these aggregates. 243 
 
2.6.7 Nuclear Magnetic Resonance Spectroscopy  
Nuclear Magnetic Resonance Spectroscopy (NMR) is a powerful, direct, method 
that has been used in monitoring protein aggregation in both the solid state and in 
solution. 252 Using solid state NMR, the amount of aggregates that solidify can be 
monitored and their conformational changes can be observed. 252 The use of solid-state 
NMR typically requires the use of labeled amino acid residues in order to obtain a 
reasonable signal. 252 One possible disadvantage is that at the higher concentrations 
required for solution NMR, proteins with a tendency to aggregate often become 
insoluble. 253 Due to the concentration and aggregation issues, typically, 2-D and 
polynuclear NMR techniques are required to monitor solution aggregation processes. 253 
 
2.6.8 Mass Spectrometry 
Mass spectrometry, in particular matrix-assisted laser desorption ionization time 
of flight (MALDI-TOF) mass spectrometry, is a direct, ex-situ method that has been used 
to monitor the formation of protein complexes. 251 Since MALDI-TOF has the ability to 
monitor species in the molecular weight range up to approximately 300,000 g/mol, both 
smaller and larger proteins can be detected. 254 One of the disadvantages of this method is 
that the use of MALDI-TOF typically requires the use of one of a number of buffer, salt, 
and co-solvent conditions. 255 
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2.6.9 Quartz Crystal Oscillator Measurements  
This technique employs an oscillating quartz crystal microbalance to detect the 
growing weight of protein fibrils on the surface of existing seeds. 256 The mass change is 
taken as a direct measurement of aggregation. 256 The main disadvantage of this sensitive 
technique is that quartz crystal oscillator measurements detect a mass change but do not 
provide information about the heterogeneity or homogeneity of the sample. Perhaps the 
use of these microbalance methods in conjunction with mass spectrometry could alleviate 
this problem. 
 
2.6.10 Sedimentation Studies  
Sedimentation studies are used to separate soluble from insoluble proteins using 
centrifugation. 242 In theory, the aggregated and thus heavier protein(s) should become 
separated from the monomeric protein. 242 However, there is evidence for the formation 
of soluble oligomeric intermediates that are in some cases hypothesized to be toxic, 257-259 
and this technique would not be able differentiate between monomeric and soluble 
oligomeric protein or between insoluble intermediates and fibrils. 242 Sedimentation 
could, however, be used in conjunction with other techniques to distinguish between the 
species contained in a heterogeneous sample. 242  
 
2.6.11 Size-Exclusion Chromatography 
Size exclusion chromatography is a method of separating aggregates of various 
sizes. 260 In combination with one or more of the other technique(s), size-separated 
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aggregates can be detected, although it is not clear if the separation process causes or just 
reports the separated sizes. 251 To date, size exclusion chromatography appears to be the 
most useful method for separating out smaller protein subsequently detected by NMR or 
absorbance measurements. 251 
 
In addition to the above-mentioned techniques, other physical techniques 
employed to determine protein aggregation are absorbance spectroscopy, 242 calorimetry, 
251 flow birefringence, 261 light scattering, 262 turbidity 242 and X-ray diffraction. 242, 263 
The next section specifically deals with various techniques that are employed to quantify 




2.7 Methods to quantify proteins deposited on contact lenses 
Several microscopic, photometric and imaging techniques have been used to 
investigate protein deposits on contact lenses. 126, 167, 178, 264, 265 The major limitation of 
microscopic and imaging techniques is that they are generally not suitable for accurate 
quantitation purposes. 1 Various biochemical assays including Enzyme-Linked 
Immunosorbent Assay, High Performance Liquid Chromatography and Sodium Dodecyl 
Sulphate Polyacrylamide Gel Electrophoresis are useful because of their increased 
sensitivity, accuracy and ability to target specific proteins.   
 
2.7.1 Enzyme-linked immunosorbent assay 
Enzyme-linked immunosorbent assay (ELISA) is a widely used method for 
investigation of tear film proteins. ELISA utilizes antibodies bound to solid surfaces, 
such as plastic or polystyrene micro-titre plates to quantify protein of interest. 266 ELISA 
relies on antibody recognition of the protein of interest in solution. A colorimetric, 
fluorescent or chemiluminescent reaction is used to quantify the amount of protein bound 
to the well, followed by detection of the specific signal. 266 
 
The major advantage of ELISA is the ability to process high number of samples 
(up to 96) at the same time and this method also reduces the need for handling the 
sample. The disadvantage with this method is that it can cross-react with non-targeted 
proteins, or the interaction between antibody and target can be disrupted by other sample 
components. 267   
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2.7.2 High Performance Liquid Chromatography  
High Performance Liquid Chromatography (HPLC) separates proteins based on 
molecular size in a column support through a tightly packed matrix (such as glass, plastic 
or silica beads) under high pressure. There are several types of HPLC and Size Exclusion 
HPLC is the widely used method for quantifying individual proteins in solution. The 
major advantage of HPLC is that several proteins can be quantified from a single 
experiment. However, Fullard (1988) found an unusually high absorbance for lysozyme, 
which may decrease the accuracy of the assay and could lead to erroneous conclusions. 77 
 
2.7.3 SDS-PAGE followed by Immuno blotting 
Sodium dodecyl sulphate - Polyacrylamide gel electrophoresis (SDS-PAGE) is a 
specific type of gel electrophoresis that uses sodium dodecyl sulphate (SDS) as a 
detergent to confer a negative charge to a protein and polyacrylamide as a matrix to 
separate proteins according to size. Electrophoresis refers to the migration of charged 
molecules in solution in response to an electric field. Electrophoresis is a simple, rapid 
and highly sensitive technique and this can be used to study the properties of a single 
charged species, and as a separation technique. 268 Once physically separated, proteins are 
visualized using antibodies and chromogenic, fluorescent or chemiluminescent substrate 
is used to quantify the binding of the antibodies to the protein. Resolution of proteins that 
migrate together in the gel is accomplished by the specificity of the antibody; a single 
antibody will recognize a small portion of the protein of interest, thereby reducing the 
potential of visualizing co-migrating tear film components. In addition, immunological 
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visualization allows identification of variations in protein conformation, such as 
unexpected polymerization or interaction with other proteins. 269, 270  
 
2.7.3.1 PhastSystem™   
The PhastSystem™ (Amersham Pharmacia Biotech, Baie d’Urfe, QC, Canada) is 
an automated mini-gel system that combines both electrophoresis and immunoblotting 
into a single apparatus (Figure 2.6). This system is different from that of traditional larger 
gel electrophoresis systems, in that it utilizes pre-cast, extremely small (4.5 cm X 5 cm) 
SDS gels for protein separation. These extremely small SDS gels confer increased 
sensitivity with a minute sample volume requirement, compared to other electrophoresis 
and immunoblotting systems.  
 
 
Figure 2-6: The PhastSystem™ 
 
Unlike other gel electrophoresis systems, the protein-containing loading buffer, in 
volumes from 0.3 µl to 1 µl, is applied to well combs with up to 12 lanes rather than 
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directly into wells cut into a gel. These disposable well combs are then automatically 
applied to the mini-gel for electrophoretic separation. The temperatures, voltage, current 
and power are automatically regulated throughout the separation process. Western 
blotting is similarly automated and simplified by the PhastSystem™. The small size of 
the gels and the small sample volume applied to the gel make the PhastSystem™ unique 
among all other systems. The low sample volumes and small pre-cast gels also provide an 
added level of sensitivity and flexibility, especially for proteins in low concentrations. 148, 
271 Several researchers have used the PhastSystem™ to detect extremely low 
concentrations of tear film proteins. 148, 208, 209, 232, 271-276 
 
Whilst the methods such as HPLC or ELISA can provide other advantages such 
as enhanced efficiency in quantifying several proteins at the same time (HPLC) or 
provide greater sample throughput (ELISA), electrophoretic separation followed by 
immunoblotting using the PhastSystem™, provides us with the best tool for quantifying 
individual proteins in extremely low concentrations. While at the same time it allows 
visualization of the protein to assess cross-reactivity between the antibody and protein of 
interest and possible aggregation or polymerization of the protein. Using this technique, a 
method has been optimized to quantify lysozyme deposition on SH lenses. 209 
 
2.7.4 Radiolabeling technique 
A number of studies have found that artificial tear solutions can be an attractive 
option in determining the binding affinity of different components and the mechanisms 
involved in such binding. 197, 277-285 The major advantages of in vitro studies are that 
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several experimental variables can be eliminated, the quantity of the bound component 
can be determined by labeling the species fluorometrically or radiometrically, and several 
experimental hypotheses can be tested without engaging in a resource consuming clinical 
trial. A number of quantitative protein methods have been applied to the analysis of 
protein deposits on contact lenses. However, many of these techniques require complex 
extraction procedures which may not be 100% efficient. The radiochemical assay is:  
(1) quantitative and reproducible with a low detection limit  
(2) able to assess a large number of samples  
(3) compatible with all contact lens materials  
(4) not dependent on complex extraction techniques  
(5) able to detect surface as well as bulk protein.  
 
The isotope 125I has been extensively used to radioactively label lysozyme and 
other proteins in previous studies. 172, 173, 286-288 The isotope is incorporated into the 




2.8 Corneal complications associated with contact lens wear 
Corneal complications associated with soft contact lens wear can be broadly 
classified as metabolic, infective, inflammatory, mechanical and allergic (Table 2.7). 
Table 2-7: Corneal complications associated with soft contact lens wear 
Epithelium 
Altered Metabolism, mitosis, 
increased thickness and decreased 
exfoliation 
Stroma Decreased Keratocyte density Metabolic 
Changes to corneal 
physiology 
Endothelium Altered metabolism, polymegethism and pleomorphism 
Infective Microbial Keratitis (MK) 
Most common bacterium is Pseudomonas 
aeruginosa 
Contact Lens Acute 
Red eye (CLARE) 
Contact Lens Peripheral 
Ulcer (CLPU) Inflammatory 
Infiltrative Keratitis 
(IK) 
Often caused by microbial contamination of lenses 
Superior Epithelial 
Arcuate Lesion (SEAL) Mechanical Corneal staining & 
Erosions 
Lens design, lens material, lens modulus, foreign 
bodies, dehydration 
Allergic Contact Lens Papillary Conjunctivitis (CLPC) Lens deposits, solution toxicity 
 
The following section provides an overview of the incidence and risk factors, 
pathogenesis and microbiology associated with Microbial Keratitis (MK), Contact Lens 
Acute Red eye (CLARE) and Infiltrative Keratitis (IK). 
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2.8.1 Microbial Keratitis 
2.8.1.1 Incidence and risk factors 
Over the years, several studies were conducted to identify the risk factors and 
incidence rates that are associated with contact lens-related microbial keratitis (MK).  
Table 2-8: Annualized incidence (per 10000 wearers) of contact lens related 
microbial keratitis 
Incidence per 10000 wearers  
(Confidence Intervals) Study 
Daily wear 
soft contact lens 
Overnight wear 
soft contact lens 
Poggio et al (1989) 289 4.1 (2.9-5.2) 20.9 (15.1-26.7) 
MacRae et al (1991) 290 5.2 (0-15.4) 18.2 (8.2-27.8) 
Nilson & Montan (1994) 291  2.2 (0.4-3.9) 13.3 (4.1-22.6) 
Cheng et al (1999) 292 3.5 (2.7-4.5) 20.0 (10.3-35.0) 
Lam et al (2002) 293 3.1 (2.1-4.0) 9.3 (4.9-13.7) 
Morgan et al (2005) 294 6.4 (4.1-9.9) 96.4 (37.5-245.2) 
 
One of the overwhelming risk factors for the development of MK is overnight 
wear of soft contact lenses. Schein and co-workers reported that the relative risk of MK 
following extended wear of soft lens was four times greater than daily wear. 295 Dart and 
co-workers showed that when compared to rigid contact lenses, overnight wear of soft 
contact lens wear carry 21 times greater risk of MK, while daily wear increases the risk 
by approximately 4 times. 296 A study by Poggio and Abelson suggested an increased risk 
of MK with disposable soft contact lenses. 297 A retrospective study from Sweden 
reported an increased risk for conventional daily wear compared to disposable daily wear. 
291 Other studies found an increased risk of MK with disposable lenses compared to daily 
wear or extended wear of conventional soft contact lenses. 298-300  
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With the introduction of high Dk silicone hydrogel contact lenses, it was assumed 
that the risk of developing MK would be much less, as these lenses reduce many of the 
clinical signs of hypoxia. 301 Preliminary studies that evaluated high Dk lenses indicated 
that there was no incidence of MK with these lenses. 302, 303 However, MK has been 
reported following extended wear of these lenses as well. 304-306 Some of the other risk 
factors for MK include trauma, altered corneal sensation, altered tear volume and altered 
tear composition, smoking and non compliance with lens care techniques. 76, 193, 293, 295, 307-
309 
 
2.8.1.2 Pathogenesis   
Three main factors are required for MK to occur: exposure to infectious micro-
organisms, binding of these micro-organisms to the cornea and, in the case of the 
majority of ocular pathogens, a compromised cornea with an epithelial break. 56, 310 MK 
is most often caused by Pseudomonas aeruginosa. 56, 310, 311 Pseudomonas keratitis 
requires corneal trauma, particularly an epithelial defect in order for it to develop. 312 
Studies have shown that lens wear by itself increased the organisms’ adhesion to the 
cornea 307 while extended wear of contact lenses further enhances its adhesion to the 
corneal epithelium. 313 Solomon and co-workers showed in an animal model, that hypoxia 
along with the presence of a contact lens was a major risk factor for the development of 
Pseudomonas keratitis, even more than the presence of the organism and epithelial 
defect. 314 It was hypothesized that corneal hypoxia led to a break in the epithelium which 




A number of microorganisms have been implicated in MK. Approximately one 
third of contact lens-related MK have been found to be associated with gram positive 
cocci such as staphylococci and streptococci, but two thirds is associated with gram 
negative rods, especially Pseudomonas aeruginosa. 315 Fungi are more commonly seen in 
therapeutic contact lens wear 316 and account for approximately 12% of the cases, 
whereas they account for 3% of cases associated with cosmetic or aphakic contact lens 
wear. 315 The following table summarizes the organisms that are frequently isolated from 
cases of patients with MK with silicone hydrogels and HEMA-based hydrogel lenses. 56 
 
Table 2-9: Bacteria isolated from cases of MK 56 
Bacteria Silicone hydrogel HEMA-based hydrogel 
Gram negatives 75% 73% 
Pseudomonas aeruginosa or spp 42% 66% 
Serratia marcescens 8% 4% 
Alcaligenes xylosidans 8% - 
Acinetobacter spp 8% - 
Haemophillus influenzae - 1% 
Morganella morganni - 1% 
Escherichia coli - 1% 
Unidentified 8% - 
Gram Positives 25% 25% 
Streptococcus viridans 17% - 
Coagulase negative staphylococci - 13% 
Staphylococcus aureus - 6% 
Corynebacterium spp. 8% 3% 
Propionibacterium spp. - 3% 
Bacillus cereus - 1% 
Unidentified - 1% 
 61
2.8.2 Contact Lens Acute Red Eye (CLARE) and Infiltrative Keratitis (IK) 
2.8.2.1 Incidence and risk factors 
Contact Lens Acute Red Eye (CLARE) has been reported following overnight 
wear of silicone hydrogel lenses as well, with an annualized incidence rate of 0.7 and 0.8 
per 10,000 for extended wear (7 days) and continuous wear (30 days) respectively. 303 
Studies conducted at the Cornea and Contact Lens Research Unit (CCLRU) and L.V. 
Prasad Eye Institute give incidence rates ranging from 1.0 to 7.0% of eyes following 
overnight wear of conventional hydrogel lenses and 2.5 to 12.5% for silicone hydrogel 
lens wearing eyes. 317 Overnight wear of lenses is the major risk factor for CLARE. 
Earlier studies concluded that the condition developed as a result of debris being trapped 
under a tight immobile lens, 318, 319 however later studies found no correlation between 
lens tightness and CLARE. 320 Bacterial contamination of contact lenses is another risk 
factor for the development of CLARE. 321 
 
Infiltrative Keratitis (IK) is the general term used to describe all infiltrative events 
not categorized as Contact Lens-induced Peripheral Ulcer (CLPU), CLARE or Microbial 
Keratitis. IK is a relatively mild inflammatory event and has been reported following 
conventional and silicone hydrogel lens wear. 322 Studies conducted at the CCLRU and 
L.V. Prasad Eye Institute give incidence rates ranging from 2.0 to 4.0% of eyes for 
disposable hydrogel lenses and 5.6 to 17.8% for continuous wear of silicone hydrogel 
lenses. 317 Since the condition resembles CLARE, it has been suggested that bacterial 
contamination of lenses or lens cases are a major risk factor. In addition, mechanical 
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trauma has also been postulated to lead to IK, as a large number of cases have been 
isolated from silicone hydrogel wearing eyes. 317 
 
2.8.2.2 Pathogenesis 
One of the key elements in the chain of events that lead to CLARE has been 
demonstrated to be due to the colonization of contact lenses with bacteria and also the 
inflammatory state of the lens wearing eye. 317 A state of sub-clinical inflammation exists 
during eye closure 137, 323 which promotes the growth of the normal ocular microbiota. 324 
These changes contribute to a pro-inflammatory state in the closed eye, which in addition 
to the accumulation of bacterial toxins and other by-products predispose to the 
development of CLARE. In addition to the accumulation of bacteria on the lens, corneal 
trauma can also lead to corneal infiltration. Trauma to the cornea, potentially triggers an 
immune response which can then lead to infiltration by Polymorphonuclear leukocytes 
(PMNs) that is observed in IK. 325 
 
2.8.2.3 Microbiology 
Several Gram positive and Gram negative bacteria are seen in the contact lenses 
of patients with CLARE, IK and CLPU and the following table (Table 2.10) lists the 




Table 2-10: Micro-organisms associated with CLARE, IK and CLPU 
Micro-organism Adverse responses 
Gram negatives   
Abiotrophia defectiva IK 
Acinetobacter spp. CLARE,IK 
Aeromonas hydrophilia CLARE 
Alcaligenes xylosoxidans subsp. Dentrificans IK 
Branhamella catarrhalis IK 
Enterobacter cloacae IK 
Eshericia coli CLARE,IK 
Haemophillus influenzae CLARE,IK 
Haemophillus parainfluenzae CLARE,IK 
Klebsiella oxytoca CLARE,IK 
Klebsiella pneumoniae CLARE 
Neisseria spp IK 
Pseudomonas aeruginosa CLARE,CLPU 
Serratia liquefaciens CLPU,IK 
Serratia marcescens CLARE,IK 
Stentrophomonas maltophilia CLARE 
Gram Positives   
Non-haemolytic Streptococcus spp. IK 
Staphylococcus aureus CLPU,IK 
Streptococcus pnuemoniae CLARE,CLPU,IK 
Streptococcus viridans CLARE,IK 





2.9 Bacterial adhesion to contact lenses 
Several factors regulate the adhesion of bacteria to biomaterials including surface 
properties of the biomaterial, bacteria-biomaterial surface interactions, van der Waals 
forces, properties of the bacterial cell and the electrolyte concentration of the suspending 
liquid. 326-329 There are several steps involved in the adhesion of bacteria to contact lens 
materials. Initially, bacteria adhere to contact lenses non-specifically by removing water 
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molecules surrounding the lenses using their hydrophobic surface components. 326, 330 
Following this reversible initial attachment, the bacteria adhere to the biomaterial 
strongly by an adhesion receptor mediated specific adhesion. 326, 330 After initial adhesion, 
bacteria adhered to the contact lens surface proliferates on the substratum within the 
polysaccharide-rich glycocalyx, forming micro-colonies. 328 As these micro-colonies 
grow, they coalesce with neighboring micro-colonies to form fully-developed biofilms. 
328  
 
It has been demonstrated that Pseudomonas aeruginosa can use several cell 
surface structures to adhere to epithelial cells. 331-335 The lipopolysaccharide (LPS) which 
is involved in the adhesion of Pseudomonas aeruginosa to corneal epithelial cells 334, 335 
is also believed to play a role in bacterial adhesion to contact lenses. It was demonstrated 
that altering the LPS of Pseudomonas aeruginosa increased its adhesion to conventional 
hydrogel FDA group IV etafilcon A lens materials. 336 It has also been suggested that the 
changes in the outer membrane proteins of Pseudomonas aeruginosa may have an effect 
on their adhesion to contact lenses. 336 Cowell and colleagues demonstrated that growth 
of Pseudomonas aeruginosa Paer1 under conditions of nitrogen or carbon limitation also 
altered the ability of this strain to adhere to etafilcon A lens materials. 337 A study by 
Stapleton and co-authors showed that the adhesion of Pseudomonas aeruginosa to low 
water content, non-ionic contact lenses was significantly greater than to ionic lenses and 
the maximal adhesion was observed after 45 minutes. 338 In addition, factors such as 
proteins and lipids deposited from tears on the contact lens surface are likely to alter the 
bacterial adhesion to a contact lens. 127, 145-147, 193, 307, 336, 339-342 Other factors that play a 
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role in the adhesion of bacteria to contact lenses include lens material, 336, 338, 343-348 
duration of wear, 193, 336, 349 and surface roughness. 350, 351 To-date, few studies have 
investigated the adhesion of bacteria to novel silicone hydrogel lens materials; 344-347 
however, none of these have determined the influence of tear components on the 
adhesion of bacteria to silicone hydrogel lens materials. 
 
2.10 Summary 
A review of the literature proves that most of the work conducted to date has 
focused on protein deposition on conventional hydrogel contact lens materials with little 
knowledge about the quantity and the conformational state of protein deposition on novel 
silicone hydrogel lens materials. Moreover, there is a clear need for further investigation 
into the quantity and the conformational state of protein deposited on conventional and 
silicone hydrogel contact lens materials as a function time. To date, there is no evidence 
concerning the relationship between the conformational state of deposited protein and 
subjective symptoms and also the effect of tear protein deposits on bacterial adhesion to 
novel silicone hydrogel contact lens materials. These are the areas that will be addressed 
in this thesis. 
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3 Thesis Objectives 
The aim of this thesis was to gain a greater understanding of the interaction of tear 
proteins with conventional and novel silicone hydrogel contact lens materials and also to 
determine the influence of tear protein deposits on the subjective symptoms and bacterial 
adhesion to contact lens materials. 
 
The specific aims of this thesis are as follows:   
 
1. To determine the total lysozyme deposition on conventional and silicone hydrogel 
contact lens materials as a function of time by artificially doping lenses with 125I- 
labeled lysozyme.  
2. To determine the conformational state of lysozyme deposited on conventional and 
silicone hydrogel contact lens materials as a function of time using an in vitro 
model. 
3. To quantify the total protein, total lysozyme and the conformational state of 
lysozyme deposited on a novel, lathe-cut silicone hydrogel contact lens material 
after three-months of wear. 
4. To determine the relationship between protein deposition and clinical signs & 
symptoms after one-day wear of etafilcon lenses in a group of symptomatic and 
asymptomatic lens wearers. 
5. To determine the influence of individual tear proteins (lysozyme, lactoferrin and 
albumin) on the adhesion of Gram positive and Gram negative bacteria to 





4 Kinetics of in vitro lysozyme deposition on silicone hydrogel, 
PMMA and FDA groups I, II and IV contact lens materials 
 
 
This chapter is published as follows: 
Lakshman N Subbaraman, Mary-Ann Glasier, Michelle Senchyna, Heather Sheardown, 
Lyndon Jones. Kinetics of in vitro lysozyme deposition on silicone hydrogel, PMMA, 




We sought to compare the kinetics of in vitro lysozyme deposition on silicone 
hydrogel (SH), PMMA, FDA groups I, II and IV contact lenses. Lenses were incubated in 
125I-labeled lysozyme for time periods ranging from 1 hour to 28 days and radioactive 
counts were determined. SH lenses and PMMA deposited less lysozyme than 
conventional hydrogel lenses (p<0.05). Lysozyme accumulation on group IV lenses 
reached a maximum on the 7th day and then plateaued. PMMA showed a deposition 
pattern similar to that seen on lotrafilcon A and lotrafilcon B SH lenses. These results 
reiterate that kinetics of lysozyme deposition is highly material dependent.  
 
Key words: contact lens; deposition; kinetics; radiolabeled lysozyme; silicone hydrogel.  
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4.2 Introduction 
Following insertion onto the eye, hydrogel contact lenses rapidly adsorb 
components from the tear film, particularly protein, 1-6 lipid, 7-11 and mucin. 12 These 
deposits create a number of problems for patients, including discomfort, reduced visual 
acuity, dryness and reduced lens life. 9, 13-15 Protein deposits may be more problematic as 
they can lead to adverse immunological responses, including Giant Papillary 
Conjunctivitis. 16-18 The newly introduced silicone hydrogel (SH) contact lenses offer 
excellent comfort and performance and superior physiological responses compared to 
traditional contact lens biomaterials. 19-21 Moreover, recent data suggest that these lenses 
deposit extremely low levels of protein when compared to conventional hydrogel (CH) 
lens materials. 22-26  
 
It is widely recognized that the adsorption of proteins at the contact lens surface is 
complex and depends upon a number of factors. Notable among these are material water 
content and surface charge. 3-7, 10, 27-31 A number of studies have investigated the kinetics 
of protein or lipid deposition on contact lens materials in vitro, 1, 12, 32-38 and in vivo 10, 27, 
39-45 on CH lens materials. Although, the quantity and/or conformation of lysozyme 
deposited on SH lens materials have been reported, 22-24 to-date, no study has examined 
the deposition of lysozyme on SH lens materials as a function of time. Knowing the rate 
of protein deposit accumulation and the duration at which protein accumulation reaches 
either a maximum or a plateau level could be clinically relevant to patient symptoms and 
in determining the most appropriate replacement frequency. In addition, this information 
would be very useful for designing clinical investigations of hydrogel lenses and 
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associated lens care products. As lysozyme approximates 90% of the protein found on 




A number of studies have found that using model artificial tear solutions in an in 
vitro model can be an attractive option for determining the binding affinity of different 
components and the mechanisms involved in such binding. 35, 47-55 The principal 
advantages of this method are that most of the experimental variables are eliminated, 
quantitation can be enhanced by labeling the species fluorometrically or radiometrically, 
and simple hypotheses can be tested without indulging in resource-consuming clinical 
studies. However, the real world provides a complex set of variables which cannot be 
excluded from having an influence in clinical lens spoilage. Although, in vitro results 
may not be directly transferable to the in vivo state, in vitro studies will provide valuable 
guidance for further in vivo studies. 
  
A number of quantitative analytical methods have been applied to the analysis of 
protein deposits on contact lenses. 42, 44, 56-59 However, many of these techniques require 
complex extraction procedures which may not be 100% efficient. The radiochemical 
assay is quantitative and reproducible with a low detection limit, able to assess a large 
number of samples, compatible with all contact lens materials, not dependent on complex 
extraction techniques and able to detect surface as well as bulk protein deposition. The 
isotope 125I has been extensively used to radioactively label lysozyme and other proteins 
in previous studies. 1, 2, 60-62 The isotope is incorporated into the protein and radioactivity 
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can be used to assess the level of protein binding. Hence in this study, we used an in vitro 
radiolabeling method using 125I to gain insight into the kinetics of lysozyme deposition on 
all the currently available SH lenses and compared these data with the results from 




4.3 Materials and Methods 
4.3.1 Reagents and materials 
Chicken egg white lysozyme was purchased from Sigma-Aldrich (St. Louis, MO, 
USA). The lenses that were used in the study included five types of SH lenses, five types 
of CH lenses and one PMMA lens. The SH lenses examined were  Night & Day™ 
(CIBA Vision, Duluth, GA, USA), O2Optix™ (CIBA Vision, Duluth, GA, USA), 
PureVision™ (Bausch & Lomb, Rochester, NY, USA), Acuvue® Advance™ (Vistakon, 
Johnson & Johnson, Jacksonville, FL, USA) and Acuvue® OASYS™ (Vistakon, 
Johnson & Johnson, Jacksonville, FL, USA). The properties of these lens materials are 
described in Table 4.1. The CH lens materials examined were Optima™ FW (Bausch & 
Lomb, Rochester, NY, USA), Proclear® (CooperVision, Norfolk, VA, USA), SofLens™ 
66 (Bausch & Lomb, Rochester, NY, USA) Acuvue® 2 (Vistakon, Johnson & Johnson, 
Jacksonville, FL, USA) and Focus® Monthly (CIBA Vision, Duluth, GA, USA). The 
properties of these lens materials are described in Table 4.2. PMMA lenses were ordered 
from Cardinal Laboratories (Cambridge, ON, Canada). Sterile, 5ml non-pyrogenic, 
polypropylene round bottom tubes were purchased from Falcon (Franklin Lanes, NJ, 
USA). All other reagents purchased were analytical grade and obtained from Sigma (St. 







Table 4-1: Properties of silicone hydrogel lens materials evaluated in the study 







USAN Lotrafilcon A Lotrafilcon B Balafilcon A Galyfilcon A 
Senofilcon 
A 





Water content (%) 24 33 36 47 38 
Oxygen 
Permeability (Dk) 140 110 91 60 103 
Centre thickness 
(mm) -3.00D 0.08 0.08 0.09 0.07 0.07 
Oxygen 
Transmissibility 
(Dk/t) at 35˚C 
175 138 101 86 147 




















































DMA (N,N-dimethylacrylamide); EGDMA (ethyleneglycol dimethacrylate); HEMA 
(poly-2-hydroxyethyl methacrylate); mPDMS (monofunctional polydimethylsiloxane) 
NVP (N-vinyl pyrrolidone); TEGDMA (tetraethyleneglycol dimethacrylate); TPVC (tris-
(trimethylsiloxysilyl) propylvinyl carbamate); TRIS (trimethylsiloxy silane); NVA (N-
vinyl amino acid); PBVC (poly[dimethysiloxy] di [silylbutanol] bis[vinyl carbamate]); 














Monthly Acuvue® 2 
USAN polymacon Alphafilcon A 
Omafilcon 
A Vifilcon A Etafilcon A 









Water content (%) 38 66  62 55 58  
FDA group I II II IV IV 








HEMA, poly(2-hydroxyethyl methacrylate); MA, methacrylic acid; NVP, N-vinyl 
pyrrolidone; PC, phosphorylcholine; PVP, polyvinyl pyrrolidone. 
 
4.3.2 Preparation of artificial lysozyme solution 
Artificial lysozyme solution was prepared at a concentration of 1.9 mg/ml using 
Phosphate Buffered Saline (PBS), pH 7.4. Lysozyme was labeled with 125I using the 
Iodine mono-chloride (ICl) method. 60, 63, 64 125I-labeled lysozyme was used as the 
isotopic tracer to quantify protein adsorption to the contact lenses. Radiolabeled 
lysozyme was dialyzed extensively against Phosphate Buffered Saline to remove free 
iodide and the percentage of free iodide was determined based on the precipitation of 
protein with trichloroacetic acid and the radioactivity of the supernatant. In all cases, the 
samples which had free iodide of less than 1% were used in the study. 125I-labeled 
lysozyme was added to unlabeled solution such that the samples had a counting rate of 
105 disintegrations per minute/ml (DPM/ml).  
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4.3.3 Incubating lenses in artificial lysozyme solution 
Four lenses from each lens type were incubated for each time period, resulting in 
a total of 444 lenses being evaluated in the study. Lenses were removed from their 
packaging and thoroughly rinsed with PBS to ensure that no packaging solution remained 
on the lens surface and interfered with the deposition process. The lenses were then 
placed in 1ml of the labeled lysozyme solution and allowed to incubate at a temperature 
of 37°C with constant rotation for various time periods. Our previous work (unpublished) 
has shown that the deposition process differs with various conventional and SH lens 
materials, thus we elected to incubate the materials for slightly differing time periods, 
particularly during the early loading period. The time points chosen for the incubation 
process are described in Table 4.3. 
 
Table 4-3: Table representing various time points for which the lenses were 
incubated in the artificial lysozyme solution 
Silicone hydrogel lens materials Conventional hydrogel lens materials and PMMA 
½ day, 1 day, 2 days, 3 days, 
5 days, 7 days, 14 days, 21 days and 
28 days 
1 hour, 6 hours, ½ day, 1 day, 2 days, 




The lysozyme-labeled incubation solution was changed every 7 days to simulate 
the availability of lysozyme within the tears during in-eye wear. Work in our laboratory 
(unpublished) has indicated that such a process adequately mimics that seen during wear. 
The lysozyme solution that was regularly changed had an identical volume and 
radioactive counting rate on each occasion. 
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Following the specified periods of incubation (Table 4.3), the lenses were 
aseptically removed from the labeled lysozyme solution using forceps and were rinsed 
briefly in saline to remove unbound protein from the lens surface. The lenses were then 
placed in sterile 5ml (12 X 75 mm), non-pyrogenic, polypropylene round bottom tubes 
and subsequently radioactive counts were determined using a Gamma Counter (Perkin 
Elmer Wallac Wizard 1470 Automatic Gamma Counter, Wellesley, MA, USA). The 
amount of protein adsorbed to the lenses was calculated by dividing the counts deposited 
on the lenses by the specific activity of the protein solution. 1 
 
4.3.4 Data Analysis 
Statistical analysis was conducted using Statistica 7 software (StatSoft Inc, Tulsa, 
OK, USA). All data are reported as mean ± SD. Repeated Measures Analysis of Variance 
was used to determine statistically significant differences between deposition across 
various time points and differences between materials at any time point. Post-hoc 
multiple comparison testing was undertaken using the Tukey-HSD test. In all cases, a p 







Figure 4.1 compares the kinetics of lysozyme deposition on alphafilcon A, 
omafilcon A, polymacon and PMMA. Figure 4.2 compares the kinetics of lysozyme 
deposition on the two group IV lens materials (etafilcon A and vifilcon A). Figure 4.3 
displays the kinetics of lysozyme deposition on the five SH lens materials. 
 
Figure 4-1: Comparison of the kinetics of lysozyme deposition on PMMA, 
alphafilcon A, omafilcon A and polymacon lens materials. 





Figure 4-2: Comparison of the kinetics of lysozyme deposition on etafilcon A and 
vifilcon A lens materials. 




Figure 4-3: Comparison of the kinetics of lysozyme deposition silicone hydrogel 
contact lens materials. 
Error bars represent mean±SD (n=4). 
 
The etafilcon A material deposited significantly more lysozyme than all other lens 
materials (p<0.001) and the amount of lysozyme increased significantly between days 1 
and 7 (p<0.001) and then reached a plateau, with no further increase occurring (p>0.05). 
FDA group IV vifilcon A material deposited significantly higher amounts of lysozyme 
than all other lens materials (p<0.05) but, significantly lower lysozyme than FDA group 
IV etafilcon A lens material at all points (p<0.05).  
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After 28 days of incubation, both the FDA group II lens materials (alphafilcon 
and omafilcon) deposited significantly more lysozyme than the group I material 
(polymacon) and PMMA (p<0.05). There was no significant difference between the two 
group II materials (p>0.05), while there was a significant difference between group I and 
PMMA (p<0.05). Among the SH lens materials, Tukey-HSD post-hoc analysis showed 
that there were no significant differences among the five SH lens materials until day 7 
(p>0.05). At day 28, there were significant differences in lysozyme deposition between 
lotrafilcon A & lotrafilcon B versus all other SH lenses (p<0.01) and senofilcon A versus 
balafilcon A lens materials (p<0.05). There were no significant differences between 
PMMA versus lotrafilcon A & lotrafilcon B (p>0.05), lotrafilcon A versus lotrafilcon B 
and galyfilcon A versus senofilcon A lens materials (p>0.05).  
 
Many of the available lens materials (with the exception of PMMA) are replaced 
every 14 or 28 days. Table 4.4 provides the amount of lysozyme deposited on each lens 
material after these two time points. To place the results in the context of general 
biomaterials research investigating protein deposition on hydrogel materials, the data in 








Table 4-4: Lysozyme deposited on various lens types represented in both µg/lens 




(µg/cm2) Lens Type FDA Group 
14 days 28 days 14 days 28 days 
PMMA - 1.7 ± 0.6 3.1 ± 0.9 0.9 ± 0.3 1.6 ± 0.5 
Polymacon I 16 ± 8 23.2 ± 9 5.2 ± 2.6 7.5 ± 2.9 
Alphafilcon A II 44.5 ± 13 53.3 ± 11 14.3 ± 4.2 17.1 ± 3.5 
Omafilcon A II 35.3 ± 8 43.8 ± 13 11.3 ± 2.6 14 ± 4.2 
Vifilcon A IV 356 ± 48 512.3 ± 51 115.7 ± 15.6 166.5 ± 16.6 
Etafilcon A IV 1433.5 ± 76 1434.5 ± 56 465.8 ± 24.7 466.2 ± 18.2 
Lotrafilcon A I 2.7 ± 0.7 4.2 ± 0.9 0.9 ± 0.2 1.4 ± 0.3 
Lotrafilcon B I 3.7 ± 0.6 6.1 ± 1.3 1.2 ± 0.2 2 ± 0.4 
Balafilcon A III 10.6 ± 1.6 19.4 ± 2.9 3.4 ± 0.5 6.3 ± 0.9 
Galyfilcon A I 8 ± 3.4 16.8 ± 4 2.6 ± 1.1 5.5 ± 1.3 




   
 109
4.5 Discussion  
Radiochemical analysis offers great sensitivity for quantification of small 
amounts of material and has previously been used to measure deposition of tear 
components on contact lenses. 1, 2, 48 The principal advantages of radiolabeling through 
the ICl method is that the number of potential oxidation steps in which 125I is transferred 
to the protein is limited. During the time of addition to the reaction mixture, iodine atoms 
are already in a reactive state and the number of substitution or oxidation reactions that 
can occur is equal to the number of active iodine atoms. 65 Previous studies have shown 
that the ICl-labeled proteins do not exhibit preferential adsorption relative to the 
unlabeled protein. 66 From a health hazard aspect, the ICl method can be carried out with 
minimal exposure to radiation. 65 Lysozyme was selected for these studies because it is 
recognized as a prominent lens soilant and a significantly greater quantity of lysozyme 
binds to ionic, high-water-content (group IV) lenses than to other types of lenses and is 
therefore often used as the prototypical marker for protein accumulation. 6, 43, 46 This is 
the first study to look at the kinetics of lysozyme deposition on SH lens materials and 
compare it with PMMA, FDA group I, group II and group IV lens materials. 
 
Figure 4.2 shows that etafilcon A lenses attracted substantial quantities of protein, 
which was significantly greater than that measured on the FDA group II, PMMA and SH 
lenses (p < 0.001). This finding is in accordance with other previous studies examining 
protein and lysozyme deposition on different lens groups 2, 3, 5, 6, 8, 10, 67 and occurs 
because methacrylic acid imparts a negative charge to the material and thus 
thermodynamically favors the deposition of lysozyme, which is a positively charged 
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species at physiological pH. The deposition of lysozyme on etafilcon A may also be due 
to increased affinity of the material for protein uptake. Previously published in vitro 
studies investigating the kinetics of protein deposition on conventional hydrogel contact 
lens materials, using artificial tear solutions containing lysozyme 1, 2, 32, 33, 37, 38, 48 or 
albumin 1, 34, 35, indicate that the proteins deposit rapidly on hydrogel materials, occurring 
within minutes of exposure. 1, 32, 34, 35, 37, 48  
 
Lysozyme accumulated rapidly on etafilcon A, reached a maximum on the 7th 
day and then maintained a plateau, with no further increase occurring (Figure 4.2). The 
kinetics of lysozyme deposition on etafilcon A lenses broadly follows a three-phase 
process, with initial adsorption, followed by a rapid increase in which saturation occurs 
rapidly, and finally a plateau. 32, 33, 35, 36, 38, 39, 41 Its adsorption neutralizes the charge on 
the lens surface to such an extent, that the charge on the lens surface is reversed. 68 Hence 
the deposition plateaus after seven days of incubation. All these factors indicate that the 
ionicity, water content, and chemical composition of the underlying polymer has a 
significant impact on the extent of protein deposited. 1, 32, 35, 38 Our data supports this 
view.     
 
Although vifilcon A is a FDA group IV material, these lenses deposited 
significantly lower amounts of lysozyme than etafilcon A lenses. These results are in 
agreement with a previously published in vitro paper, where an approximately four-fold 
increase in lysozyme deposition on etafilcon A than vifilcon A lenses after 24 hours of 
incubation was reported. 32 Etafilcon A (HEMA+MA) has an increased negative charge 
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when compared to vifilcon A (HEMA+PVP+MA), due to an increased concentration of 
MA. An increase in charge density will result in an increase in the effective pore size and 
this may promote the diffusive penetration of lysozyme. 69    
 
Both the FDA group II lens materials deposited significantly lower amounts of 
lysozyme than the FDA group IV lens materials. Both alphafilcon A (HEMA+ NVP) and 
omafilcon A (HEMA+PC) are non-ionic, high water content lens materials. Both these 
lenses have HEMA in common, which has a neutral charge; alphafilcon A has NVP, a 
hydrophilic monomer which has a neutral charge and omafilcon A has PC which is 
zwitterionic.  The ability of PC-containing lens materials to be resistant to protein-fouling 
is well documented in the literature. 70, 71  
 
In the group I, II and SH materials, lysozyme deposition was significantly less 
than that seen with the group IV materials. Figure 4.1 indicates that the group II material 
deposited approximately 30 µg in the first week and then the weekly amount reduced 
from 15 µg in the second week to <5 µg in the final week, suggesting that a plateau effect 
is occurring. Figure 4.3 shows that balafilcon A lenses deposit lysozyme at a rate of 
approximately 5 µg/lens per week, galyfilcon A lenses deposit at a rate of approximately 
4 µg/lens per week, senofilcon A lenses deposit at a rate of 3 µg/lens per week and 
lotrafilcon A & B deposit at a rate of 1-2 µg/lens per week.   
 
Results from this study clearly demonstrate that SH lens materials deposit 
significantly less lysozyme compared to traditional hydrogel group IV lens materials. SH 
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contact lens materials represent a new family of biomaterials that have properties unlike 
any other previously developed for contact lens use. In addition to differences in surface 
modification, there are fundamental differences in the bulk chemistry of the polymers. 
The difference in the quantity of lysozyme deposition measured between the five SH 
materials could be related to differences in either the bulk material or surface treatment. 
The lotrafilcon A, lotrafilcon B and balafilcon A lens materials are surface treated in an 
attempt to improve the wettability of the materials and to reduce the degree of deposition. 
72, 73 Galyfilcon A and senofilcon A lenses incorporate a long chain, high molecular 
weight molecule called Hydraclear™, and the manufacturers claim that this maintains 
flexibility and moisture. 73 This wetting agent is present throughout the lenses and hence 
no surface treatment is required for these lenses. 73  
 
Although three of the currently available SH lens materials undergo surface 
treatment, some of the studies assessing the in vitro wetting angle of the two SH materials 
indicates that they remain relatively hydrophobic compared with conventional hydrogels, 
70, 74, 75 with the balafilcon A material exhibiting a higher wetting angle than lotrafilcon A. 
The surface treatment of the balafilcon A material exposes more hydrophobic sites than 
the 25-nm homogenous surface modification that is used on the lotrafilcon A material. 76  
In addition to differences in surface modification, there are fundamental differences in 
the bulk chemistry of the polymers, as described in Table 4.1. Some of the earlier studies 
have shown that proteins have a greater affinity for hydrophobic than for hydrophilic 
surfaces. 77-79 Proteins such as lysozyme which have high internal stability do not 
normally adsorb onto hydrophilic surfaces unless there is an electrostatic attraction. 80  
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Balafilcon A is relatively more hydrophobic than other SH lens materials, as the surface 
treatment of the balafilcon A exposes more hydrophobic sites; 76 this might be the reason 
for these lenses depositing more lysozyme than other SH materials. In addition, 
balafilcon A is relatively more porous when compared to other SH lens materials. 81 
Hence, lysozyme can easily penetrate into the matrix of these lens materials, resulting in 
increased amounts of deposition than other SH lens materials. The plasma coating on 
some of the SH lens materials can create an imperturbable surface state, 82, 83 which could 
result in lower adsorption of lysozyme in these materials than when compared to CH lens 
materials. Thus, because of their unique surface and bulk properties, these newly 
developed SH lens materials are highly resistant to protein deposition.  
 
Our data are derived using an in vitro model and it is noteworthy to compare our 
results with those obtained from in vivo studies investigating lysozyme deposition on 
contact lens materials. Previous in vivo studies have shown that lenses recovered within 
the first few minutes of wear demonstrate protein deposition of some degree and the 
process of deposition continues over time. 27, 39, 41, 42, 84, 85 Sack and co-workers showed 
that lysozyme is rapidly deposited on FDA Group IV lenses. Further temporal studies 
showed that during open eye conditions, deposition is linearly related to the duration of 
wear and the deposition eventually leveled off such that similar levels of protein were 
recovered from the lenses after 12 to 14 hours of open eye or several days of extended 
wear. 43 Keith and co-workers determined lysozyme deposition as a function of time on 
etafilcon lenses. 41 They found a mean concentration of 55 µg/lens after 15 minutes of 
wear, which reached a maximum at around 1300 µg/lens after six days of wear, with a 
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plateau occurring between days four to eleven for various subjects. 41 Consistent with this 
study, Jones and co-workers determined that surface deposition reached a plateau on day 
one, while the intra-matrix deposition continued to increase up to seven days on etafilcon 
lenses. 39 Surface protein on alphafilcon also peaked within one day, but total protein 
accumulation continued for up to 30 days. 39 The concept of plateauing on etafilcon 
lenses is also supported by Richards and Tripathi. 44, 56 Lin and co-workers also showed 
that lysozyme accumulation, increased with wearing times up to one week on etafilcon 
lenses. 27 Previous data from lotrafilcon A and balafilcon A studies are also consistent 
with the data reported in this study, in which the material deposited <20 µg of lysozyme 
after a month of wear. 22, 23 Thus, our in vitro data reported in this study is consistent with 
that reported for FDA group II, IV and SH lenses collected from in vivo studies and leads 
us to believe that our kinetic results are highly predictive of that which would be seen in 
lenses worn by clinical subjects.  
 
Examination of Figures 4.1 and 4.3 indicate that replacement schedules can play 
an important role in controlling protein deposition. Currently, many patients replace their 
lens materials after 14 days rather than 28. Our data indicate that FDA group II materials 
would exhibit approximately 25% less lysozyme deposition if replaced in such a manner 
and that balafilcon and galyfilcon as much as 50% less lysozyme. These data are of 
interest to patients and clinicians alike, particularly given that protein denaturation may 
also decrease if materials are replaced more frequently. 
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One of the limitations of this study was that the lenses were incubated in a 
solution containing only one type of protein, namely lysozyme. An important factor to 
consider in the process of deposition relates to whether other substances from the tear 
film (for example, mucins, lipids or other proteins) concurrently deposit onto the material 
surface at different rates. Hence, it is necessary in future studies, to investigate the 
kinetics of deposition using a complex artificial tear solution and to look at the protein-
protein, protein-lipid and protein-mucin interactions. It is clear that SH lenses only 
deposit small amounts of lysozyme and previously published studies suggest that much of 
this lysozyme is denatured. 22, 23 Therefore, it would be interesting to investigate the 
activity of lysozyme recovered from these lenses at various time points. Hence, in 
addition to investigating the kinetics of deposition, the kinetics of denaturation and how 
they relate to wearing period, the influence of various care regimens, and the degree to 
which other tear proteins denature also require investigation.  
 
4.6 Conclusions 
In conclusion, the results from this study indicate that lysozyme deposition is 
driven by both the bulk chemistry and also the surface properties of CH and SH lens 
materials. The surface modification processes or the inclusion of high molecular entities 
or surface-active monomers on SH lens materials also play a significant role in lysozyme 
deposition on SH lens materials. The results from this study reiterate that SH lens 
materials deposit very low amounts of lysozyme. SH lenses that are surface modified 
with a 25nm plasma coating (lotrafilcon A & lotrafilcon B) showed a deposition pattern 
similar to PMMA lens materials. SH lenses that use a surface modification system based 
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on PVP (galyfilcon and senofilcon) had similar deposition patterns, while balafilcon 
lenses (which undergo a plasma oxidation process) showed the highest level of lysozyme 
deposition.  
 
The next chapter of this thesis will discuss the conformational state of lysozyme 
recovered from various conventional and silicone hydrogel contact lens materials as a 
function of time using an in vitro model. 
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5 Kinetics of lysozyme activity recovered from conventional 
and silicone hydrogel contact lens materials 
 
This chapter is currently “In Press”: 
Lakshman N Subbaraman, Lyndon Jones. Kinetics of lysozyme activity recovered from 
conventional and silicone hydrogel contact lens materials as a function of time. J 






Purpose: To determine the activity of lysozyme recovered from various conventional 
and silicone hydrogel (SH) contact lens materials as a function of time, using an in vitro 
model. 
 
Methods: Polymacon, omafilcon, etafilcon, vifilcon, lotrafilcon A, lotrafilcon B, 
balafilcon A, galyfilcon A and senofilcon A contact lenses (n=5) were incubated in 
lysozyme solution for time periods ranging from 1 hour to 28 days. Following the 
specified incubation period, the lysozyme deposited on the lenses was extracted and the 
sample extracts were assessed for lysozyme activity and total lysozyme.   
 
Results: There was no significant difference (NSD) between omafilcon and polymacon 
lens materials for the initial three days (p>0.05), however there was a significant 
difference between the two lenses from five to 28 days (p<0.05). There was NSD 
(p>0.05) between etafilcon and vifilcon lens materials at all time points and significant 
differences were seen among various SH lens materials at different time points. After 28 
days, lysozyme deposited on etafilcon (90±3%) and vifilcon (91.4±3%) exhibited the 
greatest activity. Lysozyme deposited on polymacon (17.8±4%), lotrafilcon A (23.4±4%) 
and lotrafilcon B (24±5%) exhibited the lowest activity. Lysozyme deposited on 
omafilcon, galyfilcon, senofilcon, and balafilcon exhibited 38±3%, 62.3±8%, 47±6% and 
61±7% of activity respectively.   
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Conclusions: The reduction in activity of lysozyme deposited on contact lens materials is 
time dependant and the rate of reduction varies among lens materials. This variation in 
activity recovered from lenses could be due to the differences in surface/ bulk material 
properties or the location of lysozyme on these lenses. 
 
Key words: contact lens; lysozyme; protein activity; silicone hydrogel; tear protein. 
 127
5.2 Introduction 
Following insertion onto the eye, hydrogel contact lenses rapidly sorb 
components from the tear film, particularly proteins, lipids and mucins. 1-4 At extreme 
levels of build-up, these deposits are associated with diminished visual acuity, 5 dryness 
and discomfort, 6, 7 lid-related inflammatory changes and contact lens associated papillary 
conjunctivitis. 8-11 Moreover, these deposits could potentially increase the risk of bacterial 
attachment, by providing a solid substrate and shelter. 12-14 
 
It was originally believed that the protein layer which is bound to the lens material 
is highly homogeneous, consisting almost entirely of denatured lysozyme. 15 Sack and co-
workers were the first to demonstrate that the “Lens Bound Protein Layer” retained a 
certain amount of biological activity and that the conformational state of the deposited 
protein is highly dependent on the hydrogel structure. 4 It is also of interest to note that 
some of the earlier studies have suggested that the allergenicity of adsorbed proteins on 
hydrogel lenses is related to their degree of denaturation. 10, 11, 16  
 
Using mass-spectrometry, it was recently shown that lysozyme, lipocalin, 
lactoferrin, lacritin, proline-rich 4 and Ig alpha are the tear proteins that are frequently 
detected in the proteomic profile of contact lens deposition on siloxane-based “silicone 
hydrogel” (SH) lenses. 17, 18 Among these unique tear proteins, lysozyme is a bacteriolytic 
enzyme with a relatively small molecular weight (14 kDa) and a positive charge at 
neutral pH. Lysozyme is one of the major proteins that is found on contact lens materials 
and, as lysozyme approximates 90% of the protein found on group IV contact lens, it is 
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often used as the “model protein” for protein accumulation. 4, 19-24 Once lysozyme firmly 
adsorbs onto contact lens materials, it tends to undergo conformational changes, 4, 24-26 
which might potentially result in a variety of immunological responses, including contact 
lens associated papillary conjunctivitis. 8, 10, 11, 27 Recently, our group has also shown that 
the subjective comfort of symptomatic contact lens wearers is closely associated with the 
activity of lysozyme recovered from polyHEMA-based hydrogel lenses worn for as little 
as one day. 28 Therefore, in addition to investigating the total quantity of the deposited 
protein, it is of significant clinical relevance to study the conformational state of the 
deposited protein.  
 
Although, the conformational state of lysozyme deposited on hydrogel lens 
materials after a specified period has been reported, 24, 26, 29, 30 to-date, no study has 
examined the activity of lysozyme deposited on polyHEMA-based conventional hydrogel 
(CH) and SH lens materials as a function of time. Knowing the rate of protein deposit 
accumulation and the duration over which lysozyme denatures is clinically relevant to 
patient symptoms and in determining the most appropriate replacement frequency. In 
addition, this information would be very useful for designing clinical investigations of 
hydrogel lenses and associated lens care products. Commercially available contact lens 
materials are classified into four different groups based on their water content and charge 
by the United States Food and Drug Administration (FDA). Therefore, it is of interest to 
determine whether the water content and charge of the lens material affect the biological 
activity of the deposited lysozyme. Hence, the purpose of this study was to compare the 
activity of lysozyme deposited on FDA group I, FDA group II & FDA group IV CH lens 
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materials and the first & second generation SH lens materials, as a function of time using 
an in vitro method. 
 
 
5.3 Materials and Methods 
5.3.1 Reagents and materials 
The four types of CH lenses examined were FDA group I Optima™ FW (Baush 
& Lomb), FDA Group II Proclear® (CooperVision), FDA group IV Focus® Monthly 
(CIBA Vision) and FDA Group IV Acuvue® 2 (Vistakon, Johnson & Johnson). Five 
types of SH lens materials were examined, including Night and Day™ (CIBA Vision), 
O2Optix™ (CIBA Vision), PureVision™  (Bausch & Lomb), Acuvue® Advance™ 
(Vistakon, Johnson & Johnson) and Acuvue® OASYS™ (Vistakon, Johnson & 
Johnson). The properties of each material are described in Tables 5.1 and 5.2. 
PhastSystem™ components were described previously. 26 Immuno-Blot® PVDF 
(polyvinylidene difluoride) membranes were purchased from Bio-Rad Laboratories 
(Mississauga, ON, Canada). Polyclonal rabbit anti-human lysozyme was purchased from 
Cedarlane Laboratories (Hornby, ON, Canada) and goat anti-rabbit IgG-HRP was 
purchased from Sigma (St. Louis, MO, USA). Lysozyme and lyophilized Micrococcus 
lysodeikticus cells were also purchased from Sigma (St. Louis, MO, USA). All other 




Table 5-1: Properties of silicone hydrogel lens materials evaluated in the study 







USAN Lotrafilcon A Lotrafilcon B Balafilcon A Galyfilcon A 
Senofilcon 
A 





Water content (%) 24 33 36 47 38 
Oxygen 
Permeability (Dk) 140 110 91 60 103 
Centre thickness 
(mm) -3.00D 0.08 0.08 0.09 0.07 0.07 
Oxygen 
Transmissibility 
(Dk/t) at 35˚C 
175 138 101 86 147 



















































DMA (N,N-dimethylacrylamide); EGDMA (ethyleneglycol dimethacrylate); HEMA 
(poly-2-hydroxyethyl methacrylate); mPDMS (monofunctional polydimethylsiloxane) 
NVP (N-vinyl pyrrolidone); TEGDMA (tetraethyleneglycol dimethacrylate); TPVC (tris-
(trimethylsiloxysilyl) propylvinyl carbamate); TRIS (trimethylsiloxy silane); NVA (N-
vinyl aminobutyric acid); PBVC (poly[dimethysiloxy] di [silylbutanol] bis[vinyl 






Table 5-2: Properties of conventional hydrogel lens materials evaluated in the study 




polymacon Omafilcon A Vifilcon A Etafilcon A 
Manufacturer Bausch & Lomb Cooper Vision CIBA Vision 
Johnson & 
Johnson 
Water content (%) 38 62 55 58 
FDA group I II IV IV 










polyHEMA, (poly-2-hydroxyethyl methacrylate); MA, methacrylic acid; NVP, N-vinyl 
pyrrolidone; PC, phosphorylcholine; PVP, polyvinyl pyrrolidone. 
 
 
5.3.2 Incubation of lenses in lysozyme solution 
Lysozyme solution was prepared at a concentration of 1.9 mg/ml using Phosphate 
Buffered Saline (PBS), at pH 7.4. Five lenses from each lens type were incubated for 
each time period, resulting in a total of 425 lenses being evaluated in the study. Lenses 
were removed from their packaging and thoroughly rinsed with PBS to ensure that no 
packaging solution remained on the lens surface and interfered with the deposition 
process. In order to achieve this, lenses were removed from the packaging solution using 
forceps and were placed in vials containing PBS with the lenses’ concave side up for one 
hour. The vials were then placed on a plate shaker for two minutes and this process was 
performed a total of three times with fresh PBS each time. Lenses were then placed in 
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1ml of the lysozyme solution and were allowed to incubate at a temperature of 37°C with 
constant rotation for various time periods. Our previous work (unpublished) has shown 
that the deposition process differs with various conventional and SH lens materials, thus 
we elected to incubate the materials for slightly differing time periods, particularly during 
the early loading period. The CH lens materials were incubated for one hour, twelve 
hours, one, two, three, five, seven, 14, 21 and 28 days; whereas the SH lens materials 
were incubated for twelve hours, one, two, three, five, seven, 14, 21 and 28 days.  
 
5.3.3 Protein deposit extraction and sample processing following extraction 
After the specified period of incubation, the lenses were rinsed with PBS in order 
to remove any unbound protein on the lens surface. The lenses were then placed into an 
extraction solvent consisting of acetonitrile/ trifluroacetic acid (ACN/TFA) and were 
incubated in the dark at room temperature for 24 hours. 26, 31, 32 Two 0.70 ml aliquots of 
ACN/TFA was transferred to sterile eppendorf tubes and lyophilized to dryness in a 
Savant Speed Vac (Halbrook, NY, USA). Dried protein pellets were stored at –80ºC prior 
to reconstitution. Prior to electrophoresis/Western blotting and lysozyme activity 
analysis, lyophilized protein pellets were reconstituted in modified reconstitution buffer – 
MRB (10 mM Tris-HCl; 1 mM EDTA, with 0.9% saline) pH 12.0 and BioStab® 
Biomolecule Storage Solution (Sigma Aldrich). 32  
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5.3.4 Electrophoresis and immunoblotting 
The total lysozyme deposited on the lens materials was determined using 
electrophoresis and immunoblotting techniques. 26, 32  Lysozyme standards were prepared 
fresh on the day of analysis from a 1.0 μg/μL frozen stock of purified neutrophil 
lysozyme with MRB, pH 8.0 and subjected to SDS-PAGE followed by Western blotting 
to PVDF membranes. 26, 32  
 
5.3.5 Negative control - extraction and Western blot analysis of lenses 
All lens materials (n=3 per material) were extracted in ACN/TFA solution and 
were subjected to SDS-PAGE and Western blotting, as described above. 
 
5.3.6 Measurement of lysozyme activity 
The extracts were assayed for lysozyme activity using a fresh suspension of 
Micrococcus lysodeikticus for each sample. 26, 29 Micrococcal cells were suspended in 50 
mM sodium phosphate buffer (pH 6.3) to an initial optical density of 1.0 at 450 nm 
(Multiskan Spectrum ELISA Plate Reader, fitted with a micro-cuvette, 
ThermoLabsystems). Standards and samples were applied to 1 ml cells in 10 µl or less.  
Kinetic measurements were taken at 30 sec intervals (450 nm) for 5 minutes at 30o C, 
with stirring for 10 seconds after each measurement except time zero. Lysozyme standard 
(5, 10, 50, 100 ng) was run concurrently with samples. The change in absorbance was 
plotted against time, from 30 seconds to between 3 and 5 minutes, to determine the slope 
or initial velocity. A native lysozyme standard curve was constructed of mass lysozyme 
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standard against initial velocity by least-squares, as described previously. 26 R2 values 
were always at least 0.98 and the equation of the regression line was calculated to give 
the slope. Finally, to determine the amount of lysozyme from the lens extract still in 
native form, the following formula was employed: Active lysozyme = total lysozyme 
(sample specific activity/ standard specific activity), where total lysozyme was pre-
determined via Western blot analysis as described above. The denatured lysozyme 
component was derived by: Denatured lysozyme = total lysozyme - active lysozyme. The 
final calculation was the percent of active lysozyme: % active lysozyme = (active 
lysozyme / total lysozyme) X 100. 
 
5.3.7 Statistical Analysis 
Statistical analysis was conducted using Statistica 8 software (StatSoft Inc, OK, 
USA). All data are reported as mean ± SD. Two repeated measures ANOVAs (one for 
CH and the other for SH) were performed, with the material and time course as the 
factors. Post-hoc multiple comparison testing was undertaken using the Tukey-HSD test. 




Figure 5.1 compares the kinetics of lysozyme activity recovered from polymacon 
(FDA group I) and omafilcon A (FDA group II). Figure 5.2 compares the kinetics of 
lysozyme activity recovered from the two FDA group IV lens materials (etafilcon A and 
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vifilcon A). Figure 5.3 displays the kinetics of lysozyme activity recovered from the five 
SH lens materials. Repeated Measures ANOVA for the four CH lens materials showed a 
significant interaction between lenses and time (F-statistic = 62.969, p<0.001); similarly, 
a significant interaction was seen between the lenses and time for the five SH lens 
materials (F-statistic = 22.919, p<0.0001). 
 
 
Figure 5-1: Comparison of the kinetics of percentage active lysozyme recovered 
from polymacon and omafilcon A lens materials.  






Figure 5-2: Comparison of the kinetics of percentage active lysozyme recovered 
from etafilcon A and vifilcon A lens materials.  




Figure 5-3: Comparison of the kinetics of percentage active lysozyme recovered 
from silicone hydrogel lens materials.  
Error bars represent Mean ± Standard Deviation, (n=5). 
 
Figure 5.1 shows that there was a gradual reduction in the activity of lysozyme 
deposited on omafilcon A (FDA group II) and polymacon (FDA group I) lens materials 
from one hour to 14 days (all p<0.01), with the exception of between the first and second 
days (both p>0.05) and second and third days (both p>0.05) of incubation. However, 
there was no statistically significant reduction in the activity of lysozyme deposited on 
both lens materials from days 14 to 28 (all p>0.05). There was no significant difference 
between these two materials until day three (p>0.05 for all time points), however there 
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was a significant difference between the two lens materials from day 5 through to day 28 
(p<0.05 for all time points).  
  
Figure 5.2 shows that there was no significant difference (all p>0.05) between the 
two FDA group IV lens materials (etafilcon A and vifilcon A) across any time point 
evaluated in this study. There was a significant difference between the one hour time 
point and 21, 28 day time points for both the FDA group IV lens materials (p<0.05). 
 
Figure 5.3 shows that there was a gradual reduction in the activity of lysozyme 
recovered from all the five lens materials until day seven (all p<0.05), and there was no 
statistically significant further reduction in activity for the galyfilcon A and balafilcon A 
materials (all p>0.05) after day seven. For senofilcon A, lotrafilcon A and lotrafilcon B 
lens materials, the 21 and 28 day time points were significantly lower than all other time 
points (p<0.05), except the 14 day time point (p>0.05). Among the five SH lens 
materials, there was no significant difference among them until day three (p>0.05). At the 
end of 28 days, there was no significant difference between galyfilcon A and balafilcon A 
lens materials (p=0.64) and no significant difference between lotrafilcon A and 
lotrafilcon B lens materials (p=0.72). Lysozyme recovered from senofilcon A exhibited 
significantly higher activity than those recovered from lotrafilcon A & B (both p<0.05), 
but significantly lower activity than that recovered from galyfilcon A and balafilcon A 
lens materials (both p<0.05). 
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After 28 days, lysozyme deposited on etafilcon A and vifilcon A exhibited the 
greatest activity (90±3% and 91.4±3% respectively), which was statistically greater than 
all other lens types (p<0.001). There was no significant difference between etafilcon A 
and vifilcon A lens materials at the end of 28 days (p=0.96). Lysozyme deposited on 
polymacon (17.8±4%), lotrafilcon A (23.4±4%) and lotrafilcon B (24±5%) exhibited the 
lowest activity. Lysozyme deposited on omafilcon, galyfilcon, senofilcon, and balafilcon 
exhibited 38±3%, 62.3±8%, 47±6% and 61±7% of activity respectively.  
 
In a clinical situation, SH lens materials that were evaluated in this study are 
typically replaced every 14 or 28 days. Table 5.3 provides the amount of denatured 
lysozyme in microgram per lens that was deposited on each lens material after the one, 
seven, 14 and 28 days of incubation.  No signal was seen on Western blots run on control 
lens materials after being subject to the same procedures, confirming that there was no 
background interference from the lens polymer. The percentage reduction in the activity 










Table 5-3: Denatured lysozyme deposited on conventional hydrogel and silicone 
hydrogel lens materials in µg/lens (Mean ± standard deviation). 
 
Lens Day 1 (µg DL/lens) 
Day 7 
(µg DL/lens) 
Day 14          
(µg DL/lens) 
Day 28          
(µg DL/lens) 
Polymacon 0.8 ± 0.5 6.8 ± 3 10.8 ± 4 16.5 ± 6 
Omafilcon A 1 ± 1 10 ± 3 18 ± 5 25 ± 6 
Etafilcon A 23 ± 7 120 ± 14 121 ± 12 135 ± 13 
Vifilcon A 8 ± 3 23 ± 7 28 ± 5 43 ± 9 
Lotrafilcon A BD * 0.4 ± 0.3 1.2 ± 0.8 2.4 ± 1 
Lotrafilcon B BD * 0.2 ± 0.2 1.1 ± 0.7 2.2 ± 1.3 
Balafilcon A 0.1 ± 0.1 1.9 ± 0.9 3.9 ± 1 7.8 ± 3 
Galyfilcon A 0.1 ± 0.1 1 ± 0.5 2.2 ± 1 3.5 ± 1.6 
Senofilcon A BD * 0.3 ± 0.2 0.9 ± 0.6 3.1 ± 1.7 
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5.5 Discussion  
Protein deposition on any polymeric surface is a complex process. Previous 
studies have proposed that there are distinct steps that contribute to the kinetics of protein 
sorption onto polymeric surfaces. 33, 34 Initially, there is a rapid and reversible uptake of 
proteins in the first few minutes until a pseudo equilibrium is reached, resulting in up to 
50 to 60% of the surface being covered with a random arrangement of adsorbed 
molecules, which would facilitate further protein uptake. 34 After adsorption, protein 
molecules on the polymer surface will undergo structural transition as a function of time, 
which will lead to an optimal interaction between the polymer surface and the protein.  33, 
34 With an increase in the surface-protein interaction, there is an increase in the entropy of 
the protein and the protein is less likely to desorb from the surface. Moreover, some of 
the proteins which are bound to the polymer will penetrate into the matrix of the material 
through a process of simple diffusion and complex electrostatic attraction 35 which might 
result in increased conformational changes to the protein, depending on the polymer 
make-up.  
 
Protein denaturation is commonly defined as any non-covalent change in the 
structure of a protein and this change may alter the secondary, tertiary or quarternary 
structures of the molecule. Some analytical methods are sensitive to detect very slight 
changes in structure, while others require rather large alterations in the protein structure 
before these changes can be observed. For enzymatic proteins such as lysozyme, 
denaturation can be defined as the loss of structural configuration which will render the 
enzyme inactive. Determination of loss of enzymatic activity can be a very sensitive 
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measure of denaturation, since procedures including the micrococcal assay are capable of 
detecting very low levels of activity. This study compared the kinetics of the activity of 
lysozyme deposited on FDA group I, II & IV CH lens materials and the first & second 
generation SH lens materials, using a modified micrococcal assay. 
 
Protein denaturation on any polymeric surface or a contact lens material is 
influenced by several factors, including contact time of the protein with the substrate, 
chemical composition of the substrate, surrounding pH, type of protein and temperature 
of the surrounding medium. 33, 36-39 Several studies also suggest that proteins that are 
exposed to hydrophobic surfaces are more likely to denature than those that are exposed 
to hydrophilic surfaces. 21, 33, 36, 39-42 It has also been suggested that the degree of 
denaturation of a protein is dependent on the location of the protein in a polymer; 
proteins that are located in the matrix of the lens material are less likely to denature than 
those that are adsorbed on the lens surface. 4, 39, 43 The clinical relevance of protein 
denaturation on hydrogel lenses relates to the impact of this protein on inflammation and 
lens comfort. Previous studies have suggested that protein denaturation is closely linked 
to inflammatory conditions such as giant papillary conjunctivitis. 8-11 In addition, recent 
work has suggested that even over a short period of wear that protein denaturation can 
impact on lens comfort, with little correlation being shown with total amounts of either 
lysozyme or total protein. 28 
 
Figure 5.1 shows that there was no significant difference in the percentage active 
lysozyme recovered from FDA group I polymacon and FDA group II omafilcon A lens 
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materials for up to three days of incubation (p>0.05) and the percentage active lysozyme 
recovered from polymacon was significantly lower for the remaining time periods tested. 
Polymacon is the USAN for hydrogel materials fabricated from poly-2-hydroxyethyl 
methacrylate (polyHEMA), which is a non-ionic and low water content material (Table 
5.2) with an average pore radius of 4-8 Å at its equilibrium condition of hydration. 44 
Lysozyme is a compact globular protein molecule of molar mass of 14,500 Da, with a 
slightly ellipsoidal shape, and its dimensions are 45 X 30 X 30 Å. 45 Due to the small 
pore size of polyHEMA hydrogels, penetration of even the smallest of proteins such as 
lysozyme will be prevented. 44 The deposition of lysozyme on polyHEMA hydrogels 
should entirely be a surface adsorption phenomenon, due to the scarcity of cationic and 
anionic binding sites on the lens material. Lysozyme that is bound to the lens material 
will presumably be held by hydrophobic and non-ionic hydrophilic interactions. These 
forces in turn, would favour the exposure of non-ionic amino acids that are normally 
buried within the protein interior, resulting in increased denaturation of the protein. 
However, the presence of a hydrophobic cross-linking agent in the material and other 
trace impurities including methacrylic acid (MA) present during polyHEMA processing 
may increase the pore size of the contact lens network. 46 This would force the lysozyme 
to penetrate into the matrix through the small pores of polyHEMA, which would result in 
further changes in the conformational state of the protein, potentially resulting in further 
loss of activity.  
 
Omafilcon A is a copolymer of polyHEMA and phosphorylcholine (PC), which is 
non-ionic and has high water content, and is hence classified as a FDA group II material. 
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Using confocal microscopy and fluorescently-tagged lysozyme, it has been shown that 
lysozyme rapidly penetrates into the bulk of the omafilcon material after as little as 24 
hours exposure. 47, 48 The ability of PC-containing hydrogels to resist protein-deposition 
in both the eye and following contact with blood is well documented in the literature. 23, 
49-53 Moreover, it has been shown that PC-based omafilcon has a higher resistance to 
dehydration than other CH lenses, presumably due to the high water affinity of the 
incorporated PC. 54 However, these lens materials have a relatively high water contact 
angle, when assessed using a sessile drop technique, suggesting that these materials are 
relatively more hydrophobic than ionic FDA group IV lens materials. 55  
   
Figure 5.2 shows that the percentage active lysozyme recovered from both the 
FDA group IV lens materials, etafilcon A and vifilcon A, was significantly greater than 
that measured on all the other lens materials examined, at the end of 28 days (p < 0.001). 
This finding is in accordance with other previous ex vivo and in vitro studies which have 
examined the degree of denatured lysozyme recovered from FDA group IV 4, 24-26 and SH 
lens materials. 24-26 Previous studies have also shown that both etafilcon A 3, 23-26, 56-60 and 
vifilcon A 21, 23 deposit significantly higher amounts of lysozyme than other CH and SH 
lens materials. Both these lens materials have a negative charge, due to the presence of 
the ionic monomer methacrylic acid (MA). Among these two materials, etafilcon A (a 
copolymer of polyHEMA and MA only) has an increased concentration of MA, so 
etafilcon A has a substantially higher negative charge than vifilcon A (a copolymer of 
polyHEMA, PVP and MA). An increase in charge density will result in an increase in the 
effective pore size, provoked by the repulsion of the charged groups, and this may 
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promote the diffusive penetration of lysozyme into MA-containing hydrogels. 61 
Therefore, the dynamics of lysozyme deposition will be radically different on these lens 
materials when compared to that seen in a polyHEMA hydrogel. Using confocal 
microscopy, a previous in vitro study from our group has determined that lysozyme is 
primarily located within the bulk of these FDA group IV hydrogels, with relatively little 
surface-located lysozyme being determined. 47, 48 Using a sessile drop technique, it was 
shown that the CH group IV lens materials are more wettable than other lens materials, 
indicating that these lenses are more hydrophilic. 55 Therefore, we speculate that the 
activity of lysozyme recovered from CH group IV lens materials is significantly higher 
than that recovered from other lens materials because lysozyme is exposed to a more 
hydrophilic surface and the sorbed lysozyme is located primarily in the bulk of the 
hydrogel rather than on the surface, resulting in reduced denaturation. Despite, the fact 
that lysozyme also penetrates into the omafilcon material, there is a large difference in 
the activity of lysozyme recovered from group IV and group II lens materials. This begs 
the question of whether the high amounts of lysozyme deposited on etafilcon and vifilcon 
lens materials actually helps to prevent subsequent denaturation, and this area requires 
further experimentation. 
 
Currently available SH lens materials are made up of highly complex monomers 
and contain multiple monomer components (Table 5.1). However, regardless of the 
polymer make-up, the hydrophobic and surface active nature of the silicone component 
necessitates additional modification or surface treatment. These SH lens materials can be 
broadly classified into three groups, based upon their surface treatment. 62-70 The two 
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CIBA Vision materials (lotrafilcon A and lotrafilcon B) have a plasma-coated surface 
consisting of a high refractive index polymer. 65-67 Bausch & Lomb’s balafilcon A has a 
plasma-treatment that converts the hydrophobic silicon at the surface into a highly 
wettable “glassy” surface that consists of silicate. 63, 64 The two Johnson and Johnson 
materials (senofilcon A and galyfilcon A) do not undergo a surface modification process, 
but rather incorporate polyvinyl pyrrolidone (PVP) during the polymerization process, 
which then acts to assist with surface wetting and hydrophilicity. 68-70 
 
Among the SH materials, balafilcon A and galyfilcon A materials had the highest 
percentage of lysozyme activity at the end of 28 days. This could be attributed to the 
location of lysozyme on these lens materials. Using confocal microscopy, we have shown 
that there was a significant amount of lysozyme penetration into the bulk of the matrix of 
balafilcon material, with a gradual build-up of lysozyme as a function of time for up to 28 
days. 47, 48 Lysozyme can easily penetrate into the interior matrix of the balafilcon 
material due to its macroporous nature, as shown by scanning electron microscopy and 
atomic force microscopy. 62, 63 Under conditions of dehydration and hydration, it was 
found that the diameter of these macropores could be as high as 0.5 μm, which is 
significantly larger than the pore size of CH lenses. It is therefore reasonable to assume 
that these macropores are sufficiently large enough to permit the diffusion of lysozyme, 
with relatively low structural transitions. In addition, the incorporation of N-vinyl 
aminobutyric acid imparts an overall negative charge to the balafilcon material (it is the 
only FDA group III SH material commercially available) and this will also increase the 
amount of lysozyme that sorbs onto the material.  
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In the galyfilcon A lens material, it was found that a significant amount of 
lysozyme remained on the surface, but a significant amount of lysozyme also penetrated 
into the bulk of the material, when assessed by confocal microscopy. 47, 48 Surprisingly, 
senofilcon A, which undergoes a similar process of incorporating PVP into the lens to aid 
wettability as that used in galyfilcon A, showed very little penetration of lysozyme, with 
most lysozyme remaining on the surface. 47, 48 This difference in the location of lysozyme 
on lens materials may help to explain the differences in the active lysozyme recovered 
from these two lens materials, despite their similar compositions.  
 
SH lens materials that were surface modified with a 25nm plasma coating 
(lotrafilcon A & B) showed a deposition pattern similar to polyHEMA lens materials. 
These materials are surface treated by coating them with a 25nm thick cross-linked 
hydrocarbon-containing plasma polymer. 62, 65, 66 It would appear that the “sealed-in” 
nature of the surface of lotrafilcon A and lotrafilcon B, coupled with their very low water 
content (Table 5.1) and lack of surface charge, produces lens materials that are highly 
resistant to protein deposition. Therefore, the deposition of lysozyme on lotrafilcon A and 
B lens materials will entirely be a surface adsorption phenomenon. The results from 
confocal microscopy also support this view. 47, 48 This would result in lysozyme 
remaining entirely on the lens surface, with no penetration occurring, thereby resulting in 
further denaturation of the deposited protein.  
 
One of the limitations of this study was that the lenses were incubated in a 
solution containing only one type of protein, namely lysozyme. An important factor to 
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consider in the process of deposition relates to whether other substances from the tear 
film (for example, mucins, lipids or other proteins) concurrently deposit onto the material 
surface at different rates. Moreover, certain tear proteins such as lactoferrin are known to 
protect lysozyme from losing their activity. 71-73 Hence, it is necessary in future studies to 
investigate the activity of lysozyme using a complex tear solution and to look at the 
protein-protein, protein-lipid and protein-mucin interactions. It would also be of interest 
to study the activity of other major tear proteins such as lactoferrin, once they deposit 
onto conventional and silicone hydrogel contact lens materials. In addition to 
investigating the kinetics of denaturation and how they relate to the wearing period, the 
influence of various care regimens on denaturation also require investigation.  
 
5.6 Conclusions 
In conclusion, the results from this study suggest that the reduction in the activity 
of lysozyme deposited on contact lens materials is time dependent and that the rate of 
reduction in the activity of lysozyme varies between lens materials. This reduction in the 
loss of biological activity could be due to the differences in surface or bulk properties of 
the lens materials and also depend on the location of lysozyme on these lens materials. 
These results reiterate that the levels of lysozyme activity are highly variable between 
lens materials and also that SH lens materials deposit very low amounts of lysozyme. 
After 28 days, lysozyme recovered from CH FDA group IV lens materials (etafilcon A 
and vifilcon A) retained the highest amount of percentage activity, while lysozyme 
recovered from SH lenses that are surface modified with a 25nm plasma coating 
(lotrafilcon A & B) retained an activity similar to that of a CH FDA group I lens material. 
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Among SH lenses, lenses that use a surface modification system based on PVP 
(galyfilcon A) and lenses that undergo a plasma oxidation process (balafilcon A) retained 
similar levels of percentage active lysozyme.  
 
To our knowledge, this is the first study to investigate the kinetics of lysozyme 
activity recovered from SH and CH lens materials. It provides hitherto unavailable 
information on the rate of reduction of lysozyme activity deposited on contact lens 
materials, which will be useful for contact lens practitioners, the contact lens industry and 
the general field of biomaterials research.  
 
The next chapter of this thesis will determine the total protein, total lysozyme and 
active lysozyme deposition on a novel, lathe-cut silicone hydrogel contact lens material 
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6 Protein deposition on a novel, lathe-cut silicone hydrogel 
contact lens material (sifilcon A)  
 
This chapter is published as follows: 
Lakshman N Subbaraman, Jill Woods, Jonathan H Teichroeb, and Lyndon Jones. Protein 
deposition on a lathe-cut silicone hydrogel contact lens material. Optom Vis Sci. 2009; 
86(3): 244-50.  




Purpose: To determine the quantity of total protein, total lysozyme and the 
conformational state of lysozyme deposited on a novel, lathe-cut silicone hydrogel (SiHy) 
contact lens material (sifilcon A) after three months of wear.  
 
Methods: 24 subjects completed a prospective, bilateral, daily-wear, nine month clinical 
evaluation in which the subjects were fitted with a novel, custom-made, lathe-cut SiHy 
lens material. The lenses were worn for three consecutive three-month periods, with 
lenses being replaced after each period of wear. After 3 months of wear, the lenses from 
the left eye were collected and assessed for protein analysis. The total protein deposited 
on the lenses was determined by a modified Bradford assay, total lysozyme using 
Western blotting and the lysozyme activity was determined using a modified micrococcal 
assay. 
 
Results: The total protein recovered from the custom-made lenses was 5.3±2.3 µg/lens 
and the total lysozyme was 2.4±1.2 µg/lens. The denatured lysozyme found on the lenses 
was 1.9±1.0 µg/lens and the percentage of lysozyme denatured was 80±10%.  
 
Conclusions: Even after three-months of wear, the quantity of protein and the 
conformational state of lysozyme deposited on these novel lens materials was very 
similar to that found on similar surface-coated SiHy lenses after two to four weeks of 
wear. These results indicate that extended use of the sifilcon A material is not deleterious 
in terms of the quantity and quality of protein deposited on the lens.  
 158




Protein deposition on contact lens materials is a complex process and is dependent 
upon several factors, including chemical composition of the lens material, material water 
content and surface charge. 1-9 In addition to the aforementioned factors, studies have 
shown that the fabrication process and the surface regularity of the lens material can also 
influence the deposition of tear components on to lens materials. 10-14 Previous in vitro 
and ex vivo studies have shown that proteins increasingly accumulate on lens materials 
over time, with longer incubation times or in-eye wearing periods resulting in increased 
deposition. 5, 6, 10, 12, 15-26 
 
A recent study that investigated the proteomic profile of contact lens deposition 
on silicone hydrogel (SiHy) lens materials using mass-spectrometry identified lysozyme, 
lipocalin, lactoferrin, lacritin, proline-rich 4 and Ig alpha as frequently recognized tear 
proteins. 27 Among the unique tear proteins that are found on hydrogel lens materials, 
lysozyme is a bacteriolytic enzyme with a relatively small molecular weight (14 kDa) and 
a positive charge at neutral pH. Once lysozyme firmly adsorbs onto contact lens 
materials, it tends to denature fairly rapidly, 3, 28-30 which might potentially result in a 
variety of immunological responses, including contact lens associated papillary 
conjunctivitis (CLAPC). 31-34   
 
Currently available SiHy lens materials are cast-moulded and are available only in 
a limited range of parameters, which limit their usage. A novel SiHy lens material has 
been developed by CIBA Vision (sifilcon A) which is lathe cut, allowing for an increased 
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parameter range to be fitted, and for practitioners to “custom-design” the lens in terms of 
diameter, base-curve and back vertex power. 35, 36 This lens is also unique in that it is 
currently the only SiHy lens to be replaced on a three monthly basis, which is 
considerably longer than other currently available SiHy lens materials, which are 
replaced every two or four weeks. The use of such a lens has been welcomed by contact 
lens practitioners, as it opens up the opportunity to fit SiHy lenses to patients with 
parameters that are typically outside those currently available. 37, 38 
 
Several ex vivo studies which have investigated protein deposition on 
commercially available cast-moulded SiHy lens materials after two or four-weeks of 
wear have shown that SiHy lenses deposit significantly lower quantities of protein than 
conventional FDA group II or IV lens materials. 28, 29, 39-43 Similar results were obtained 
through in vitro studies which investigated the protein deposition on contact lenses by 
artificially “soiling” various lens materials with tear proteins for time periods ranging 
from one-hour to one-month. 16, 17, 30, 44-46 A previous ex vivo study that examined the 
protein deposition on SiHy lens materials after two weeks of wear has shown that 
lotrafilcon-based, galyfilcon and senofilcon lens materials deposit 5 to 7 µg of total 
protein per lens, while balafilcon lens material deposits 27 µg of total protein per lens. 41 
However, to-date no study has investigated the protein deposition on a lathe-cut SiHy 
lens material, particularly one used for three months of wear. Moreover, no study has 
investigated the conformational state of the deposited protein on any contact lens material 
after three months of lens wear. Thus, the purpose of this study was to determine the 
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quantity of total protein, total lysozyme and the conformational state of lysozyme 
deposited on a novel, lathe-cut SiHy lens material after three months of in-eye wear.  
 
 
6.3 Materials and Methods 
6.3.1 Study design and collection of worn contact lenses 
Ethics clearance was obtained from the Office of Research Ethics at the 
University of Waterloo before commencement of the study. The study was carried out in 
accordance with the tenets of the Declaration of Helsinki. Informed consent was obtained 
from all participants prior to enrolment in the study. This study was conducted as a 
prospective, bilateral, daily wear, nine-month clinical evaluation at the Centre for Contact 
Lens Research, School of Optometry, University of Waterloo.  
 
All the participants were adapted daily-wear hydrogel soft lens wearers. A total of 
26 participants (18 females and 8 males; mean age, 31.6 ± 10.75 years; Range, 18-54 
years) were enrolled, of which two participants discontinued from the study. Of these, 
one discontinued due to poor visual quality and the other discontinued due to discomfort 
and dryness with the lenses. The sifilcon A lens materials were ordered for the 
participants based on the screening examination and trial lens fitting, and were fitted 
according to the manufacturer’s guidelines. 35 Lenses were worn for three consecutive 
three-month periods, with lenses being replaced after each period of wear. The 
commercially available multi-purpose solution CLEAR CARE® (CIBA Vision®, 
Duluth, GA) was used during this study. Upon removal at the end of each daily wear 
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period, participants were instructed to rub the lenses for five seconds with the CLEAR 
CARE® solution, prior to soaking in fresh solution overnight. Participants were advised 
to exercise special caution when using the peroxide-based care system with the rubbing 
step, to avoid getting any peroxide in their eye. They were advised to remove both lenses 
and place them in the open “baskets” of the lens case before they began the rub/rinse step 
with either lens, to avoid removing the second lens with a peroxide-laden finger. No 
enzyme removal systems or stand-alone surfactant cleaners were allowed. Participants 
habitually using rewetting drops were permitted to continue to use these drops as 
required.  
 
6.3.2 Collection of worn contact lenses 
Upon completion of three-months of daily wear, lenses from the left eye were 
collected (using non-powdered surgical gloves) and placed in individual, sealed glass 
vials containing 1.5 ml of a 50:50 mix of 0.2% trifluoroacetic acid and acetonitrile (ACN/ 
TFA). 29, 40, 47, 48 The vials were incubated in the dark at room temperature for 24 hours 
following which the aliquots of lens extracts were transferred to sterile Axygen 
microcentrifuge tubes and evaporated to dryness in a Savant Speed Vac (Halbrook, NY, 




6.3.3 Reagents and materials 
Sifilcon A lenses (O2OPTIX Custom™) were provided by CIBA Vision® 
(Duluth, GA). The known properties of this material are given in Table 6.1. The 
PhastSystem™ components were described in detail previously. 29 Immuno-Blot® PVDF 
(polyvinylidene difluoride) membranes and protein assay reagents were purchased from 
Bio-Rad Laboratories (Mississauga, ON, Canada). Polyclonal rabbit anti-human 
lysozyme was purchased from Cedarlane Laboratories (Hornby, ON, Canada) and goat 
anti-rabbit IgG-HRP was purchased from Sigma (St. Louis, MO, USA). Human 
lysozyme (neutrophil) and BioStab Biomolecule Storage Solution (Sigma # 92889) were 
purchased from VWR (Toronto, ON, Canada). Micrococcus lysodeikticus and all other 














Table 6-1: Properties of the lens materials investigated in the current study 
 O2OPTIXCustom O2OPTIX 
United States Adopted 
Name sifilcon A lotrafilcon B 
Water content 32% 33% 
Modulus 1.1 MPa 1.0 MPa 
Handling tint Light green Light blue 
Wearing schedule Daily wear Daily wear and extended wear up to six nights  
Replacement schedule Quarterly Two-week 
Dk 82 110 
Centre thickness (@         
-3.00D) 0.07mm 0.08mm 
Dk/t (@-3.00D) 117 138 
Sphere powers +20.00 to -20.00 DS in 0.25 steps +6.00 to -10.00 DS 
Surface treatment 25nm plasma coating 25nm plasma coating 
Manufacturing process Lathe cut Cast mould 
Monomers undisclosed DMA+TRIS+Siloxane monomer 
DMA (N,N-dimethylacrylamide); TRIS (trimethylsiloxy silane) 
 
6.3.4 Measurement of total lysozyme deposition - Electrophoresis and 
immunoblotting 
Lenses collected in ACN/TFA were incubated in the dark at room temperature for 
24 hours and the samples were processed. 40, 48 Lysozyme standards were prepared fresh 
on the day of analysis from a 1.0 μg/μL frozen stock of purified human neutrophil 
lysozyme with modified reconstitution buffer, pH 8.0 and subjected to SDS-PAGE 
(sodium dodecyl sulphate polyacrylamide gel electrophoresis) followed by Western 
blotting to PVDF membranes. 29, 40, 48  
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6.3.4.1 Negative control - extraction and western blot analysis of unworn lenses 
Three new, unworn sifilcon A lenses were extracted in ACN/TFA solution and 
were subjected to SDS-PAGE and Western blotting, as described above. 
 
6.3.5 Measurement of lysozyme activity 
The contact lens extracts were assayed for lysozyme activity using a fresh 
suspension of Micrococcus lysodeikticus for each sample. 29, 30, 40  Micrococcal cells were 
suspended in 50 mM sodium phosphate buffer (pH 6.3) to an initial optical density of 1.0 
at 450 nm (Multiskan Spectrum ELISA Plate Reader, fitted with a micro-cuvette, 
ThermoLabsystems). Human neutrophil lysozyme standard (2.5, 5, 12.5, 50, 150, 250 ng) 
was run concurrently with the samples. The mass of active lysozyme in contact lens 
extracts was extrapolated from the native lysozyme standard curve. 29, 30, 40 
 
6.3.6 Measurement of total protein deposition 
A Bradford assay 49, 50 was used to determine the total protein deposited on the 
sifilcon A lens material; however, modifications were made to quantify the contact lens 
extracts. Bovine Serum Albumin (0, 0.5, 1, 2, 4, 6, 8, 10 µg) was used as the protein 
standard. All tubes were neutralized with 25µl 0.5M phosphate pH 7.2 and 145µl water, 
and neutrality was confirmed with pH paper. The total volume for this initial sample 
preparation was 190µl (20µl + 25µl + 145µl water). Calcium chloride (10µl, 500mM) 
was added and all tubes were mixed well by vortexing. The samples were allowed to 
precipitate for 5 minutes and 1 ml of 99.9% ethanol was added. The tube was vortexed 
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and centrifuged (15000g for 1 minute) and the supernatant was aspirated, avoiding the 
pellet. 1 ml of 90% (v/v) ethanol was then added which was followed by vortexing, 
centrifuging and aspiration. The samples were then dried in the SpeedVac for 15 minutes. 
50 µl of the Bradford reagent was added to the samples and the samples were placed 
statically for 10 minutes at room temperature. The tubes were then placed in boiling 
water for 30 seconds to dissolve the precipitates, followed by vortexing. Once the tubes 
returned to room temperature, they were centrifuged briefly, such that the Bradford 
reagent sedimented at the bottom of the tube. 200 µl of cold NaCl was added to the 
samples and were vortexed twice. 200 µl of the sample was then transferred to a 96-well 
microtitre plate and the absorption ratio was read within 10 minutes. Samples were read 
on three occasions and the average of these was recorded. A standard curve was prepared 
and the line of best-fit was determined. The sample A595 values were compared with the 
curve to calculate the amount of total protein in the samples. 
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6.4 Results 
Table 6.2 shows the total protein, total lysozyme, denatured lysozyme in 
microgram per lens and the percentage denatured lysozyme after three months of daily 
wear of the sifilcon A lens material. For comparison purposes, Table 6.2 also shows the 
protein deposition data from another ex vivo study from our group 41 which reports on the 
total protein, total lysozyme, denatured lysozyme in microgram per lens and the 
percentage denatured lysozyme after two weeks of wear of lotrafilcon A, lotrafilcon B, 
balafilcon A, galyfilcon A and senofilcon A lens materials.  
 
No signal was seen on Western blots run on unworn sifilcon A lenses after being 
subject to the same procedures, confirming that there was no background interference 
from the lens polymer.  
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Table 6-2: Protein deposition on sifilcon A lens material after three months of lens wear.  
 
This table also shows the protein deposition on five other silicone hydrogel lens materials after two-weeks of lens wear from a 
previously published study. 41 In both studies CLEAR CARE® was used as the care regimen 
  
 Sifilcon A Lotrafilcon A * Lotrafilcon B * Balafilcon A * Galyfilcon A * Senofilcon A * 
Total protein deposition (in µg/lens) 5.3 ± 2.3 5.2 ± 2.2 6.6 ± 3.4 26.9 ± 9.3 6.3 ± 3.4 4.6 ± 2.5 
Total lysozyme deposition (in µg/lens) 2.4 ± 1.2 1.1 ± 0.8 1.4 ± 1.1 13.3 ± 9.0 1.9 ± 1.4 0.9 ± 0.6 
Denatured lysozyme (in µg/lens) 1.9 ± 1.0 0.8 ± 0.7 1.1 ± 0.9 7.3 ± 5.8 1.1 ± 1.0 0.6 ± 0.3 
Percentage denatured lysozyme 80 ± 10 74 ± 17 78 ± 14 53 ± 17 53 ± 19 66 ± 19 
 
* Data from a previously published ex vivo study. 41  
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6.5 Discussion 
 This is the first study to report on protein deposition levels on a novel, custom-
made, lathe-cut SiHy lens material after three months of daily wear. Traditionally, lathe 
cut lens materials undergo a “polishing” step to eliminate any surface irregularities. 
However, the sifilcon A lens materials do not undergo this polishing step because these 
lenses undergo a state-of-the-art custom lathing process through the InnoLathe™ 
manufacturing technology (CIBA Vision, personal communication), obviating the 
necessity for this final polishing step. The finished lenses then undergo a similar plasma 
surface treatment to that seen with CIBA Vision’s other SiHy materials, which are 
permanently modified in a gas plasma reactive chamber using a mixture of 
trimethylsilane oxygen and methane to create a permanent, ultrathin (25nm), high 
refractive index, continuous hydrophilic surface. 51-55  
 
Figures 6.1 and 6.2 show the AFM images of lotrafilcon B and sifilcon A lens 
materials, respectively, at 20X20µm scan size. The AFM image of the lotrafilcon B lens 
material (Figure 6.1) shows that the surface of these lenses exhibit characteristic multiple 
linear marks, that are similar to that previously reported for lotrafilcon A 56, 57 and 
lotrafilcon B lenses. 58 Surprisingly, these characteristic linear “lines” are not seen on the 
surface of the lathe-cut sifilcon A material (Figure 6.2), as linear marks are commonly 
seen on lenses that are fabricated through a lathe-cutting process. 59, 60 Interestingly, the 
surface of the sifilcon A lens material demonstrates a porous, “sponge-like” surface 
topography similar to that of galyfilcon A and senofilcon A lens materials. 58 This is of 
interest, as it appears that lathing a “rubbery”, siloxane-based material such as sifilcon A 
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produces a different topography to that typically seen in lathed HEMA materials. It is 
clear from Figures 6.1 and 6.2 that the surface topography of the lathe-cut sifilcon A 
material is “less smooth” than that of the lotrafilcon B lens material. It has previously 
been shown with HEMA-based materials that lathe-cut lenses have surfaces that are 
generally “rougher” than those fabricated by cast-moulding. 59, 61  
 
 
Figure 6-1: AFM image an unworn lotrafilcon B lens material.  
Atomic Force Microscopy (AFM) image (20x20µm) of a rinsed, unworn, lotrafilcon B 





Figure 6-2: AFM image of an unworn sifilcon A lens material.  
Atomic Force Microscopy (AFM) image (20x20µm) of a rinsed, unworn, sifilcon A lens 
(-10.00D) fabricated via a lathing process. 
 
 
It is noteworthy to compare the total protein deposited on the sifilcon A lens 
material with that deposited on a conventional hydrogel contact lens after three months of 
wear. In this study, sifilcon A deposited 5.3±2.3 µg/lens of total protein (Table 6.2) after 
three months of wear, as compared with a conventional hydrogel FDA group II material 
(vasurfilcon A), which deposited 106±16 µg/lens of total protein 62 after the same period 
of wear. In the other study, 62 Bausch & Lomb’s ReNu Multi-Purpose was used as the 
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care regimen, which was used with a “Rub-and-Rinse” format. The Vasurfilcon A lens 
material has methyl methacrylate and N-Vinyl pyrrolidone as its principal monomers, 
thus it is non-ionic, high water content (74%) material, which is classified as a FDA 
group II material. It has also been shown in an earlier in vitro study using a radiolabeling 
technique that FDA group II lens materials deposit significantly lower amounts of 
lysozyme than a high water content, ionic FDA group IV lens material, but deposit higher 
amounts of lysozyme than most SiHy lens materials. 16 Despite the fact that the care 
regimen and the methods used to examine the total protein were different in these two 
studies, this information puts into perspective the fact that SiHy lens materials still 
deposit substantially less protein than conventional lens materials, even after periods of 
wear longer than that typically seen with most SiHy lenses.   
 
 It is also interesting to note that the total protein and total lysozyme deposited on 
the sifilcon A lens material is similar to that found on similar surface-coated SiHy lens 
materials (such as lotrafilcon A and lotrafilcon B) after two-weeks of lens wear. 41 The 
results from the other ex vivo study 41 showed that lotrafilcon A, lotrafilcon B, galyfilcon 
A and senofilcon A deposited 5.2±2.2, 6.6±3.4, 6.3±3.4 and 4.6±2.5 µg of total protein 
per lens respectively, while balafilcon A deposited 26.9±9.3 µg of total protein per lens 
after two-weeks of wear (Table 6.2). It is also of interest to note that the total protein and 
total lysozyme deposition on the sifilcon A lens material is similar to that seen on 
galyfilcon A and senofilcon A lens materials. As mentioned previously, the AFM images 
(Figure 6.2) shows that sifilcon A lens has a similar surface topography to that of 
galyfilcon A and senofilcon A lens materials. 58 Both this study and the other ex vivo 
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study 41 used the peroxide-based CLEAR CARE® solution as the care regimen. 
However, in this study the participants used the solution in a “Rub-and-Rinse” format, 
whereas in the other study 41 the solution was used only in the “Rinse” format. Despite 
this difference, the levels of deposition were remarkably similar. More work looking at 
the role of “Rubbing-and-Rinsing” and its role in keeping the sifilcon A lenses “clean” of 
deposits is warranted, as this study only investigated protein deposition and not other 
tear-derived deposits, particularly lipid, which are known to be an issue with SiHy lenses. 
28, 63-65 
 
 Previous studies which have compared the protein uptake by contact lens 
materials that are fabricated by means of spin-casting, cast-moulding and lathe-cut 
processes have shown that lathe-cut lens materials typically attract more deposits than the 
other fabricating methods. 10-12 This enhanced deposition could be due to the presence of 
an increased number of binding sites on the lens material, which are caused by the 
fabrication defects on the lathe-cut lenses. A study by Fowler and Gaertner, 14 using a 
scanning electron microscope, also demonstrated that there was “heaping-up” of deposits 
in the lathe-cut areas of worn contact lenses. In contrast, a study by Kaplan and Gundel 13 
showed that there was no significant difference in deposition between polished and 
unpolished lathe-cut lens materials. The results from this study would suggest that factors 
such as material water content, surface charge or treatment and material composition play 




 This is the first study to determine the conformational state of lysozyme deposited 
on a SiHy lens material after three-months of wear. The results from this study show that 
after three months of lens wear, the percentage denatured lysozyme recovered from these 
materials was 80 ± 10% (Table 6.2). The percentage denatured lysozyme recovered from 
these lenses is comparable to that from the lotrafilcon A lens material worn on an 
extended wear basis for 30 days 28 and comparable to lotrafilcon A and lotrafilcon B lens 
materials after two-weeks of daily lens wear. 41 It is highly unlikely that lysozyme which 
is irreversibly bound to the lens polymer will have retained any biological activity after 
three-months of wear. The 20% “active” lysozyme which is recovered from the sifilcon A 
lens material is more likely to be adsorbed “firmly” but not “irreversibly” on to the lens 
material. In addition, it is speculated that the lysozyme which has retained its biological 
activity might have adsorbed either “reversibly” or “irreversibly” on the lenses on the day 
when the lens was collected for laboratory analysis. 
 
6.6 Conclusions 
In conclusion, the results from this study indicate that the extended use of the 
sifilcon A lens material used in the O2OPTIX Custom™ SiHy lens is not deleterious in 
terms of the amount and the quality of protein that is deposited on the lens. These results 
indicate that even after three months of wear, the quantity of protein and the 
conformational state of lysozyme deposited on these novel lenses (when worn using a 
care regime employing a rub-and-rinse format) is very similar to that found on similar 
surface-coated SiHy lenses (lotrafilcon A and lotrafilcon B) after two to four weeks of 
wear. These results reiterate that SiHy lens materials, although fabricated via a lathe-
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cutting process, deposit low quantities of total protein and total lysozyme even after 
extended period of daily wear. Further work is required to determine the location of 
lysozyme on these lathe-cut lens materials. Lysozyme forms only a portion of the total 
protein deposited on the sifilcon A lens material; hence the quantity of other protein types 
deposited should also be investigated. It would also be of interest to study lipid 
deposition on these lens materials and also to determine the impact of care regimen on 
protein/ lipid deposition.   
 
 The next chapter of this thesis will discuss the relationship between protein 
deposition and clinical signs & symptoms after one-day wear of etafilcon A contact 
lenses in a group of symptomatic and asymptomatic contact lens wearers. 
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7 Influence of protein deposition on subjective symptoms in 
one day wear of etafilcon lenses in symptomatic and 





Purpose: To determine the relationship between clinical signs & symptoms and protein 
deposition over eight hours wear of etafilcon lenses in symptomatic and asymptomatic 
contact lens wearers.  
 
Methods: 30 adapted soft contact lens wearers (16 symptomatic and 14 asymptomatic) 
were fitted with etafilcon lenses. In vivo wettability, non-invasive tear break-up time 
(NITBUT) and subjective symptoms (vision, comfort and dryness) were assessed at 
baseline and after hours 2, 4, 6 and 8. After 2, 4, 6 and 8 hour time points, lenses were 
collected and total protein, total lysozyme and active lysozyme deposition were assessed.   
 
Results: There was a significant reduction (p<0.05) in the NITBUT at 8 hours in both 
groups. In the symptomatic group, there was a significant reduction in subjective comfort 
and dryness ratings at 6 and 8 hour measurement with respect to baseline (p<0.05). There 
was a significant increase in total lysozyme and total protein deposition (p<0.05) across 
all time points in both groups; most of the lysozyme remained active (>94% at 8h). 
Pearson’s correlations between subjective symptoms and protein deposition showed poor 
correlations for total protein/ lysozyme and any subjective factor (r<0.3; p>0.05), and 
only weak correlations between dryness and % active lysozyme (r=0.3–0.4 for all time 
points; p<0.05). However, stronger correlations were found between active lysozyme and 
subjective comfort (r=0.7-0.8; p<0.05).  
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Conclusions: In addition to investigating the total protein deposited on contact lenses, it 
is of significant clinical relevance to determine the conformational state of the deposited 
protein.  
 
Key words: comfort, contact lens, deposition, lysozyme activity, tear protein. 
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7.2 Introduction 
One of the primary reasons for contact lens intolerance and discontinuation is 
dryness and discomfort that is associated with lens wear. 1-3 Contact lens-related dry eye 
has been associated with other correlates including alterations in functional visual acuity, 
4, 5 reduced wearing time, 6 increased risk of bacterial adhesion, ocular surface desiccation 
and infection. 7, 8 Several studies have attempted to determine the potential mechanisms 
for contact lens-related dry eye and it has been observed that increased evaporation of the 
tear film, 9 rapid pre-lens tear film thinning, 10 limbal injection, 10 inflammation, 11-13 
reduced lacrimation with concurrent increased osmolality 14, 15 and an increase in tear 
film osmolality 10 as significant factors that are typically associated with contact lens-
related dry eye. In addition, higher water content contact lenses, 10, 16 reduced wettability 
of the lens surface 17-19 or any of the above-mentioned factors could also be associated 
with contact lens-related dry eye, confirming that this condition is multifactorial. Some 
studies have demonstrated that dryness and discomfort ratings become worse 
independently of the amount of dehydration or water content of the hydrogel lenses. 2, 20, 
21  
 
The tear film is by far the most dynamic unit in the lacrimal functional unit, which 
consists of a variety of components, including proteins, lipids, mucins, peptides, 
electrolytes and salts. Using a proteomic technique, 97 proteins have been identified in 
the tear film 22 and many of these proteins are known to sorb onto contact lens materials. 
23, 24 Protein deposition on contact lens materials is highly material dependent, with water 
content and surface charge having significant impacts on the amount of protein deposited. 
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25-36 One of the major tear proteins that is recovered from FDA group IV contact lens 
materials is lysozyme. 28, 34, 36-40 Lysozyme is a bacteriolytic enzyme with a relatively 
small molecular weight (14 kDa) and a positive charge at neutral pH. Once lysozyme 
firmly adsorbs onto contact lens materials, it tends to undergo conformational changes, 28, 
40-42 which might potentially result in a variety of immunological responses, including 
contact lens associated papillary conjunctivitis. 43-46   
 
In the past, several studies have determined the changes in tear film protein/ lipid 
levels in contact lens wearers, with some of these studies classifying contact lens wearers 
as being either “tolerant” or “intolerant”. 11, 13, 47-61 However, these studies did not 
quantify the protein deposited on the lens materials per se, therefore it was not possible to 
determine the relationship between various clinical parameters and the amount of protein 
deposited on the contact lenses. Another study which quantified the protein deposited on 
the lens material, determined the effect of overnight eye closure on the rate and 
composition of protein deposition on the probable change in the rate of reflex-type tear 
secretion associated with eye closure. 38 Some studies have determined the link between 
protein deposition on contact lenses and subjective symptoms reported by lens wearers. 
62-66 However, all these studies determined the deposition on lenses by employing 
relatively insensitive techniques such as visible deposition or video image analysis. 64-66  
 
Although some studies have speculated that the conformational state of the 
deposited protein could have an influence on various subjective symptoms in contact lens 
wearers, 62, 67 to-date, no study has determined the relationship between subjective 
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symptoms and the conformational state of the deposited protein, or indeed the differences 
in these factors in symptomatic and asymptomatic contact lens wearers. Thus, the 
purpose of this study was to investigate the impact of wearing time on clinical signs, 
subjective symptoms and the quantity of total protein & lysozyme deposition and the 
conformational state of the lysozyme deposited over an eight-hour wear period of a high 
water content ionic lens material (etafilcon A; Acuvue®; Johnson & Johnson) in a group 
of symptomatic and asymptomatic contact lens wearers. The other purpose of this study 
was to determine if there is any association between the clinical signs & symptoms and 
the protein deposition measured on the lenses.  
 
 
7.3 Materials and Methods 
Ethics clearance was obtained from the Office of Research Ethics at the 
University of Waterloo before commencement of the study. The study was carried out in 
accordance with the tenets of the Declaration of Helsinki. Informed consent was obtained 
from all participants prior to enrolment. The study was conducted at the Centre for 
Contact Lens Research, School of Optometry, University of Waterloo. This was a 
masked, non-dispensing and randomized study involving 30 previously adapted soft 
contact lens wearers. Participants were classified as being “symptomatic” or 
“asymptomatic” based on their responses to a pre-screening questionnaire. Patients who 
were classified as being symptomatic with their soft lenses were those subjects who 
reported reduced comfortable lens wear after a minimum of 6 hours of wear and who 
needed to resort to ocular lubricants in order to sustain their lens wear. All participants 
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were fitted with etafilcon A contact lenses (FDA group IV lens material; Acuvue®; 
Johnson & Johnson, Jacksonville, Florida) and the participants were not permitted to use 
any rewetting drops during the course of the study. 
 
Each participant attended on two consecutive days, with a baseline and two study 
visits on each day. All the study visits were randomly determined based on a 
randomization table. During the baseline visit on day one, contact lenses were inserted 
into both eyes and, after the lenses had settled, objective and subjective measurements 
were determined. During the first study visit (which was randomly determined) on day 
one, objective and subjective measurements were determined and at the end of this visit, 
one lens was randomly removed from one of the participant’s eyes for protein analysis. A 
new lens was re-inserted into that eye to ensure the subject was binocularly corrected. 
During the second study visit later that day (which was again randomly determined), 
objective and subjective measurements were taken and at the end of this visit, the lens 
from the other eye was collected for protein analysis. On the following day, the same 
procedures were repeated, for the remaining two time points, which were determined 
using a randomization table. Thus, each participant had lenses collected for analysis after 
4 time periods (2 per day), with the periods of time being after two, four, six or eight 




7.3.1 Clinical measurements 
7.3.1.1 Objective measurements 
The objective measurements were performed at baseline and after, two, four, six 
and eight hours of wear. Tear film stability was assessed by determining the  non invasive 
tear breakup time (NITBUT) using the ALCON Eyemap® model EH-290 topography 
system (ALCON Inc., Forth Worth, Texas, USA). Participants were asked to blink three 
times before each measurement was taken. NITBUT was determined by measuring the 
time taken for distortions or discontinuities to appear in the reflected image of the 
concentric ring pattern. The time (in seconds) for the tear-film to rupture (and thus distort 
the rings) was measured to the nearest 0.1 of a second. Three measurements were taken 
on each eye and the average of these was used for analysis purposes. 
 
 Overall wettability of the contact lenses was assessed in vivo using the grid 
viewed on the ALCON Eyemap® (ALCON Inc., Forth Worth, Texas). The image of the 
placido disc was viewed on the monitor of the Eyemap and the in vivo wettability of the 
contact lenses was graded on a five-point scale (0 to 4), where “0” related to a lens 




7.3.1.2 Assessment of subjective symptoms 
Participants completed visual analogue scales at baseline, two, four, six and eight 
hour study visits. Participants rated the subjective symptoms of vision, comfort and 
dryness on a scale of 0-100 (0 = worst rating, 100 = best rating). 
 
After two, four, six and eight hours of lens wear, lenses were collected by a 
gloved examiner and the lenses were briefly rinsed with saline to remove any residual, 
loosely adhered tear film and placed in individual, sealed glass vials containing a 50:50 
mix of 0.2% trifluoroacetic acid and acetonitrile (ACN/ TFA). 37, 42 The vials were 
incubated in the dark at room temperature for 24 hours, then the aliquots of lens extracts 
were transferred to sterile Axygen microcentrifuge tubes and evaporated to dryness in a 
Savant Speed Vac (Halbrook, NY, USA). Dried protein pellets were stored at –80ºC for 
up to two weeks prior to reconstitution. 
  
 
7.3.2 Analytical measurements 
7.3.2.1 Reagents and materials 
Immuno-Blot® PVDF (polyvinylidene difluoride) membranes were purchased 
from Bio-Rad Laboratories (Mississauga, ON, Canada). Polyclonal rabbit anti-human 
lysozyme was purchased from Cedarlane Laboratories (Hornby, ON, Canada) and goat 
anti-rabbit IgG-HRP was purchased from Sigma (St. Louis, MO, USA). Human 
lysozyme (neutrophil) and lyophilized Micrococcus lysodeikticus cells were also 
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purchased from Sigma (St. Louis, MO, USA).  BSA standard was obtained from Pierce 
Biotechnology Inc (Rockford, IL, USA).  All other reagents purchased were of analytical 
grade. 
 
7.3.2.2 Measurement of total lysozyme deposition - Electrophoresis and 
immunoblotting 
Lysozyme standards were prepared fresh on the day of analysis from a 1.0 μg/μL 
frozen stock of purified human neutrophil lysozyme with modified reconstitution buffer, 
pH 8.0 and subjected to SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel 
electrophoresis) followed by Western blotting to PVDF membranes. 42, 68, 69  
  
7.3.2.3 Negative control - extraction and western blot analysis of unworn lenses 
Three new, unworn etafilcon A lenses were extracted in ACN/TFA solution and 
were subjected to SDS-PAGE and Western blotting, as described above. 
 
7.3.3 Measurement of lysozyme activity 
The contact lens extracts were assayed for lysozyme activity using a fresh 
suspension of Micrococcus lysodeikticus for each sample. 40, 42, 69  Micrococcal cells were 
suspended in 50 mM sodium phosphate buffer (pH 6.3) to an initial optical density of 1.0 
at 450 nm (Multiskan Spectrum ELISA Plate Reader, fitted with a micro-cuvette, 
ThermoLabsystems). Human neutrophil lysozyme standard (2.5, 5, 12.5, 50, 150, 250 ng) 
was run concurrently with the samples. The mass of active lysozyme in contact lens 
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extracts was extrapolated from the native lysozyme standard curve, as described 
previously. 40, 42, 69 The final calculation was the percent of active lysozyme: % active 
lysozyme = (active lysozyme / total lysozyme) X 100.  
 
7.3.4 Measurement of total protein deposition 
The total protein extracted from the lenses was determined using the Micro-BCA 
assay. Manufacturer’s instructions were followed for the Micro BCA™ Protein Assay 
Reagent Kit (Pierce Biotechnology, Rockford, IL, USA). Phosphate buffered saline was 
used as the buffer. Each data point was the average of 3 determinations. 
 
7.3.5 Statistical Analysis 
Statistical analysis was conducted using Statistica 7 software (StatSoft Inc, OK, 
USA). All data are reported as mean ± standard deviation and range, unless otherwise 
indicated. A repeated measures analysis of variance (RM-ANOVA) was performed to 
determine significant differences at various time points and post-hoc multiple comparison 
testing was undertaken using the Tukey-HSD test. Pearson’s correlations were performed 
to determine the relationship between various clinical signs and symptoms versus the 






Based on the participants’ responses to the pre-screening questionnaire, 16 
participants (mean age 24.73 ± 5.31) were classified as symptomatic and 14 participants 
(mean age 25.31 ± 4.78) were classified as asymptomatic. 
 
7.4.1 Objective measurements 
Figure 7.1 shows the NITBUT values over time for the symptomatic and 
asymptomatic groups. There was no significant difference in the NITBUT values 
between the two groups at any time point (p>0.05), but the eight hour time point was 
significantly lower than the baseline measurement in both the symptomatic and 
asymptomatic groups (p<0.05). Figure 7.2 shows the in vivo wettability over time for the 
symptomatic and asymptomatic participants. While in vivo wettability is seen to reduce 
over the course of the day for both groups, this reduction was not statistically significant 
for either group (p>0.05). There was also no significant difference between the two 







Figure 7-1: Non-invasive tear break up over time in symptomatic and asymptomatic 
contact lens wearers.  




Figure 7-2: In vivo wettability over time in symptomatic and asymptomatic contact 
lens wearers.  
Error bars represent Mean ± SD. 
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7.4.2 Subjective symptom ratings 
Figure 7.3 shows that there was no significant difference for subjective vision 
ratings for both the groups over time (p>0.05) and also between the two groups at any 
time (p>0.05), although the symptomatic group showed lower ratings at all time points.  
 
Figure 7-3: Subjective vision ratings over time in symptomatic and asymptomatic 
contact lens wearers.  
Error bars represent Mean ± SD.  
 
Figure 7.4 shows that there was no significant decrease in comfort over time in 
the asymptomatic group (p>0.05); however in the symptomatic group, the six and eight 
hour ratings were significantly lower than the baseline measurement (p<0.05). The 
symptomatic group had significantly lower comfort ratings than the asymptomatic group 
at the six and eight hour time points (p<0.05). However, there was no significant 
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difference between the two groups at other time points (all p>0.05), although the 
symptomatic group had lower comfort ratings at these times. 
 
Figure 7-4: Subjective comfort ratings over time in symptomatic and asymptomatic 
contact lens wearers.  
Error bars represent Mean ± SD. * represents p<0.05 within the same group from 0 
hours; + represents p<0.05 between groups. 
 
 
Figure 7.5 shows that there was no significant reduction in dryness ratings over 
time in the asymptomatic group (p>0.05); however in the symptomatic group, the six and 
eight hour ratings were significantly lower than the baseline measurement (p<0.05). The 
symptomatic group reported significantly more dryness than the asymptomatic group at 
the six and eight hour time points (p<0.05). However, there was no significant difference 
between the two groups at other time points (all p>0.05), although the symptomatic group 




Figure 7-5: Subjective dryness ratings over time in symptomatic and asymptomatic 
contact lens wearers.  
Error bars represent Mean ± SD. * represents p<0.05 within the same group from 0 
hours; + represents p<0.05 between groups. 
 
7.4.3 Analytical measurements 
 Table 7.1 shows the total protein, total lysozyme deposition and percentage active 
lysozyme recovered from the lenses at various time points in the asymptomatic and 
symptomatic participants. There was a gradual increase in total protein deposition and 
total lysozyme deposition on the lenses across the four time points (p<0.05) both in the 
asymptomatic and symptomatic group of participants. However there was no significant 
difference between the two groups at any time point (p>0.05). There was a gradual 
reduction in the activity of lysozyme deposited across the four time points, albeit it was 
not statistically significant (p>0.05). The percentage active lysozyme recovered from the 
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symptomatic wearers was lower at all time points, although this was not statistically 
significant (all p>0.05). 
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Table 7-1: Protein deposition on etafilcon lenses 
 
Total protein, total lysozyme and percentage active lysozyme (mean±standard deviation) recovered from etafilcon contact lenses worn 




Total protein (µg/lens) Total lysozyme (µg/lens) Percentage active lysozyme 
 
Asymptomatic Symptomatic Asymptomatic Symptomatic Asymptomatic Symptomatic 
2 hours 147.87±43.41 183.89±55.04 123.23±36.18 141.45±42.34 99.15±1.06 97.95±1.96 
4 hours 307.45±83.56 347.26±78.24 227.74±61.90 253.94±64.66 98.79±2.12 96.87±2.42 
6 hours 371.78±79.57 417.66±86.93 288.21±61.68 321.28±66.87 98.19±3.06 95.98±2.62 




Pearson’s correlations between clinical signs and any of the protein deposition 
measures showed poor, insignificant correlations (r<0.2; p>0.05). Pearson’s correlations 
between subjective symptoms and protein deposition showed poor correlations for total 
protein/ total lysozyme and any subjective factor (r<0.3; p>0.05) as shown in Tables 7.2 
and 7.3, and only weak correlations between dryness and active lysozyme (r=0.3 to 0.4 
for all time points; p<0.05) as shown in Table 7.4. However, stronger correlations were 
found between the active lysozyme and subjective comfort (r=0.7 to 0.8; p<0.05) as 
shown in Table 7.4. 
 
Table 7-2: Correlation between total protein recovered from etafilcon contact lenses 
and various subjective symptoms at different time points.  
 Comfort Dryness Subj. Vision 
Total protein (2 hrs) R = -0.16  R = -0.16 R = -0.25 
Total protein (4 hrs) R = -0.09 R = -0.29 R = -0.06 
Total protein (6 hrs) R = -0.09 R = -0.39 R = 0.11 
Total protein (8 hrs) R = 0.06 R = -0.32 R = 0.05 
 
 
Table 7-3: Correlation between total lysozyme recovered from etafilcon contact 
lenses and various subjective symptoms at different time points.  
 Comfort Dryness Subj. Vision 
Total lysozyme (2 hrs) R = -0.11 R = -0.13 R = 0.04 
Total lysozyme (4 hrs) R = -0.05 R = -0.35 R = 0.13 
Total lysozyme (6 hrs) R = -0.03 R = -0.12 R = 0.11 
Total lysozyme (8 hrs) R = 0.06 R = -0.23 R = 0.08 
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Table 7-4: Correlation between active lysozyme recovered from etafilcon contact 
lenses and various subjective symptoms at different time points.  
* represents p<0.05. 
 Comfort Dryness Subj. Vision 
Active lysozyme (2 hrs) R = 0.77 * R = 0.37 * R = 0.08 
Active lysozyme (4 hrs) R = 0.80 * R = 0.36 * R = 0.05 
Active lysozyme (6 hrs) R = 0.71 * R = 0.47 * R = 0.13 
Active lysozyme (8 hrs) R = 0.72 * R = 0.31 R = 0.35 
 
7.5 Discussion 
To date, this is the only study that reports on the relationship between clinical 
signs, subjective symptoms and the conformational state of the lysozyme deposited on 
contact lenses. These results clearly suggest that there is a good correlation between 
lysozyme activity recovered from contact lenses and subjective comfort, even over short 
periods of lens wear. Previous studies have shown that tolerant contact lens wearers have 
fewer symptoms of discomfort and a more stable tear film (as measured by a higher 
maximum forced interval between blinks, tear meniscus height and volume and non-
invasive tear film break-up time). 70 In the past, studies have also shown that the tear film 
of tolerant lens wearers showed lower levels and activity of secretory phospholipase A2, 
lower concentration of lipocalin and lower levels of peroxidised lipids. 47 It has also been 
shown that in the absence of lens wear, there were no differences between tolerant and 
intolerant lens wearers in conjunctival or limbal redness, lipid layer appearance, tear flow 
rate, tear film osmolality, and total protein, lactoferrin, lysozyme or secretory 
Immunoglobulin A concentrations in the tear film. 70  
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Figure 7.1 shows that there was a significant reduction in the NITBUT after eight 
hours of lens wear in both symptomatic and asymptomatic contact lens wearers, but there 
was no significant difference between the two groups at any time point. When a contact 
lens is inserted into the eye, the tear film is disturbed and tear film break-up time reduces 
significantly. 71, 72 Previous studies have shown that the NITBUT of soft contact lens 
wearers to be in the range of 3 – 10 seconds, 59, 73, 74 which is similar to that found in the 
current study. A study by Guillon and colleagues showed that there was no difference in 
the tear film stability between asymptomatic and symptomatic contact lens wearers, 
although they found a significant difference between asymptomatic and symptomatic 
non-contact lens wearers. 72 However, another study by Glasson and colleagues showed 
that contact lens wear affected the stability of the tear film in tolerant contact lens 
wearers more than in intolerant contact lens wearers. 75 In their study, NITBUT decreased 
more dramatically in the tolerant contact lens wear group and it was also shown that the 
NITBUT of intolerant subjects was significantly lower initially before lens wear and 
remained low over 6 hours of lens wear. Another study by Fonn and colleagues also 
demonstrated a statistically significant decrease in pre-lens TBUT in symptomatic 
wearers during a 5 hour period, regardless of soft lens type, compared to no significant 
change in asymptomatic subjects. 20 
 
Figure 7.2 demonstrates that there was no significant reduction in the in vivo 
wettability of etafilcon contact lens materials over eight hours of wear in both 
symptomatic and asymptomatic contact lens wearers. Although high levels of total 
protein and total lysozyme deposited on etafilcon lens materials within a few hours of 
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wear (Table 7.1), it is quite clear that these deposits do not modify the measured in vivo 
wettability of these lenses to any appreciable extent. In the past, studies which 
determined the wettability of etafilcon lens materials over short periods of wear using 
indirect methods such as PLNITBUT also showed similar findings. 76 Previous in vitro 
and ex vivo studies which determined the influence of tear proteins on wettability of 
etafilcon lens materials also found that these deposits do not reduce the wettability of 
etafilcon lens materials over short periods of wear or over short periods of in vitro 
incubation. 77-79  
 
As expected, symptomatic contact lens wearers in this study showed a significant 
reduction in subjective comfort and dryness ratings over eight hours of wear, while the 
ratings of asymptomatic wearers remained relatively constant (Figures 7.4 and 7.5). 
These results are consistent with those from previous studies where symptomatic wearers 
showed a decrease in comfort and dryness ratings using visual analog scales over time. 2, 
20, 70  
 
It is clear from Table 7.1 that etafilcon lenses attracted substantial quantities of 
total protein and total lysozyme even after 8 hours of lens wear in both the symptomatic 
and asymptomatic participants. This finding is in accordance with other previous in vitro 
and ex vivo studies that evaluated protein and lysozyme deposition on etafilcon contact 
lenses. 30, 36, 39-42, 80-84 31, 85 The increased affinity of lysozyme to the etafilcon material 
occurs because methacrylic acid imparts a negative charge to the material and thus 
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thermodynamically favors the deposition of lysozyme, which is a positively charged 
species at physiological pH.  
 
After eight hours of wear, the percentage active lysozyme recovered from 
etafilcon lenses worn by symptomatic and asymptomatic lens wearers was over 94% 
(Table 7.1), which is significantly higher than those seen from novel silicone hydrogel 
lens materials. 41, 42, 69, 86-88 Previous ex vivo 41, 42 and in vitro 86, 87 studies have also 
demonstrated that the percentage active lysozyme recovered from conventional hydrogel 
FDA group IV etafilcon lens materials is significantly higher than those seen in novel 
silicone hydrogel and other groups of conventional hydrogel lens materials. Denaturation 
of a protein on any polymeric surface is dependent on several factors, including contact 
time of the protein with the substrate, chemical composition of the substrate, surrounding 
pH, type of protein, temperature of the surrounding medium and also the location of the 
protein in a polymer. 28, 67, 80, 89-92 Using confocal microscopy, it has recently been shown 
that lysozyme is primarily located within the bulk of etafilcon lens materials, with 
relatively little surface-located lysozyme 93, 94 resulting in significantly increased levels of 
lysozyme remaining active.  
 
Although this study did not find a significant correlation between clinical signs & 
symptoms versus total protein and total lysozyme deposited on the lens materials (Tables 
7.2 and 7.3), we were able to demonstrate a significant correlation between the activity of 
the lysozyme recovered from the lens materials and subjective comfort and dryness 
(Table 7.4). A previous study by Lever and colleagues which investigated the relationship 
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between total protein deposition and patient-rated lens comfort, found that there was no 
statistical correlation between these two factors. 62 This was the only study which 
attempted to determine the relationship between protein deposition on contact lenses and 
subjective comfort by quantifying the total protein deposited on lenses using biochemical 
techniques; 62 other studies estimated the relationship by evaluating the visible 
deposition/video image analysis of deposits on the lenses. 4, 63-66 Most studies that 
employed visible deposition/video image analysis showed that there was an association 
between visible deposition and comfort, 4, 64-66 however, one study that surveyed fifty 
comfortable and uncomfortable contact lens wearers did not show a difference in the 
amount of visible deposition on the lenses between the two groups. 63 Despite the fact 
there is no significant association between total protein deposited on contact lenses and 
subjective symptoms, it is extremely important to recognize that these findings do not 
eliminate total protein deposits as an important factor in contact lens wear. Indeed, 
protein deposition has a significant potential to cause problems as these deposits do play 
a significant role in modulating microbial adherence to lens materials. 95-98 Therefore, it is 
important that practitioners advise their patients regarding the importance of lens 
disinfection and cleaning and appropriate lens replacement schedules.  
 
This study is the first to demonstrate that a significant correlation exists between 
subjective comfort and active lysozyme recovered from etafilcon lens materials, even 
over very short periods of wear. However, these results should be interpreted with 
caution as it would be erroneous to conclude that denatured lysozyme on contact lenses 
are solely responsible for the symptoms experienced by symptomatic contact lens 
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wearers. Rather they should be interpreted as lysozyme deposited on the contact lenses of 
symptomatic lens wearers tend to denature more than that seen in asymptomatic lens 
wearers. This is likely to happen because of the biochemical changes that occur in the 
tear film of symptomatic lens wearers, resulting in altered properties of the lens material, 
potentially leading to a change in the conformational state of the deposited lysozyme. 
Therefore, in addition to the other factors mentioned earlier, the conformational state of 
the deposited protein, inflammatory and sub-inflammatory mediators and the 
secretomotor response of the lacrimal system could also be significant factors in contact 
lens-induced dry eye, reiterating that this condition is multifactorial.  
 
7.6 Conclusions 
In conclusion, the results from this study suggests that even over a short period of 
wear, a significant correlation exists between subjective symptoms of comfort and 
dryness and the activity of lysozyme recovered from etafilcon contact lenses, with little 
correlation being shown with total amounts of either total protein or total lysozyme. 
Therefore, in addition to investigating the total quantity of the deposited protein, it is of 
significant clinical relevance to study the conformational state of the deposited protein. 
These results have tremendous implications, in that the novel contact lens materials that 
are being developed should possess properties that can retain the activity of the deposited 
protein, in addition to being deposit-resistant. Care regimens and multipurpose solutions 
should be capable of removing denatured proteins that are deposited on the lens 
materials.  
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Further work is required to determine if this important clinical finding is 
transferable to those patients who use silicone hydrogel lens materials. It would also be of 
interest to determine if there is a difference in the activity of lysozyme recovered from 
the tears of symptomatic and asymptomatic contact lens wearers. In addition to 
determining the activity of lysozyme, it would also be of interest to determine the activity 
of lactoferrin which is the other major tear protein found on contact lenses. 
 
The next chapter of this thesis will determine the influence of individual tear 
proteins (lysozyme, lactoferrin and albumin) on the adhesion of Gram positive and Gram 
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8 Influence of protein deposition on bacterial adhesion to 
contact lens materials 
 
The following manuscript is currently under preparation: 
Lakshman N Subbaraman, Lyndon Jones, Roya Borazjani, Hua Zhu, Zhenjun Zhao, 
Mark DP Willcox. Influence of protein deposition on bacterial adhesion to conventional 
and silicone hydrogel contact lens materials. 
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8.1 Abstract 
Purpose: To determine the adhesion of Gram positive and Gram negative bacteria onto 
conventional hydrogel (CH) and silicone hydrogel (SH) contact lens materials with and 
without lysozyme, lactoferrin and albumin coating. 
 
Methods: Four lens types (three SH – balafilcon A, lotrafilcon B & senofilcon A; one 
CH - etafilcon A) were coated with lysozyme, lactoferrin and albumin; uncoated lenses 
acted as controls. Uncoated and protein-coated contact lens samples were incubated in 
1ml of bacterial suspension of Staphylococcus aureus (Saur 31) and two strains of 
Pseudomonas aeruginosa (Paer 6294 & 6206) for 24 hours at 37° C with PBS as the 
medium. The total counts of the adhered bacteria were determined using the 3H-
Thymidine method and the viable counts of the adhered bacteria were assayed by 
counting the number of colony-forming units on agar media. 
 
Results: All three tested strains adhered at significantly lower levels to uncoated 
etafilcon A lenses when compared to uncoated SH lens materials (p<0.05). There was no 
significant difference between the total and viable counts (p>0.05) of all the three strains 
that were bound to uncoated lenses.  
Effect of lysozyme coating: All four lens types with lysozyme-coating showed 
significantly increased binding (total and viable counts) of Saur 31 when compared to 
uncoated lenses (p<0.05). However, lysozyme-coating on all four lens materials did not 
have a significant influence on the adhesion (total and viable counts) of Paer 6206 and 
6294 strains (p>0.05). There was no significant difference between the total and viable 
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counts (p>0.05) for all the three strains of bacteria which were bound to coated and 
uncoated lens materials.  
Effect of lactoferrin coating: All four lens types with lactoferrin-coating showed 
significantly increased binding (total and viable counts) of Saur 31 when compared to 
uncoated lenses (p<0.05). There was no significant difference between the total and 
viable counts (p>0.05) of Saur 31 bound to uncoated and coated lenses. When compared 
to uncoated lenses, all four lactoferrin-coated lens types showed significantly higher total 
counts (p<0.05) of adhered Paer strains, while the lactoferrin-coated lenses showed 
significantly lower viable counts (p<0.05) of adhered Paer strains. There was a significant 
difference between the total and viable counts (p<0.05) that were bound to lactoferrin-
coated lenses. 
Effect of albumin coating: All four lens types with albumin-coating showed significantly 
increased binding (total and viable counts) of Saur 31, Paer 6206 and 6294 strains when 
compared to uncoated lenses (p<0.05). There was no significant difference between the 
total and viable counts (p>0.05) of all the three strains bound to uncoated and albumin-
coated lenses. 
 
Conclusions: These results demonstrate that uncoated SH lens materials bind more Gram 
positive and Gram negative bacteria than uncoated CH lens materials. These results also 
suggest that lysozyme deposited on contact lens materials does not possess antibacterial 
activity against certain bacterial strains, while lactoferrin possess an antibacterial effect 
against certain Gram negative strains tested in this study.  
Key words: contact lens; deposition; Pseudomonas; silicone hydrogel; Staphylococcus.  
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8.2 Introduction 
Contact lens-induced corneal adverse responses have been conveniently classified 
into: 
a) serious sight threatening responses - microbial keratitis (MK) 
b) significant adverse responses - contact lens acute red eye (CLARE), contact 
lens peripheral ulcers (CLPU) and infiltrative keratitis (IK) 
c) non-significant adverse responses  - asymptomatic infiltrative keratitis (AIK) 
and asymptomatic infiltrates (AI) 1  
 
Of these adverse responses, bacterial colonization of contact lenses is one of the 
initiating factors in MK, 2 CLARE, 3, 4 CLPU 5 and certain IK & AIK events. 6 Bacterial 
adhesion to the contact lens material is the first step in a series of events that leads to 
contact lens-related infections or inflammation. 7, 8 The colonization of bacteria on the 
contact lens allows the bacteria to multiply, which increases the contact time of the 
pathogen with the ocular surface, facilitating transfer of bacteria on to the cornea, thereby 
increasing the risk for infection. 8, 9 
 
The tear film is composed of several proteins including lysozyme, lactoferrin, & 
immunoglobulin A and polymorphonuclear leukocytes, which have an antibacterial and/ 
or bacteriostatic role. 10-12 In addition, mechanical defenses such as blinking and tear flow 
assist the eye in eliminating bacteria from the ocular surface. 10 The presence of a contact 
lens disrupts most, if not all, of these functions of the tear film, 13 and the contact lens 
provides a surface to which bacteria attach, further assisting bacteria in evading the 
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defense mechanisms of the eye. During contact lens wear, a protein-rich coating, or 
conditioning film, forms on the contact lens surface. 14-17 It has recently been shown that 
over 60 proteins are deposited onto contact lens materials and some of the major sorbed 
tear film components include lysozyme, lactoferrin and albumin. 18, 19 The exact 
composition of the conditioning film on contact lens materials is affected by several 
factors, including water content, 20-25 hydrophobicity, 22, 25-28 charge, 20, 23, 29, 30 pore size 
20, 31 and surface roughness 27 of the lens material.  
 
To date, several studies have investigated the ability of various bacteria to adhere 
to contact lens materials and these studies have shown that adhesion is dependent upon a 
variety of factors including lens material, 9, 32-38 tear film deposits, 9, 39-48 duration of wear, 
9, 46, 49 and surface roughness. 50, 51 Most previous studies have determined the influence 
of deposits on bacterial adhesion only on conventional hydrogel contact lens materials. 9, 
39-48 Albumin coated onto the surface of etafilcon A or polymacon contact lenses 
increased the adhesion of Pseudomonas aeruginosa. 44 Similarly, some strains of Serratia 
marcescens adhered more to etafilcon A lenses coated in an artificial tear fluid. 52 
Another study showed that lysozyme adsorbed to etafilcon A contact lenses increases the 
adhesion of Staphylococcus aureus to lenses. 42 It has also been demonstrated that 
lactoferrin deposited on the lens surface promotes the adhesion of Pseudomonas 
aeruginosa strain Paer 1; nevertheless, once adherent, this protein reduces the proportion 
of viable bacteria on the lens surface. 43 To-date, few studies have investigated the 
adhesion of bacteria to novel silicone hydrogel lens materials; 33, 34, 36, 37 and none of these 
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studies have determined the influence of tear components on the adhesion of bacteria to 
silicone hydrogel lens materials.  
 
Thus, the purpose of this study was to examine the effect of the contact lens 
conditioning film on bacterial adhesion by comparing the adhesion of three different 
bacterial strains to uncoated contact lenses and to contact lenses that are coated with 
individual major tear proteins (lysozyme, lactoferrin and albumin). The other purpose of 
the study was to determine whether the presence of these individual tear proteins had any 
effect on the viability of the attached bacteria.  
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8.3 Materials and Methods 
8.3.1 Contact lenses 
The silicone hydrogel lens materials examined in this study were lotrafilcon B 
(O2Optix; CIBA Vision, Duluth, GA, USA), balafilcon A (PureVision™; Bausch & 
Lomb, Rochester, NY, USA) and senofilcon A (Acuvue® OASYS™; Vistakon, Johnson 
& Johnson, Jacksonville, FL, USA). The conventional hydrogel lens material examined 
was etafilcon A (Acuvue 2; Vistakon, Johnson & Johnson, Jacksonville, FL, USA). The 
properties of these lens materials are described in Table 8.1.  
 
 
8.3.1.1 Treatment of uncoated lens materials 
Three test and control lenses from each lens type were used for adhesion assays. 
Contact lenses were removed from their packaging and thoroughly rinsed with PBS to 
ensure that no packaging solution remained on the lens surface. In order to achieve this, 
lenses were removed from the packaging solution using forceps and were placed in vials 
containing PBS with the lenses’ concave side up for one hour. The vials were then placed 
on a plate shaker for two minutes and this process was performed a total of three times 






Table 8-1: Properties of conventional and silicone hydrogel lens materials evaluated in the study 
Silicone Hydrogel Conventional hydrogel Proprietary name 
O2 Optix™ PureVision™ Acuvue® OASYS™ Acuvue® 2 
United States Adopted 
Name (USAN) Lotrafilcon B Balafilcon A Senofilcon A Etafilcon A 
Manufacturer CIBA Vision Bausch & Lomb Johnson & Johnson Johnson & Johnson 
Water content (%) 33 36 38 58 
Oxygen Transmissibility 
(Dk/t) at 35˚C 138 101 147 20 
FDA group I III I IV 
Surface Treatment 25nm plasma coating with high refractive index 
Plasma oxidation 
process 
None. Internal wetting 
agent None 










DMA (N,N-dimethylacrylamide); MA, methacrylic acid; mPDMS (monofunctional polydimethylsiloxane); NVA (N-vinyl amino acid); NVP (N-
vinyl pyrrolidone); polyHEMA (poly-2-hydroxyethyl methacrylate); PBVC (poly[dimethysiloxy] di [silylbutanol] bis[vinyl carbamate]); PVP 
(polyvinyl pyrrolidone); TEGDMA (tetraethyleneglycol dimethacrylate); TPVC (tris-(trimethylsiloxysilyl) propylvinyl carbamate); TRIS 
(trimethylsiloxy silane) 
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8.3.1.2 Protein coating on contact lenses 
Three lenses from each lens type were coated with three different tear proteins: 
lysozyme, lactoferrin and albumin (Sigma-Aldrich Pty. Ltd., Castle Hill, NSW, 
Australia). The tear proteins were coated onto the lenses such that their final 
concentration was similar to that found on worn contact lenses. In order to achieve this, 
lysozyme, lactoferrin and albumin solutions were prepared at a concentration of 
1.9mg/ml, 1.9mg/ml and 0.5mg/ml respectively. The conventional hydrogel lens material 
was incubated in the lysozyme solution for 5 days, while the silicone hydrogel lens 
materials were incubated for 7 days. All the lenses were incubated in lactoferrin and 
albumin solutions for 7 days. After the specified incubation periods, the lenses were 
removed from the vials and washed in a plate shaker with PBS to remove loosely-bound 
protein. These lenses were the “protein-coated” lenses.  
 
8.3.2 Bacterial preparation 
Three bacterial strains were investigated in this study, of which one was a Gram 
positive strain (Staphyloccus aureus 31; Saur 31) and two were Gram negative strains 
(Pseudomonas aeruginosa 6206 and 6294; Paer 6206 and 6294). The Gram positive Saur 
31 was isolated from a patient with contact lens induced peripheral ulcer at the Institute 
for Eye Research, Sydney, Australia. Both strains of Paer used in this study (6294 and 
6206) were isolated from human MK specimens and were obtained from the School of 
Optometry, University of California, Berkeley, USA. Strain 6206 has been shown to be a 
cytotoxic strain, while strain 6294 is an invasive strain. 53 
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Stock cultures of Saur 31, Paer 6206 and Paer 6294 were stored in 30% glycerol 
at -80º C. Bacteria were grown overnight in 10 ml of Tryptone Soy Broth (TSB; Oxoid, 
Sydney, Australia) at 37º C for 18 hours. Bacterial cells were harvested by centrifugation 
(Eppendorf 5810, Hamburg, Germany) for 10 minutes (3000 rpm at 180C) and washed in 
sterile phosphate buffered saline, pH 7.4 (PBS). The cells were then resuspended in 
sterile PBS and the concentration was adjusted using a spectrophotometer (Heliosβ, 
Unicam Instruments, Cambridge, UK) to give an optical density at 660nm of 0.1, which 
gave 1.0X108 colony forming units (cfu)/ml. The suspension was serially diluted (1:10) 
to obtain the required concentration.  
 
8.3.3 Determination of viable counts 
The uncoated and protein-coated lenses were then placed in a 24 well plate 
containing 1 ml of bacterial suspension in each well and incubated at 37ºC for 24 hours. 
After 24 hours of incubation the lenses were removed from the incubator and shaken for 
30 seconds on a plate shaker at 175 rpm to remove loosely adherent bacteria. The lenses 
were then washed three times in 1 ml of sterile PBS for 30 seconds, transferred to a 
sterile 5 ml plastic container (Greiner Bio-One Inc, Longwood, FL, USA) and vortexed 
vigorously for one minute in 2 ml of sterile PBS, using sterile magnetic stirring bars. For 
quantitation of viable bacteria per contact lens, the homogenate was serially diluted in 
PBS 1:10 by taking 100µl and adding it to 900µl of deneutralizing broth (Difco 
Laboratories Inc., MI, USA) in a micro-centrifuge tube. 50 µl of the serially diluted 
samples were plated in triplicate on nutrient agar plates (Oxoid, Sydney, Australia) and 
incubated for 18 hours at 37ºC. Dilutions with growth between 10-100 colonies were 
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counted on a colony counter. The number of colonies per dilution were recorded and used 
to calculate the number of colony forming units (cfu) per contact lens. The assay was 
repeated twice and the average values were computed to enumerate the viable counts of 
the bacteria adhered to contact lenses.  
 
8.3.4 Determination of total counts 
The total counts were determined using the 3H-Thymidine method. Stock cultures 
of Saur 31, Paer 6206 and 6294 were grown in of 10mL Tryptone Soy Broth (TSB; 
Oxoid, Sydney, Australia) and 3H-Thymidine (80Cui) for 18 hours. Bacterial cells were 
harvested by centrifugation (Eppendorf 5810, Hamburg, Germany) for 15 minutes (3000 
rpm at 180C) and washed in sterile phosphate buffered saline, pH 7.4 (PBS). This was 
repeated a total of three times. The cells were then resuspended in sterile PBS and 1 
Cui/ml of 3H-Thymidine and the concentration was adjusted using a spectrophotometer 
(Heliosβ, Unicam Instruments, Cambridge, UK) to give an optical density at 660nm of 
0.1. The protein-coated and uncoated lenses were then placed in a 24 well plate 
containing 1 ml of radiolabeled-bacterial suspension in each well and incubated at 37ºC 
for 24 hours. After 24 hours of incubation the lenses were removed from the incubator 
and shaken for 30 seconds on a plate shaker at 175 rpm to remove loosely adherent 
bacteria. The lenses were then washed three times in 1 ml of sterile PBS for 30 seconds. 
The vials were then placed with 500µL 0.2M NaOH at 80°C for 1 hour, following which 
they were allowed to cool down by placing them on ice. Scintillation fluid was then 
added to the vials and the counts per minute were determined using a Beta counter. A 
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standard curve was plotted to determine the (cfu)/lens values of total counts of adhered 
bacteria. 
 
8.3.5  Statistical Analysis 
Statistical analysis was conducted using Statistica 7 software (StatSoft Inc, OK, 
USA). All data are reported as mean ± SD. Repeated Measures Analysis of Variance was 
used to determine statistically significant differences. Post-hoc multiple comparison 





8.4.1 Bacterial adhesion to uncoated lens materials 
Figures 8.1, 8.2 and 8.3 show the adhesion of Gram positive Saur 31, Gram 
negative Paer 6206 and Paer 6294 strains respectively. All three tested strains adhered at 
a significantly lower level to uncoated etafilcon A lenses when compared to uncoated SH 
lens materials (p<0.05). Among the silicone hydrogels, the adhesion was highest on 
balafilcon A and lotrafilcon B lens materials, when compared to the senofilcon A 
material (p<0.05). Figures 8.1 to 8.3 show that there was no significant difference 




Figure 8-1: Adhesion of Gram positive Saur 31 to uncoated contact lens materials 
 
 





Figure 8-3: Adhesion of Gram negative Paer 6294 to uncoated contact lens materials 
 
8.4.2 Effect of lysozyme-coating on bacterial adhesion 
Figure 8.4 shows the adhesion of Gram positive Saur 31 to uncoated and 
lysozyme-coated contact lens materials. There was no significant difference between the 
viable and total counts for uncoated lenses (p>0.05 for all lens types) and no significant 
difference between the viable and total counts for lysozyme-coated lenses (p>0.05 for all 
lens types). When compared to uncoated lenses, there was a significant increase in the 
viable and total counts of Saur 31 adhered to the lysozyme-coated lenses for all lens types 
(p<0.05 for all lens types). Between the lysozyme-coated lens materials, there was no 
significant difference in Saur 31 adhesion between balafilcon A and lotrafilcon B 
(p>0.05) and no significant difference in Saur 31 adhesion between senofilcon A and 
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etafilcon A lens materials (p>0.05). Lysozyme-coated senofilcon A and etafilcon A lens 
materials showed significantly lower Saur 31 binding than lysozyme-coated balafilcon A 
and lotrafilcon B lens materials (p<0.05). 
 
 
Figure 8-4: Adhesion of Gram positive Saur 31 to uncoated and lysozyme-coated 
contact lens materials 
 
 
Figures 8.5 and 8.6 show the adhesion of Gram negative Paer 6206 and 6294 
strains to uncoated and lysozyme-coated contact lens materials. There was no significant 
difference between the viable and total counts for uncoated lenses (p>0.05 for all lens 
types) and no significant difference between the viable and total counts for lysozyme-
coated lenses (p>0.05 for all lens types). When compared to uncoated lenses, there was 
no significant increase in the viable and total counts of Paer 6206 and 6294 strains 
adhered to lysozyme-coated lenses for all lens types (p<0.05 for all lens types). Between 
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the lysozyme-coated lens materials, there was no significant difference in Paer 6206 and 
6294 adhesion between balafilcon A and lotrafilcon B (p>0.05) and etafilcon A lens 
materials showed the lowest adhesion of Paer 6206 and 6294 strains. Lysozyme-coated 
senofilcon A showed significantly lower binding of Paer strains than lysozyme-coated 
balafilcon A and lotrafilcon B lens materials (p<0.05), but higher binding than etafilcon 
A lens material (p<0.05). 
 
 
Figure 8-5: Adhesion of Gram negative Paer 6206 to uncoated and lysozyme-coated 
contact lens materials 
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Figure 8-6: Adhesion of Gram negative Paer 6294 to uncoated and lysozyme-coated 
contact lens materials 
 
8.4.3 Effect of lactoferrin-coating on bacterial adhesion 
Figure 8.7 shows the adhesion of Gram positive Saur 31 to uncoated and 
lactoferrin-coated contact lens materials. There was no significant difference between the 
viable and total counts for uncoated lenses (p>0.05 for all lens types) and no significant 
difference between the viable and total counts for lactoferrin-coated lenses (p>0.05 for all 
lens types). When compared to uncoated lenses, there was a significant increase in the 
viable and total counts of Saur 31 adhered to the lactoferrin-coated lenses for all lens 
types (p<0.05 for all lens types). Between the lactoferrin-coated lens materials, there was 
no significant difference in Saur 31 adhesion between balafilcon A and lotrafilcon B 
(p>0.05) and lactoferrin-coated etafilcon A lens material showed the least adhesion of 
Saur 31. Lactoferrin-coated senofilcon A showed significantly lower binding of Saur 31 
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than lactoferrin-coated balafilcon A and lotrafilcon B lens materials (p<0.05), but higher 
binding than etafilcon A lens material (p<0.05). 
 
Figure 8-7: Adhesion of Gram positive Saur 31 to uncoated and lactoferrin-coated 
contact lens materials 
 
 
Figures 8.8 and 8.9 show the adhesion of Gram negative Paer 6206 and 6294 
strains to uncoated and lactoferrin-coated contact lens materials. There was no significant 
difference between the total and viable counts (p>0.05) of Paer strains that were bound to 
uncoated lenses, whereas there was a significant difference between the total and viable 
counts (p<0.05) that were bound to lactoferrin-coated lenses. When compared to 
uncoated lenses, all four lactoferrin-coated lens types showed significantly higher total 
counts (p<0.05) of adhered Paer strains, while the lactoferrin-coated lenses showed 




Figure 8-8: Adhesion of Gram negative Paer 6206 to uncoated and lactoferrin-
coated contact lens materials 
 
 
Figure 8-9: Adhesion of Gram negative Paer 6294 to uncoated and lactoferrin-
coated contact lens materials 
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8.4.4 Effect of albumin-coating on bacterial adhesion 
Figure 8.10 shows the adhesion of Gram positive Saur 31 to uncoated and 
albumin-coated contact lens materials. There was no significant difference between the 
viable and total counts for uncoated lenses (p>0.05 for all lens types) and no significant 
difference between the viable and total counts for albumin-coated lenses (p>0.05 for all 
lens types). When compared to uncoated lenses, there was a significant increase in the 
viable and total counts of Saur 31 adhered to the albumin-coated lenses for all lens types 
(p<0.05 for all lens types). Between the albumin-coated lens materials, there was no 
significant difference in Saur 31 adhesion between balafilcon A and lotrafilcon B 
(p>0.05) and no significant difference in Saur 31 adhesion between senofilcon A and 
etafilcon A lens materials (p>0.05). Albumin-coated senofilcon A and etafilcon A lens 
materials showed significantly lower Saur 31 binding than albumin-coated balafilcon A 
and lotrafilcon B lens materials (p<0.05).  
 
Figure 8-10: Adhesion of Gram positive Saur 31 to uncoated and albumin-coated 
contact lens materials 
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Figures 8.11 and 8.12 show the adhesion of Gram negative Paer 6206 and 6294 
strains to uncoated and albumin-coated contact lens materials. There was no significant 
difference between the viable and total counts for uncoated lenses (p>0.05 for all lens 
types) and no significant difference between the viable and total counts for albumin-
coated lenses (p>0.05 for all lens types). When compared to uncoated lenses, there was a 
significant increase in the viable and total counts of Paer 6206 and 6294 strains adhered 
to albumin-coated lenses for all lens types (p<0.05 for all lens types). Between the 
albumin-coated lens materials, there was no significant difference in Paer 6206 and 6294 
adhesion between balafilcon A and lotrafilcon B (p>0.05) and no significant difference in 
the adhesion of Paer 6206 and 6294 strains between the albumin-coated senofilcon A and 
etafilcon A lens materials (p>0.05). Albumin-coated senofilcon A and etafilcon A lens 
materials showed significantly lower binding of Paer 6206 and 6294 strains than 





Figure 8-11: Adhesion of Gram negative Paer 6206 to uncoated and albumin-coated 
contact lens materials  
 
 
Figure 8-12: Adhesion of Gram negative Paer 6294 to uncoated and albumin-coated 
contact lens materials 
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8.5 Discussion  
This is the first study to determine the effect of individual tear proteins on 
bacterial adhesion to silicone hydrogel lens materials. These results demonstrate that 
different tear proteins deposited on contact lenses have varying effects on the adhesion of 
bacteria to contact lenses. Historically, there has been disagreement concerning the 
effects of protein conditioning on the adhesion of bacteria to hydrogel contact lenses. 
Initial studies showed that bacteria readily adhered to unworn contact lenses, 38 but 
adhesion was shown to increase in patient-worn lenses 39, 41, 46, 54 Conversely, other 
studies showed that there was no increase, 45, 55 or inhibition of bacterial adhesion to 
patient-worn lenses 48 when compared to unworn lenses. However, all these studies had 
determined the influence of bacterial adhesion to worn lenses and did not determine the 
effect of the individual tear proteins. Later studies determined the influence of individual 
tear proteins on bacterial adhesion to contact lenses and these studies demonstrated that 
various proteins have the ability to modulate bacterial binding to conventional hydrogel 
contact lens materials.  
 
Miller and Ahearn reported that mucin, Immunoglobulin A, bovine serum 
albumin, lysozyme and lactoferrin coated onto unworn lenses enhanced the adhesion of 
Pseudomonas aeruginosa to hydrogel contact lens materials. 56 Williams and colleagues 
showed that lactoferrin coated onto the lens surface promotes the adhesion of 
Pseudomonas aeruginosa strain Paer 1; nevertheless, once adherent, this protein reduces 
the proportion of viable bacteria on the lens surface. 43 Albumin coated onto the surface 
of etafilcon A or polymacon contact lenses increased the adhesion of Pseudomonas 
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aeruginosa. 44 Similarly, some strains of Serratia marcescens adhered better to etafilcon 
A lenses coated in an artificial tear fluid. 52 Thakur and colleagues demonstrated that 
lysozyme adsorbed to a contact lens increases the adhesion of Staphylococcus aureus to 
etafilcon A contact lenses. 42 Some studies demonstrated that Pseudomonas aeruginosa 
can bind to ocular mucins. 11, 57 Willcox and colleagues showed that the bacteria isolated 
from adverse responses had the ability to adhere differently to various contact lens 
materials and for most material/ strain combinations there were increases in adhesion to 
worn lenses or no differences between adhesion to worn or unworn lenses. 9 It was 
suggested that the increase in adhesion seen for certain strains to worn lenses may 
indicate that the tear components, most likely proteins that are bound to the contact 
lenses, were conducive to bacterial adhesion. 9 
 
8.5.1 Bacterial binding to uncoated lenses 
The results from this current study suggest that there was an increased binding of 
all three strains of bacteria to the tested uncoated silicone hydrogel lens materials, when 
compared with one type of uncoated conventional hydrogel lens material. Among the 
silicone hydrogels, the adhesion was highest on balafilcon A and lotrafilcon B lens 
materials, when compared to the senofilcon A material. Bacterial adhesion to a 
biomaterial is known to depend on the hydrophobicity or hydrophilicity of the 
biomaterial, and therefore on the nature of the polymer of the contact lens. 9, 33, 34, 37, 58, 59  
Furthermore, the water content of the lens material is also known to affect the adhesion of 
bacteria, decreasing with increasing water content of the lens material. 34, 35, 60 The results 
from this study agree with these findings, in that etafilcon A, the material with the highest 
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water content (58%) of the four contact lenses demonstrated the lowest bacterial binding, 
while the opposite was true for the lotrafilcon B material. These results are in accordance 
with other published studies that have compared the bacterial adhesion to conventional 
and silicone hydrogel contact lens materials. 33, 34, 37 
 
8.5.2 Effect of lysozyme-coating on bacterial adhesion 
It is clear from Figure 8.4 that lysozyme coating on all four contact lens types 
significantly increased the adhesion of Saur 31, when assayed by both total and viable 
counts. These results are in accordance with a previous study, where it was demonstrated 
that lysozyme deposits on contact lenses increased the adhesion of several strains of 
Staphylococcus to etafilcon A lenses. 42 However, the study by Thakur and colleagues did 
not examine whether the adherent bacteria were alive or dead. 42 Figures 8.5 and 8.6 
demonstrate that lysozyme coatings on contact lenses had no effect on the adhesion of 
Paer 6206 and 6294 strains, when assayed by either viable or total counts. Moreover, 
these results demonstrate that there was no difference between the total counts and viable 
counts of all three adherent strains, suggesting that lysozyme deposited on contact lenses 
do not have an antibacterial effect against the tested bacterial strains.  
 
The bactericidal effects of lysozyme are most potent against Gram positive 
bacteria which, unlike Gram negative bacteria, lack an extra outer membrane around the 
peptidoglycan layer targeted by lysozyme. 61, 62 Surprisingly, the results from this study 
show that lysozyme deposited on the lens materials do not possess an antibacterial effect 
against both the Gram positive and Gram negative strains tested in this study. It is known 
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that once lysozyme deposits on conventional and silicone hydrogel contact lens materials, 
it tends to undergo conformational changes, 16, 63-66 which could potentially result in the 
loss of antibacterial activity against these strains of bacteria. 
 
8.5.3 Effect of lactoferrin-coating on bacterial adhesion 
Figure 8.7 shows that lactoferrin coating on all four types of contact lenses 
significantly increased the adhesion of Saur 31, when assayed by both total and viable 
counts. However, there was no significant difference between the total and viable counts 
of bacteria adhered to lactoferrin-coated lenses, suggesting that lactoferrin deposited on 
contact lenses do not possess an antibacterial effect against Gram positive Saur 31 strain. 
Figures 8.8 and 8.9 also indicate that lactoferrin bound to the lens surface does indeed 
promote adhesion of Paer 6206 and 6294 strains. At the same time, this protein reduced 
the proportion of viable bacteria on the lens surface. Both lactoferrin and lysozyme are 
known to possess antibacterial properties and they occur in high concentrations in the tear 
fluid. 10, 67 These two proteins are known to deposit on all types of conventional and 
silicone hydrogel contact lens materials. 16, 18, 19, 64, 68, 69  
 
The striking contrast in the results of the viable and total counts for lactoferrin-
coated lens samples can be explained based on the antibacterial mechanism of lactoferrin. 
Lactoferrin has traditionally been regarded as a bacteriostatic protein, since it sequesters 
the iron that bacteria require for growth. 70 Moreover, lactoferrin has also been 
demonstrated to possess direct bactericidal effects. 71, 72 Lactoferrin has also been shown 
to have a destabilizing effect on the lipopolysaccharide (LPS) of Gram negative bacteria, 
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by targeting either the metal cations that stabilize the negative charge of the LPS, 73, 74 or 
the LPS directly. 71, 75 Therefore, lactoferrin reduces the viability of the adhered Paer 
strains; however, there is an increase in the total counts of the adhered Paer strains. It has 
been proposed that lactoferrin and other glycoproteins adsorbed to the lens may promote 
bacterial adhesion since their carbohydrate moieties may act as receptors for bacterial 
lectins, resulting in increased total counts of the adhered Paer strains. 76, 77  
 
8.5.4 Effect of albumin-coating on bacterial adhesion 
Figures 8.10 to 8.12 demonstrate that albumin-coating on all the contact lens 
types increased the adhesion of all three strains of bacteria, when assayed by both total 
and viable counts. These results are in agreement with a previous study which determined 
the effect of albumin coating on etafilcon and polymacon lens materials. 44  The results 
from the previous study demonstrated that Staphylococcus epidermidis and Pseudomonas 
aeruginosa adhered significantly higher with increasing concentration of albumin on 
contact lenses. 44 However, the study by Taylor and colleagues did not evaluate whether 
the adhered bacteria were alive or dead, 44 while the results from this present study 
evaluated both the total and viable counts. These results suggest that albumin-coating on 
contact lenses increase the adhesion of all three strains of bacteria and also that the 
albumin deposits do not possess an antibacterial effect against the three bacterial strains 
tested in this study.  
 
It has been demonstrated that bacteria prefer to attach to low-energy, hydrophobic 
surfaces rather than to high-energy, hydrophilic surfaces. 78 Some studies have concluded 
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that the adsorbed macromolecules on the surfaces will increase or reduce the surface 
wettability of the biomaterial. 79, 80 Such macromolecules could convert a hydrophilic 
surface into a hydrophobic one, which is favourable for bacterial binding, thereby 
increasing the bacterial attachment. It is possible that albumin deposits on the contact 
lenses increase the hydrophobicity of the surface, resulting in increased binding of all the 
strains of bacteria.   
 
8.6 Conclusions 
In conclusion, these results suggest that different tear proteins have varying 
effects on the adhesion of bacteria to contact lens materials. Lysozyme deposits on 
contact lenses increase the adhesion of Gram positive Staphyloccocus aureus 31 strain, 
while albumin deposits increase the adhesion of both the Gram positive Staphyloccocus 
aureus and Gram negative Pseudomonas aeruginosa 6206 & 6294 strains. Lactoferrin 
deposits increase the total counts of both the Gram positive and Gram negative strains, 
while they reduce the viable counts of the Gram negative strains. These results indicate 
that lysozyme and albumin do not possess antibacterial activity against all the three tested 
strains, while lactoferrin has an antibacterial effect against the Gram negative strains 
tested in this study.  
 
Further investigation is required to determine the adhesion of more bacterial 
strains that are involved in the pathogenesis of contact lens-related infections. 
Furthermore, it will be of significant clinical relevance to evaluate the impact of various 
care regimens and the impact of “rub and rinse” steps on bacterial adhesion to contact 
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lenses. This study has demonstrated that lactoferrin-coating on contact lenses has the 
ability to reduce the viability of certain Gram negative strains of bacteria and that it may 
be worthwhile to develop antibacterial contact lenses with some form of lactoferrin 
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This thesis has for the first time determined the kinetics of lysozyme deposition 
and also the conformational state of lysozyme deposited on conventional and silicone 
hydrogel lens materials as a function of time. This thesis has also determined the protein 
deposition levels on a novel, lathe-cut silicone hydrogel lens material after three months 
of wear. Further, this thesis has also evaluated the relationship between protein deposition 
and clinical signs & symptoms and also the effect of individual tear protein deposition on 
bacterial adhesion to various contact lens materials. The following section summarizes 
the results from all these chapters.  
 
Chapter 4 determined the kinetics of lysozyme deposition on conventional and 
silicone hydrogel lens materials and demonstrated that lysozyme deposition is driven by 
both the bulk chemistry and also the surface properties of conventional and silicone 
hydrogel contact lens materials. The surface modification processes or the inclusion of 
high molecular entities or surface-active monomers on silicone hydrogel lens materials 
also play a significant role in lysozyme deposition on these lens materials. The results 
from this study reiterate that silicone hydrogel lens materials deposit very low amounts of 
lysozyme. Silicone hydrogel lenses that are surface modified with a 25nm plasma coating 
(lotrafilcon A & B) showed a deposition pattern similar to PMMA lens materials. 
Silicone hydrogel lenses that use a surface modification system based on PVP (galyfilcon 
and senofilcon) had similar deposition patterns, while balafilcon lenses (which undergo a 
plasma oxidation process) showed the highest level of lysozyme deposition. However, 
this was still lower than that seen with most conventional materials. 
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Chapter 5 determined the lysozyme activity recovered from conventional and 
silicone hydrogel contact lens materials as a function of time and these results suggest 
that the reduction in the activity of lysozyme deposited on contact lens materials is time 
dependent and that the rate of reduction in the activity of lysozyme varies between lens 
materials. This reduction in the loss of biological activity could be due to the differences 
in surface or bulk properties of the lens materials and also depend on the location of 
lysozyme on these lens materials. These results reiterate that the levels of lysozyme 
activity are highly variable between lens materials and also that SH lens materials deposit 
very low amounts of lysozyme. After 28 days, lysozyme recovered from conventional 
hydrogel FDA group IV lens materials (etafilcon A and vifilcon A) retained the highest 
amount of percentage activity, while lysozyme recovered from SH lenses that are surface 
modified with a 25nm plasma coating (lotrafilcon A & B) retained an activity similar to 
that of a conventional hydrogel FDA group I lens material. Among silicone hydrogel 
lenses, lenses that use a surface modification system based on PVP (galyfilcon A) and 
lenses that undergo a plasma oxidation process (balafilcon A) retained similar levels of 
percentage active lysozyme.  
 
Chapter 6 determined the protein deposition on a novel, lathe-cut silicone 
hydrogel lens material after three months of lens wear and these results indicate that the 
extended use of the sifilcon A lens material used in the O2OPTIX Custom™ silicone 
hydrogel lens is not deleterious in terms of the amount and the quality of protein that is 
deposited on the lens as long as the lens is rubbed and rinsed. These results indicate that 
even after three months of wear, the quantity of protein and the conformational state of 
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lysozyme deposited on these novel lenses (when worn using a care regime employing a 
rub-and-rinse format) is very similar to that found on similar surface-coated silicone 
hydrogel lenses (lotrafilcon A and lotrafilcon B) after two to four weeks of wear. These 
results reiterate that silicone hydrogel lens materials, although fabricated via a lathe-
cutting process, deposit low quantities of total protein and total lysozyme even after 
extended period of daily wear. 
 
Chapter 7 determined the relationship between protein deposition and clinical 
signs & symptoms. These results suggest that even over a short period of wear, a 
significant correlation exists between subjective symptoms of comfort and dryness and 
the activity of lysozyme recovered from etafilcon contact lenses, with little correlation 
being shown with total amounts of either total protein or total lysozyme. Therefore, in 
addition to investigating the total quantity of the deposited protein, it is of significant 
clinical relevance to study the conformational state of the deposited protein. These results 
have tremendous implications, in that the novel contact lens materials that are being 
developed should possess properties that can retain the activity of the deposited protein, 
in addition to being deposit-resistant. Care regimens and multipurpose solutions should 
be capable of removing denatured proteins that are deposited on the lens materials.  
 
Chapter 8 determined the influence of protein deposits on contact lenses on the 
adhesion of Gram positive and Gram negative bacteria. These results suggest that 
different tear proteins have varying effects on the adhesion of bacteria to contact lens 
materials. Lysozyme deposits on contact lenses increase the adhesion of Gram positive 
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Staphyloccocus aureus 31 strain, while albumin deposits increase the adhesion of both 
the Gram positive Staphyloccocus aureus and Gram negative Pseudomonas aeruginosa 
6206 & 6294 strains. Lactoferrin deposits increase the total counts of both the Gram 
positive and Gram negative strains, while they reduce the viable counts of the Gram 
negative strains. These results indicate that lysozyme and albumin do not possess 
antibacterial activity against all the three tested strains, while lactoferrin has an 
antibacterial effect against the Gram negative strains tested in this study.  
 
This thesis has provided hitherto unavailable information on contact lens 
deposition and its influence on subjective symptoms and bacterial binding. These results 
suggest that protein deposition has a significant potential to cause problems. Therefore, it 
is important that practitioners advise their patients regarding the importance of lens 
disinfection and cleaning and appropriate lens replacement schedules. These results will 
also be useful for the contact lens industry and the general field of biomaterials research. 
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10 Future work 
This chapter recommends a list of projects that can be conducted as a continuation 
of this research work, which would be a valuable addition to the literature and would help 
in the development of safer and more comfortable contact lenses. Some of these include: 
 
Quantifying other major proteins deposited on contact lenses: 
Using a proteomic technique, 97 proteins have been identified in the tear film. 1 
Many of these proteins are known to sorb onto contact lens materials, 2, 3 and lysozyme, 
lipocalin, lactoferrin, lacritin, proline-rich 4 and Ig alpha have been identified as the 
frequently recognized tear proteins on contact lenses. This thesis has studied lysozyme 
deposition on conventional and silicone hydrogel contact lens materials. Another recent 
study from our group has determined the kinetics of lactoferrin deposition on contact lens 
materials. 4 It will be of interest to quantify the other frequently recognized tear proteins 
found on novel silicone hydrogel contact lens materials. 
 
Competitive interaction of proteins and other tear components:  
An important factor to consider in the process of deposition relates to whether 
other substances from the tear film (for example, mucins, lipids or other proteins) 
concurrently deposit onto the material surface at different rates. It would be of interest to 
investigate the kinetics of deposition using a complex artificial tear solution consisting of 




Relationship between lysozyme activity and symptoms in silicone hydrogel lens wearers: 
Chapter 7 of this thesis has demonstrated that even over a short period of wear, a 
significant correlation exists between subjective symptoms of comfort & dryness and the 
activity of lysozyme recovered from etafilcon contact lenses, with little correlation being 
shown with total amounts of either total protein or total lysozyme. Further work is 
required to determine if this important clinical finding is transferable to those patients 
who use silicone hydrogel contact lens materials. 
 
Determination of active lysozyme recovered from tears: 
This thesis determined the activity of lysozyme deposited on various conventional 
and silicone hydrogel contact lenses. It will be of interest to determine the activity of 
lysozyme that is present in tears and investigate if there are any differences in the activity 
of lysozyme in tears of contact lens wearers and non-contact lens wearers. Further, it 
would be worthwhile to determine if these differences exist after overnight wear of 
contact lenses. It would also be of interest to determine if there is a difference in the 
activity of lysozyme recovered from the tears of symptomatic versus asymptomatic 
contact lens wearers and dry eyed versus non-dry eyed individuals. 
 
Determination of the activity of lactoferrin deposited on contact lenses: 
Our group has recently reported on the kinetics of lactoferrin deposition on 
conventional and silicone hydrogel contact lenses using an in vitro model. 4 It would be 
worthwhile to determine the activity of lactoferrin deposited on conventional and silicone 
hydrogel contact lens materials. In addition to investigating the activity of lactoferrin 
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deposited on contact lenses, it would be of clinical relevance to determine the kinetics of 
lactoferrin denaturation, how they relate to the wearing period, and also the influence of 
various care regimens on denaturation.  
 
Effect of individual tear proteins on the wettability of contact lenses: 
Chapter 8 of this thesis has speculated that certain tear proteins like lysozyme, 
lactoferrin and albumin once deposited on the contact lenses, will alter the wettability of 
the lenses. Our group recently reported on the effect of in vitro lipid doping on contact 
lens wettability using a sessile drop contact angle method. 5 It would be of interest to 
determine the impact of the major tear proteins on the wettability of conventional and 
silicone hydrogel contact lens materials. 
 
Impact of care regimen on bacterial adhesion to contact lenses: 
 Chapter 8 of this thesis investigated the adhesion of three bacterial strains. It will 
be interest to investigate the adhesion of more bacterial strains that are involved in the 
pathogenesis of contact lens-related infections. Furthermore, it will be of significant 
clinical relevance to evaluate the impact of various care regimens and the impact of “rub 
and rinse” steps on bacterial adhesion to contact lenses. 
 
 Development of antibacterial lenses with lactoferrin coating: 
Chapter 8 of this thesis has demonstrated that lactoferrin-coating on contact lenses 
has the ability to reduce the viability of certain Gram negative strains of bacteria and that 
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it may be worthwhile to develop antibacterial contact lenses with some form of 
lactoferrin coating, which might potentially reduce the risk of corneal infection. 
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Efficacy of an extraction solvent used to quantify lysozyme  
and albumin deposition on conventional and silicone hydrogel  
contact lens materials 
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materials. Eye Contact Lens. 2007; 33(4):169-73. 
 
(2) Lakshman N Subbaraman, Mary-Ann Glasier, Heather Sheardown and Lyndon Jones. 
Efficacy of an extraction solvent used to quantify albumin deposition on hydrogel contact 
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Abstract 
Purpose: Extracting proteins from conventional hydrogel (CH) and silicone hydrogel 
(SH) lens materials using a mixture of trifluoroacetic acid/ acetonitrile (TFA/ACN) is a 
well established procedure for quantifying individual and total protein deposited on 
contact lenses. The purpose of this study was to determine the efficiency of TFA/ACN in 
extracting lysozyme and albumin from SH and a CH group IV lens material using an in 
vitro model. 
 
Methods: One CH (etafilcon A) and four SH (lotrafilcon A, lotrafilcon B, balafilcon A 
and galyfilcon A) lens materials were incubated in both simple lysozyme solution and a 
complex Artificial Tear Solution (ATS) consisting of multiple tear components 
containing 125I-labeled lysozyme. All the SH lenses were incubated in the lysozyme 
solution for 28 days, while etafilcon lenses were incubated for 7 days at 37o C with 
constant rotation. The CH group IV lens material and four different SH lens materials 
were incubated in both simple albumin solution and an artificial tear protein solution 
containing 125I-labeled albumin. All the lens materials were incubated in the albumin 
solution for 14 days. Following the incubation period, radioactive counts on the lenses 
were determined and the lenses were placed in an appropriate volume of the buffer for 24 
hours in darkness. The lenses were removed from the buffer and radioactive counts were 




Results: Extraction efficiencies for lysozyme from the ATS solution were 97.2%±1.2 for 
etafilcon A, 64.3%±6.2 for lotrafilcon A, 62.5%±5.6 for lotrafilcon B, 53.5%±5.8 for 
balafilcon A, and 89.2%±3.4 for galyfilcon A. Results were similar for the lysozyme 
extracted after incubating in the simple lysozyme solution.    
Extraction efficiencies for albumin from the ATS solution were 97.2%±2 for 
etafilcon A, 77.3%±6.2 for lotrafilcon A, 73.5%±5.6 for lotrafilcon B, 81.5%±5.8 for 
balafilcon, and 91.2%±3.4 for galyfilcon A. Results were similar for the albumin 
extracted after incubating in the simple albumin solution.   
 
Conclusion: TFA/ACN is extremely efficient at extracting lysozyme and albumin 
deposited on etafilcon lenses. However, it does not extract all the lysozyme/ albumin that 
is deposited on SH lenses and alternative extraction procedures should be sought.  
 
Key words: contact lens; extraction; lysozyme; 125I-labeled lysozyme; 125I-labeled 
albumin; tear protein.  
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Introduction 
Contact lenses suffer from the same problems of deposition that other 
biomaterials exhibit when in contact with a biological fluid, being rapidly coated with a 
variety of proteins, lipids and mucins from the tear film, in addition to several other 
substances. 1-8 Of all these deposit types, protein deposits have attracted the greatest 
degree of attention. Several microscopic, photometric and imaging techniques have been 
used to investigate deposits on contact lenses. 4, 9-16 The major limitation of microscopic 
and imaging techniques is that they are generally not suitable for accurate quantification 
purposes. 8 Therefore, various biochemical assays 6, 9, 17-19 have been developed and are 
typically employed because of their increased sensitivity, accuracy and ability to target 
specific proteins. In order to accurately perform these assays, it is critical that all the 
deposited proteins are extracted from the lens materials, because accurate quantification 
of the protein deposited on a surface requires that all - or at least a known percentage - of 
the protein of interest be removed. To-date, elution of proteins from the contact lens 
surface remains the best option to quantify specific proteins deposited on the surface of 
contact lenses. 5, 9, 18, 20, 21 Hence, the ability of an extraction buffer to maximally extract 
proteins for analysis is a point of major interest.  
 
The most common method for protein extraction involves the use of a 
combination of detergents and reducing agents to break chemical bonds between the 
sorbed proteins and the contact lens surface. Some of the agents that have been 
incorporated in elution mixtures include sodium dodecyl sulphate (SDS), dithiothreitol 
(DTT), urea, NaOH, ethylene diamine tetraacetic acid (EDTA) and Tris-HCL. 4, 6, 9, 18, 21-
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29 One of the significant earlier works on deposit removal was conducted by Wedler 28 
using various chemical reagents including urea, guanidine hydrochloride, potassium 
thiocyanate, potassium perchlorate, hydroxylamine, EDTA, SDS and DTT. It was found 
that the deposits were most effectively removed from the lenses by using a combination 
of heat, SDS detergent and DTT. Many other researchers have subsequently used these 
techniques, in particular those that are based upon SDS. 4, 9, 18, 22-27 In addition to chemical 
“mixtures” to extract proteins, heat and sonication have been utilized to increase the 
efficiency of protein extraction, theoretically by agitating the biomaterial in the extraction 
solution and helping to break apart the bonds. 16, 30 However, Yan and colleagues 
suggested that these common extraction procedures may fail to remove even 75% of the 
total material on the lenses. 26 
 
Keith and co-workers developed a quick, simple and efficient extraction 
technique 31 using an extraction solvent consisting of a 50:50 mix of trifluoroacetic acid 
and acetonitrile (TFA/ ACN). Using this method, the extraction efficiency for lysozyme 
from laboratory deposited FDA group IV lenses was found to be close to 100%. Similar 
extraction procedures have been adopted by many other researchers since then. 32-37 
However, the efficacy of this technique in extracting lysozyme and albumin from silicone 
hydrogel (SH) lens materials has not been reported. Thus, the purpose of this study was 
to quantify the percentage of lysozyme and albumin extracted by TFA/ ACN from SH 
and etafilcon lens materials by artificially incubating lenses in 125I-labeled lysozyme and 
125I-labeled albumin. 
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Materials and Methods 
Reagents and materials 
Lysozyme and albumin were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). The lenses that were used in the study included four types of SH lenses and one 
type of conventional hydrogel (CH) lens. The SH lenses examined were  Night & Day™  
(CIBA Vision, Duluth, GA, USA), O2Optix™ (CIBA Vision, Duluth, GA, USA), 
PureVision™ (Bausch & Lomb, Rochester, NY, USA), Acuvue® Advance™ (Vistakon, 
Johnson & Johnson, Jacksonville, FL, USA) and Acuvue® 2 (Vistakon, Johnson & 
Johnson, Jacksonville, FL, USA). The properties of these lens materials are described in 
Table A.1. Sterile, 5ml non-pyrogenic, polypropylene round bottom tubes were 
purchased from Falcon (Franklin Lanes, NJ, USA). All other reagents purchased were of 













Table A-1: Silicone hydrogel lens materials and the conventional hydrogel lens 
material evaluated in the study. 
 




Advance™ Acuvue® 2 
USAN Lotrafilcon A Lotrafilcon B Balafilcon A Galyfilcon A 
Etafilcon 
A 





Water content (%) 24 33 36 47 58 
Centre thickness 
(mm) -3.00D 0.08 0.08 0.09 0.07 0.07 
Oxygen 
Transmissibility 
(Dk/t) at 35˚C 
175 138 101 86 21 









































DMA (N,N-dimethylacrylamide); EGDMA (ethyleneglycol dimethacrylate); HEMA 
(poly-2-hydroxyethyl methacrylate); mPDMS (monofunctional polydimethylsiloxane); 
NVP (N-vinyl pyrrolidone); TPVC (tris-(trimethylsiloxysilyl) propylvinyl carbamate); 
TRIS (trimethylsiloxy silane); NVA (N-vinyl amino acid); PBVC (poly[dimethysiloxy] 








Preparation of the doping solution 
(a) Lysozyme solution 
The concentrations of various tear components in the artificial tear solution (ATS) 
are described in Table A.2, along with a description of the concentration of various ATS 
components from previous in vitro doping experiments, for comparative purposes. 38, 39 
The simple lysozyme doping solution was prepared at a concentration of 1.9 mg/ml, 
using Phosphate Buffered Saline (PBS) at a pH 7.4. Lysozyme was labeled with 125I 
using the Iodine mono-chloride (ICl) method. 40-42 125I-labeled lysozyme was used as the 
isotopic tracer to quantify protein adsorption to the contact lenses. Radiolabeled 
lysozyme was dialyzed extensively against PBS to remove free iodide and the percentage 
of free iodide was determined based on the precipitation of protein with trichloroacetic 
acid and the radioactivity of the supernatant. In all cases, the samples which had free 
iodide of less than 1% were used in the study. 125I-labeled lysozyme was added to 
unlabeled solution such that the samples had a counting rate of 105 disintegrations per 
minute/ml (DPM/ml).  
 
(b) Albumin solution 
The simple albumin doping solution was prepared at a concentration of 0.2 
mg/ml, using Phosphate Buffered Saline (PBS) at a pH 7.4. A complex tear protein 
solution was prepared as given in Table A.2. Albumin was labeled with 125I using the 
Iodine mono-chloride (ICl) method. 40-44 Free iodide was removed from the radiolabeled 
albumin by extensive dialysis against PBS and the percentage of free iodide was 
determined based on the precipitation of protein with trichloroacetic acid and the 
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radioactivity of the supernatant. 43, 44 In all cases, the samples which had free iodide of 
less than 1% were used in the study.  
 
Table A-2: Table comparing the concentration of various tear components in 
artificial tear solutions for previous in vitro experiments and in the current study. 
Component Mirejovsky, et al (mg/ml) Prager, et al (mg/ml) 
Current study 
(mg/ml) 
Lysozyme 1.9 1.9  1.9 
Lactoferrin 1.8 1.8  1.8 
α Acid Glycoprotein 0.5 0.5  - 
Albumin 0.2 0.2  0.2 
Mucin 0.15 0.15  0.15 
γ Globulins 0.1 0.1  - 
Cholesteryl linoleate 0.024 0.0262  0.075 
Linalyl acetate 0.02 - - 
Triolein 0.016 0.0035  0.016 
Oleic acid propyl ester 0.012 0.0311  - 
Oleic acid methyl ester - - 0.024 
Dicaproin 0.0032 - - 
Undecylenic acid, 
sodium salt 0.003 - - 
Dioleoyl - 0.0142  - 
Oleic acid - 0.0018 0.008 
Cholesterol 0.0016 0.0016  0.056 
Sodium Chloride 6.626 - 6.63 
Potassium Chloride 1.716 - 1.72 
Sodium Bicarbonate 1.376 - 1.68 
Lactic acid 0.27 - - 
Calcium chloride, 
dihydrate 0.147 - 0.147 
Sodium dihydrogen 




acid @ 4.18 mg/ml 
Hank’s Balanced 









Incubating lenses in the tear solutions  
Lenses were removed from their packaging and thoroughly rinsed with PBS to 
ensure that no packaging solution remained on the lens surface and interfered with the 
deposition process. Five lenses from each lens type were then placed in 1ml of the 
labeled ATS and labeled simple lysozyme/albumin solutions and were allowed to 
incubate at a temperature of 37°C with constant rotation. SH lenses were incubated in the 
lysozyme solution for 28 days, while etafilcon lenses were incubated for 7 days. All the 
lens materials were incubated in the albumin solution for 14 days. Previous data from our 
laboratory showed that etafilcon lenses accumulate enough quantity of lysozyme in a 
shorter period of time than the SH lenses, 45 so etafilcon lenses were incubated in the 
lysozyme solutions for a shorter span. The labeled ATS and lysozyme/albumin solutions 
were replaced once every seven days with a protein-doping solution at an identical 
volume and radioactivity. The labeled ATS and lysozyme/albumin solutions were 
replaced once after seven days, with a protein-doping solution at an identical volume and 
radioactivity. 
  
Following the specified days of incubation, the lenses were aseptically removed 
from the labeled solutions using forceps and were rinsed briefly in saline to remove 
unbound protein from the lens surface. The lenses were then placed in sterile 5ml (12 X 
75 mm), non-pyrogenic, polypropylene round bottom tubes and subsequently radioactive 
counts were determined in a Gamma Counter (Perkin Elmer Wallac Wizard 1470 
Automatic Gamma Counter, Wellesley, MA, USA). This count gave the total quantity of 
labeled lysozyme/albumin that was deposited on the lens (Total DPM). 
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Extraction of lysozyme/ albumin from contact lenses 
The lenses were then placed in individual glass vials containing the extraction 
solvent under test (TFA/ACN). The lenses were incubated in the extraction solvent in 
darkness at room temperature for 24 hours. Following this, the lenses were carefully 
removed from the vials and were placed in the sterile, 5ml (12 X 75 mm), non-pyrogenic, 
polypropylene round bottom tubes and radioactive counts were determined again on the 
lenses using a Gamma Counter. This count gave the total quantity of labeled lysozyme/ 
albumin that remained on the lenses following its extraction (Lens DPM). In addition to 
measuring the Lens DPM, radioactive counts were determined from the extraction buffer 
(Extract DPM), to ensure consistency of the results obtained.  
 
The percentage of lysozyme/albumin extracted from the lens was calculated by 
the formula, 
% lysozyme/ albumin extracted = (Total DPM – Lens DPM)/ Total DPM X 100 
 
Data Analysis 
Statistical analysis was conducted using Statistica 7 software (StatSoft Inc, OK, 
USA). All data are reported as mean ± SD. An Analysis of Variance was performed on 
all the data and post-hoc testing was undertaken using the Tukey-HSD test to determine 




Extraction efficiency for lysozyme 
The extraction efficiencies for different lens types incubated in ATS and simple 
lysozyme solution using the TFA/ACN extraction buffer are reported in Table A.3. 
 
Table A-3: Percentage of lysozyme extracted by TFA/ACN. 
Table representing the percentage of lysozyme extracted from different lens materials 
using the 0.2% trifluoroacetic acid and acetonitrile extraction solvent when the lenses 
were incubated in the two tear solutions. 
 
Lens Type 
Percentage extracted in 
complex artificial tear 
solution 
Percentage extracted in 
simple lysozyme solution 
Etafilcon A 97.2 ± 1.2 99.3 ± 1.0 
Lotrafilcon A 64.3 ± 6.2 66.3 ± 5.2 
Lotrafilcon B 62.5 ± 5.6 64.4 ± 6.7 
Balafilcon A 53.5 ± 5.8 56.7 ± 3.8 
Galyfilcon A 89.2 ± 3.4 91.4 ± 1.4 
 
 
The statistically significant differences between various lens materials for 
extraction efficiency using the extraction buffer are shown in Table A.4. There were no 
significant differences between the extraction efficiencies when the lenses were incubated 
in ATS and simple lysozyme solution (p=0.74).  
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Table A-4: Significant differences seen between different lens materials for lysozyme 
extraction efficiency.  
Table shows the significant differences seen between different lens materials for 
extraction efficiency using 0.2% trifluoroacetic acid and acetonitrile extraction solvent. 
 
Lens Types p 
Etafilcon versus all SH lens materials <0.01 
Galyfilcon versus other SH lens materials <0.01 
Balafilcon versus Lotrafilcon A  <0.05 
Balafilcon versus Lotrafilcon B <0.05 
Lotrafilcon A versus Lotrafilcon B 0.63 
 
 
Extraction efficiency for albumin 
The extraction efficiencies for different lens types incubated in ATS and simple 
albumin solution using the TFA/ACN extraction solvent are reported in Table A.5. 
Table A-5: Percentage of albumin extracted by TFA/ACN. 
Table representing the percentage of albumin extracted from different lens materials 
using the 0.2% trifluoroacetic acid and acetonitrile extraction solvent when the lenses 
were incubated in two artificial tear solutions. 
 
Lens Type % extracted in complex artificial tear protein solution 
% extracted in simple 
albumin solution 
Etafilcon A 97.2 ± 2.0 97.3 ± 2.0 
Lotrafilcon A 77.3 ± 6.2 80.3 ± 7.2 
Lotrafilcon B 73.5 ± 5.6 72.4 ± 6.7 
Balafilcon A 81.5 ± 5.8 80.7 ± 3.8 
Galyfilcon A 91.2 ± 3.4 92.2 ± 3.4 
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The statistically significant differences between various lens materials for 
extraction efficiency using the extraction solvent are shown in Table A.6. There were no 
significant differences between the extraction efficiencies when the lenses were incubated 
in ATS and simple albumin solution (p=0.67).  
 
Table A-6: Significant differences seen between different lens materials for albumin 
extraction efficiency. 
Table shows the significant differences seen between different lens materials for 
extraction efficiency using 0.2% trifluoroacetic acid and acetonitrile extraction solvent. 
 
Lens Types p 
Etafilcon A versus all SH lens materials <0.05 
Galyfilcon A versus other SH lens materials <0.05 
Lotrafilcon A versus lotrafilcon B 0.32 
Lotrafilcon A versus balafilcon A 0.68 




Extraction of proteins from FDA group IV hydrogel lenses using 0.2% TFA/ACN 
is a commonly reported technique 31-33, 38, 46 and this buffer has previously been used for 
extraction of protein deposits from SH materials. 32, 34-37 Only one previous study has 
discussed the efficacy of removing lysozyme using this acid-based extraction technique 
on SH materials, 36 and this study compared the acid-based method to one based on SDS, 
and showed it to be a superior method.  
 
When looking at the efficacy of an extraction solvent, some form of technique to 
accurately determine protein deposition on the biomaterial of interest is required. 
Previous researchers have utilized the UV spectrophotometer to assess extraction 
efficiency. 36, 47 However, many modern materials incorporate a UV blocking agent, 
negating the use of such a methodology. In addition, UV spectrophotometry is a 
relatively insensitive technique, and such a method would be too insensitive for analyzing 
SH materials, due to the extremely low levels of lysozyme or albumin deposited on these 
materials. 32, 34-36, 45 One method which is very sensitive at detecting very low quantities 
of lysozyme or albumin deposited on hydrogel materials is that based upon protein 
radiolabeling. 1, 19, 30, 40, 45, 48 The isotope 125I has been extensively used to radioactively 
label lysozyme and other proteins in previous studies. 1, 19, 30, 40, 48 The isotope is 




This unique study specifically investigated the efficacy of the TFA/ACN 
technique for removing protein from a FDA group IV material (etafilcon A) and four 
types of novel SH lens materials (lotrafilcon A, lotrafilcon B, balafilcon A and galyfilcon 
A) using an in vitro deposition model based on radiolabeled lysozyme or albumin. This 
radiolabel technique is sensitive enough to thoroughly investigate the extraction 
efficiency from SH lens materials, which deposit very low quantities of lysozyme/ 
albumin and could not easily be examined using any other technique.  
 
Tables A3, A4, A5 and A6 clearly show that the method developed by Keith and 
colleagues based upon TFA/ACN is almost 100% efficient at removing lysozyme or 
albumin from artificially spoiled etafilcon lenses, which is consistent with previous work. 
31 The possible mechanisms for protein removal by this solution could be partly attributed 
to an ion exchange interaction between the solution, protein and lens. 31 As the solution is 
acidic, protons from the solution interact with the negative sites on the lenses. This can 
occur as an ionic interaction at an open negative site or as an exchange at an existing 
ionic bond between protein and lens. 49  In addition, this solution has strong solvation 
properties for proteins, in that it has ionic, aqueous and organic properties. 31 Thus, these 
two combined properties of this solution provide a means of effectively extracting the 
protein from the lenses and readily solubilizes and maintains it in the solution. 31, 49 
 
However, examination of Tables A3, A4, A5 and A6 clearly demonstrate that the 
efficacy of this method in extracting lysozyme or albumin from SH lens materials is 
lower. Although the current method could extract approximately 90% of the lysozyme or 
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albumin deposited on artificially spoiled galyfilcon lenses, it was not as efficient at 
extracting lysozyme/albumin from the other three SH lens materials under test. The 
possible reason for this reduced extraction efficiency from these three lens types could be 
due to the surface modification process that is involved with these lens materials. The 
surfaces of the lotrafilcon A and lotrafilcon B lenses are permanently modified in a gas 
plasma reactive chamber 50, 51 while the balafilcon lenses are surface treated in a gas 
plasma reactive chamber, which transforms the silicone components on the surface of the 
lenses into hydrophilic silicate compounds. 50, 52 No surface treatment is required for 
etafilcon and galyfilcon lenses. It is possible that these surface modification processes in 
lotrafilcon A, lotrafilcon B and balafilcon lens types could interfere with the buffer’s 
ability to break the bonds between deposited lysozyme/albumin and the lens surface 
resulting in decreased extraction from these two lens materials. A further explanation 
could be that once proteins deposit onto these relatively hydrophobic substrates that the 
protein deposited is more denatured than that found on more hydrophilic surfaces and 
thus more difficult to remove easily.  
 
It is a well established fact that protein deposition is affected by the water content, 
hydrophobicity, charge, pore size and surface roughness of the lens material. 1, 2, 4, 6, 13, 31, 
53-64 However, it is not known if these factors affect lysozyme or albumin removal or if 
the extraction buffers are strong enough to overcome these effects. The ability of the 
components of an extraction buffer to break chemical bonds and encapsulate proteins for 
removal from the contact lens surface is determined by the extraction efficiency. Each 
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type of protein deposited on a material may have a different set of bonds and steric 
constraints, allowing it to remain on the surface.  
 
It is clear that SH lenses deposit significantly lower amounts of lysozyme or 
albumin compared to traditional hydrogel lens materials. To overcome this issue of 
inefficiency, a new buffer has to be developed which has the capability to remove a 
greater percentage of the deposited protein. Ideally, such a buffer should have a minimal 
effect on protein conformation and be compatible with current and future methodologies 
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